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Pref 1: cc 
the S%nthcas Of hcterocsclie compounds has always drawn the attention of researchers over the 
,,I:, ln,11rnl\ bcclal e ilice compounds have played vital roles in biological processes 
W,chenlicms. pharmaceuticals and also in human life. Therefore, the development of simple, 
facile, efficient and en' 1ronmentally benign chemical processes or methodologies to synthesize 
novel heterocycles and their derivatives is one of the major aspects in organic synthesis. 
The work embodied in this thesis entitled "Studies in Chemistry of Oxygen and Nitrogen 
heteroc' cle." deals s% itli the design and development of simple and efficient protocol to synthesize 
new biologically important heteroc\ dlie dens ativ es from cheap and readily available starting 
materials such as 4-h\droxvCoutuarin. ? t or;vlchrouioac. 	cltlo:o--tnethvl-l-phenylpyrazole 4- 
e irhoxaldeh\de and t-norm\ 1indole. To discuss systematically, thesis is divided into five chapters, 
ssiu:h are as follciw : 
Chapter I 
N raiolcs. I'cridine\. (uulnarir,. Chrontones and lndolcs are well known nitrogen and oxygen 
heterocv'clic compounds which are employed as important skeletons in organic synthesis, 
medicinal chemistry and pharmacology. Therefore, various applications associated with these 
molecules motivated Its to ;elect them as potential candidates for the synthesis of novel 
heterocycles. This chapter contains scope of present work and depicts a comprehensive survey of 
literature on the synthesis and reactions of starting materials namely, 4-hydrosycoumarin, 3- 
forme lchroinone, 5-chloro- 3-methyl- I -pnenylpvrazole--4-carboxaldeltvdc, 3-formylindole, which 
were taken throughout the thesis and for their applications in the synthesis of different five and six 
membered heterocycles such as !3-enaminones, pyrazoles, pyridines, dicoumarols, chromanones, 
indolvI chalcone. indolvl pvrazolincs etc. 
Chapter 2 
(t-Enaminones are important synthetic intermediates for the synthesis of various biologically active 
heterocyclic compounds due to presence of an coin group linked through a C-C to a carbonyl 
groiry. Thus, due to their in 	in pharmaceuticals and in organic synthesis as intermediates, 
in this section, we have described a simpler and clean method for the synthesis of heterocyclic (3- 
enammones (176a-d) by condensation of heterocyclic methyl ketones (174a-d) with DMF-DMA 
(175) by thermal heating under solvent- and catalyst-free condition at lower temperature in 
excellent yields. Attempts were made to synthesize pyrazole (178a-h) and pyrnnyl pyridine 
derivatives (ISOa-h) by the reaction of~3-enaminone (176a) with different hydrazines (177a-b) and 
active methylene compounds (179a-h) respectively under thermal solvent-free condition in the 
presence of NaH504-SiO_, As expected reactions proceeded efficiently and the desired products 
were obtained in excellent yields. The catalytic system, NaHSO4-SiOo and products were 
characterized by powder XRD, SEM and EDX and spectral analysis respectively. 
Chapter 3 
Dicoumacul is a naturally occurring anticoagulant drag that functions as a vitamin K antagonist 
and possesses various other pharmacological activities such as insecticidal, anthelmintic, hypnotic, 
antifungal, phytoalexin, HIV protcases inhibition. antimicrobial and antioxidant etc. In clinical 
trials, such compounds have also demonstrated to have some activity against prostate cancer, 
malignant melanoma and metastatic renal cell carcinoma. Homogeneous catalysis play a key role 
in the development of greener, more sustainable chemical processes, and are powerful tools for the 
synthesis of fine chemicals, pharmaceuticals and materials.This chapter is divided into two 
sections and describes die synthesis of dicomnamis and 2-hydroxy-4-chmmanones in the presence 
of 7,n[(L)prolinc]'as an efficient, environmentally benign, water-tolerant, Lewis acid catalyst in 
green solvent. "water" as the reaction medium. 
Initially. attempt \\ cre made to synthesize dicoumarol derivatives ( 182a—j ) bV the reaction 
of 4-hydroxvcoumarin (29) with a variety of aromatic heteroaromatic aldehydes (181a—j) 
in the presence of 5 viol %Zn[(L)proline]2 in rellux water. The products were obtained in 
excellent yield in a short time period. In order to show the superiority of 
Zn[(L)proline],:water catalytic system, a model reaction of 4-hydroxycoumarin and 4- 
hydroxybenzaldehyde was carried out in different catalysts, solvents and with different 
amount of catalysts. And it was observed that Zn[(L)proline]2 exhibited the highest 
catalytic activity over other catalyst and water as the best solvent for the formation of 
dicoumarols in tcriiis of reduced reaction time and the maximum yield of the products. 
The catalyst was successfully recovered and recycled without significant loss in yield and 
selectivity. All the synthesized compounds were characterized by spectroscopic data. 
Further Zn[(L)prulinc]2 as explored for the synthesis of new series of chrumanaone derivatives 
(185a-j) by the reaction of 3-formylchromone (64) with various amines (183a-j) in refluxing 
\+ater. All the reactions were found to be completed within 10-15 min and afforded chromanone 
derivatives (185a-j) in excellent yields. The method was advantageous in terms of mild reaction 
conditions, use of water as solvent, cleaner reaction proliles, simplicity in operation, excellent 
yields of the products, faster reaction rates and reusability of the catalyst with no loss in its activity. 
CHAPTER 4 
Due to the widespread applications associated with pyrazole and their derivatives from 
pharmacological, agrochemicals and industrial point of view, this chapter is divided int two 
sections. Section A, deals with the synthesis of novel halopyrazole derivatives (187) and (189) in 
good yields by using 5-chloro-3-methyl-l-phcnylpyrazolc-4-carboxaldchyde (105) as starting 
material. The structures of the compounds isolated were characterized by elemental and spectral 
analysis. 
The infections caused by various microorganisms pose a serious challenge to the medical 
community and need for an effective therapy led to a search For novel antimicrobial agents. 
Therefore, all the newly synthesized compounds were evaluated for their in vitro antimicrobial 
activity against Streptococcus pvogenes, Methicillin resistant Staphylococcus aureus, 
Pseudomwms aeruginosa. Klebsiella pneumonia, Bacillus subrllis, Salmonella typhimurium and 
Escherichia colt bacterial strains and fungal cultures of Candida albicans, Aspergiffus fumigates, 
Aspergillus niger. 7'richoplzyto;i ureruagrophytes and Penicilfium marneffei by disk diffusion assay. 
The investigation of antibacterial and antifungal screening data revealed that all the tested 
compounds (187) and (189) showed moderate to good bactericidal and fungicidal activities. MIC 
of compounds was in the range of 12.5-59 sgimL. The MBC of compounds was found to be two 
or four folds higher than the corresponding MIC results. 
Chapter 5 
This section divided into two sections 
Microwave-assisted organic reaction enhancement is well-established technique for rapid and 
efficient synthesis of variety of heterocycles particularly from the viewpoint of green chemistry. In 
the microwave environment chemical reactions usually proceed faster and give higher yields with 
less by-products and allows fast optimization of chemical reactions compared In conventional 
heating. 
Chalcones (1,3-diaryl-2-propene-1-ones) are natural substances found in fruits, vegetables, 
spices, tea and soy based foodstuff and has been subject of great interest for possessing 
interesting pharmacological activities. On the other hand pyrazolino nucleus is a 
ubiquitous feature of various compounds possessing many pharmacological and 
physiological activities. 
Keeping in vie %% the potential biological activities of indole, chalcones and pyrazolines as well as 
the utilit\ of microwave irradiation in organic synthesis, this section of the chapter deals with the 
synthesis of indolyl chalcones (192a-c) and their substituted pyrazoline derivatives (193a-f) under 
microwave irradiation. As visualized, the reaction proceeded smoothly under solvent-free 
condition and the products were obtained in excellent yield in shorter time period. The work also 
describes the Superiority of green synthetic methods over conventional heating procedure. All the 
newly synthesized compounds were characterized by elemental and spectral analysis. 
In recent \ears. there is a considerable therapeutic interest in novel anti-Inflammatory drugs with a 
mode of action different from that of the classical acidic nonsteroidal anti-inflammatory drugs 
(NSAIDs). mainly for use in patients with arthritis of varying degree of severity. The classical 
NSAIDs do not prevent progression of such a disease and are subject to irritant side effects. The 
most prevalent side effect of the use of NSAIDs is the occurrence of gastrointestinal damage with 
gastric upset. bleeding. nephrotoxicity, intolerance and renal toxicity and irritation being the major 
problems. Therefore, the discovery of new and safer anti-inflammatory drugs represents a 
challenging goal for such a research area. A literature survey reveals that the compounds ith the 
backbone of chalcone and pvrazolines attached to an indole nucleus may show improved anti- 
inflammatory activity in carrageenan induced inflammation model. Thus, keeping this in view, in 
this section the present stud% 	as undertaken to investigate the anti-inflammatory activity of the 
synthesised compounds (indolvl chalcones and pyrazolines) (192a-c and 193a-f) in experimental 
models using carrageenan induced paw edema assay model of inflammation on Wistar rats, using 
aspirin as reference drug. 
Abbreviations and Symbols 
AcOI i Acetic acid 
Ac2O Acetic anhydride 
CAN Ceric ammonium nitrate 
CDC 1: Deuterated chloroform 
CI ICI; Chloroform 
C'H,C 1,  Dichloromethane 
l)BI 1 1,8-DiazabicycIo[5.4.0]undec-7-ene 
DMF N, N-Dimethylformamide 
DMF-DMA N, N-Dimethylformamide dimethyl acetal 
DMSO Dimethyl sulfoxide 
Equiv. Equivalent 
EtOH Ethanol 
h or hrs Hours 
H. 	 Hertz 
I 	 Iodine 
IR 	 Infra-red 
N1e 	 Methyl 
McOH Methanol 
mg Milligram 
nil. Millilitre 
mmol Millimole 
M.p. 	 Melting point 
NMR 	 Nuclear magnetic Resonance 
PEG 	 Poly ethylene glycol 
p-TSA 	 puru-Toluenesulfonic acid 
11 IF 	 Tetrahydrofuran 
MeCN 	 Acetonitrile 
DMS 	 Dimethyl sulfide 
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CHAPTER 1 
THEORETICAL 
1. REVIEW AND LITERATURE 
The structural diversity and biological importance of nitrogen and oxygen containing , 
heterocycles have always drawn the attention of researchers over the years. Their 
importances as precursors to many biologically active compounds have focused a 
tremendous amount of attention on developing methods to functionalise these systems. 
Synthetically produced heterocycles designed by organic chemists are used for instance as 
agrochemicals, pharmaceuticals and as additives with a variety of other functions which 
play an important role in human life.' The remarkable ability of heterocyclic nuclei to 
serve both as biornimetics and reactive pharmacophores has largely contributed to their 
unique value as traditional key elements of numerous drugs.` 
Due to the widespread interest in heterocycles. the design of novel methods to prepare the 
privileged heterocyclic medicinal scaffold has always been among the most important 
research areas in synthetic chemistry. Taking in view of the applicability of heterocyclic 
compounds the present work was under taken to synthesized novel heterocycles such as 
pyrazoles and pyridine, dicoumarol, chromanones, halopyrazoles, indolyl chalcones, 
indolvl pyrazolines from different nitrogen and oxygen heterocycles such as R- 
enarninones. 	4-hydroxvcoumarin. 	3-formylchromone. 	5-chloro-3-methyl- 1 - 
phem 1pvrazole-4-carboxaldehyde and 3-formylindole etc. Green chemistry aspect is used 
for the synthesis of these heterocyclic compounds. 
'l'herefore. intention of this chapter is to focus mainly on research work of the last ten 
years dealing with the starting materials used in the thesis. 
1 
2 	 3 	 4 
1.1. P-EnilII1lIlOIIes 
3-Enaminones are the chemical compounds that contain the conjugate system NC=C-C=O. 
From the structural point of view, enaminones are usually classified according to the 
degree of substitution on the nitrogen atom into primary (1°), secondary (2°) and tertiary 
(3") enaminones (Scheme 1). 
0 	 0 	 0 
R~" \% ~N}{,
R ~% 	, _R 	R=CH3 R  
1~ 	 ~1 
R R 
10 	 2° 	 30 
Scheme I 
Accordin~a to their carbon skeleton, enaminones are usually classified into acyclic 1, 
endocyclic 2. exocyclic 3 and heterocyclic 4 enaminones (Scheme 2). 
Scheme 2 
A literature survey reveals that enaminones are very stable compounds that combine the 
ambident nucleophilicity of enamines with the ambident cletrophilicity of enones and 
constitute a versatile class of useful precursors in organic synthesis, in pharmaceutical 
development and in heterocyclic synthesis.; Moreover, enaminones have been found to 
exhibit several biological activities as antitumor, antibacterial and anticonvulsant agents.4 
In the light of these facts a iv current examples on the application of enaminones for the 
synthesis of heterocyclic compounds are discussed below: 
K 
1.1.1. Sti vthesis of pyridines 
Kantevari et al developed one-pot, three-component condensation of (3-enaminones (5), ~3- 
dicarbonyl compounds (6) and ammonium acetate in the presence of a catalytic amount of 
K ;Co W 12040.3 H2O as catalyst under solvent-free conditions, as well as in refluxing 
isopropanol for the synthesis of trisubstituted pyridines (7) (Scheme 3). 
0 
0 
,CH3 
N _ 	KrCoWI2403H,I 
H~ 	Neat, 1 15°C 
CI 	/ 	 1H4OAc 
,Hc 
5 6 	 7 
Scheme 3 
1.1.2. Synthesis of dihydropyridines 
\I-.A~vadi et a16 reported the synthesis of dihydropyridines (11) by the reaction of f-
enaminones (8). aromatic aldehyde (9) and ammonium acetate or aromatic amine (10) 
in glacial acetic acid under reflux condition (Scheme 4). 
0 
	
Ar 	Ar 	AcOH. \111' 
t'41t) 	150°C 
8 	9 	10 
o 	Ar' 	o 
Ar 	I 	Ar 
Ar = C6Ht 
R 	Ar' = C1-l3, p-('l-Cl1, 
II 	R=H,C<,IIS 
Scheme 4 
3 
1.1.3. Reactions with amines 
(a) Synthesis of li-amino ketones 
V ishvakartna et al reported the KHSO4 assisted Michael addition elimination 
reaction of (3-enaminone (12) with different aromatic amines (13) in stirring water 
at 50 -- C to afford (3-amino ketones (14) (Scheme 5). 
O 	 ,H~ R 
O" 	1~ 
RHSO4/1T)O 
+ RNH, 
:\s• 	 \~1e, 50 GC 
:fir = CHc, 4-MeCF1 I;, 4-CIC6H4 	 R = Me, Et 
12 	13 14 
Scheme 5 
(b) Synthesis of pyrimidine derivatives 
Shawali et al' reported the reactions of the enaminone 15 with different heterocyclic 
amine such as 5-amino-l.2.4-triazole 16a, 5-amino-3-phenylpyrazole 16b and 2- 
aminobenzimidazole 16c, in acetic acid under retlux to yielded the respective fused 
pyrimidine derivatives 17a-c (Scheme 6). 
4 
Ph 
	
Ph~, 	\N / 
I~ 	~I 	EtOOC 
16 b H 
AcOl I. reflux 	N 
Ph N 
0 	1 C6H4C1-p 
FtOOC 	 "Me 
AcOH. N~Me 
ti 	 N 
Ph 	Nom. 
17 b 
16a 	~~
N 
	N 	15 
EtOOC 
Ph 	\' 
Ch114c1-/) 
17a 
NN 
EtOOC 
16cH2 
Ac011. ref lux 	~N 
Ph 	ti 
1 
C6H4CI-p 
17 c 
Scheme 6 
1.1.4. S1vzNtesis of tetraizydropyrimidine 
Al-Mousawi et a19 reported the Biginelli reaction of 18 with equimolecular amounts of 
benzaldehyde and urea in acetic acid to afford a 3:1 mixture of tetrahydropyrimidine 
19 and dih} dropvridine 20. which were readily separated by fractional crystallization 
(Scheme 7). 
0 
0 	0 
PhCHOIUrea I 	N 	 O 	Ph 
0 Me2N 	AcOH 	 NH,  o 
I 
H 
o 
INI 	
0 
H 
18 	 19 	 20 
Scheme 7 
1.1.5. S~•irthesis of pl'razoles 
A. P. Martins et al l " reported a series of NH-pyrazoles 23 by reaction of the enaminones 
21 \\ ith hvdrazine sulphate 22 on grinding in the presence of PTS. All the reactions 
proceeded smoothly at room temperature and the products were obtained in excellent 
yields in shorter time periods (Scheme 8). 
U 	 / 1 
Grinding, R T e Nay VMS. + N{I•T:H, H,SC)4 	- 	 H 
PTS 
21 	22 / 
23 
Scheme 8 
1.1.6. Reaction of enaminone with active methylene compounds 
Ilamad Al-Matar et al l I reported the reaction of enaminone 24 with malononitrile 25 and 
ethyl acetoacetate 26 in the presence of catalytic amount of chitosan in refluxing ethanol to 
afford 27 and 28 respectively (Scheme 9). 
CN 
NC 
~C 
2S 
R 	/ 	N\1e, Chitosan, Ethanol. rcFlux i 	/ 
2i 
O 
COV[iI 	 27 
R 
0 U 26 
11:C 	O 
R 
28 
R (111. Ph 
Scheme 9 
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1.2. 4-Hydroxy Coumarin 
29 
Coumarin and its derivatives are important core in building block of an ever growing 
number of natural and non-natural products which display an impressive array of 
biological activities including antimicrobial,' 	antioxidant,2 analgesic,3 anti- 
intlammatory,4 antithrombotic, anti-HIV,6 anti-viral,7 anticancer' antineoplastic9 etc. They 
are %vidclv used as additives in food. perfumes, agrochemicals, cosmetics, 
pharmaceuticals'" and in the preparations of insecticides, optical brightening agents, 
dispersed fluorescent and tunable dye lasers.' Coumarins are extremely variable in 
structure, due to the various types of substitutions in their basic structure, which influence 
their biological activity as well. Among the various substituted coumarins, 4- 
hydroxycoumarin represents a versatile scaffold and shows diversified chemical reactivity 
in organic as well as in heterocyclic chemistry due to the presence of OH group at position 
4 which gives nucleophilic character at position 3. It also acts as a cyclic (3-keto ester 
which can be used as a convenient three-carbon synthon in processes accompanied by 
recvclization of the chromene ring system.'2 The synthetic versatility of 4- 
hydroxvcoumarin has led to the extensive use of this compound in organic synthesis. Thus, 
0 
a literature survey of last ten years was done and some relevant reactions of 4- 
hvdrox vcoumarin are discussed below. 
1.2.1. Synthesis offurocoutnarins 
A facile synthesis of furo[3,2-c]coumarins (31) has been reported via cyclocondensation 
of 4-hydroxycoumarin (29), a-tosyloxyketones (30) and acetic acid/ N1_14OAc 	in 
rcfluxing absolute ethanol (Scheme 10).'' 
off 	 0 \ 
Ar 
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O 	0 	 0 	O 
29 30 (1382%) 	31 
Ar = Cba-1 5. 4-McC6H4, 4-OU1cC6H4. 4-CIC6H4. 4-E3rG6N4, 4-1(),C61 l,t, 4-FC'6114 
Scheme 10 
1.2.2. Reactions of 4-hydroxycoumarins with alkynes 
Jie \Va et al'4 reported the palladium-catalyzed direct coupling reactions of 4- 
hvdroxycoumarins (29) with various alkynes (32) in the presence of p-toluenesulfonyl 
chloride under copper-free conditions to affords 33 ( Scheme 11). 
R 
0i 	 I1 
!tPrh\Et, McCN 	/ Oóc=  ?SCI, 60 °C O  
29 	32 	 33 
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Scheme 11 
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1.2.3. Domino Knoevenagel Iretero-Diels Alder reactions 
J. S. Yadav and co-workers' ; described a novel protocol for the synthesis of sugar fused 
i'uro[ 3 2-b]pyrano[4,3 -dl pyrans (35) via domino Knoevenagel hetero-Diels--Alder 
reactions by the treatment of 4-hydroxycoumarin (29) with an O-prenyl derivative of a 
sugar aldehyde (34) in the presence of sodium acetate in acetic acid at 80 °C. This reaction 
is a highly stereoselective and proceeds via a tandem Knoevenagel and hetero-Diels—Alder 
pathway to afford product (35) in 82% yield (Scheme 12). 
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Scheme 12 
1.2.4. Synthesis of aminoalkyhnaphthols 
Multicomponent one-pot synthesis of aminoalkylnaphthols (36) and (37) is achieved by 
the reaction of (29). aromatic aldehydes and secondary amine (morpholine and 
dimethylamine respectively) in dichloromethane under catalyst-free conditions at room 
temperature. ' The reaction completes in 2 hrs and gives product in excellent yield 
(Scheme 13). 
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1.2.5. Synthesis of diliydropyrano/clehrofnrenes 
The reaction of (29), aromatic aldehydes (38) and malononitrile (25) in the presence of 
magnetic nano-organocatatyst in water under reflux condition17 affords 
dihydropyrano[c]chromenes derivatives (39) (Scheme 14). 
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Ar 
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Scheme 14 
1.2.6. Synthesis of tctrahyydrobenzoIcixanthenedione 
Xiao-Jun Sun et al'8 reported the one-pot condensation of 4-hydroxycoumarin (29), 
aromatic aldehydes (40), 5,5-dimethylcyclohexane-1,3-dione (41) and acetic acid in the 
presence of catalytic amount of iodine under microwave irradiation to give series of 
tetrahydrobenzo[c]xanthcne-1,1 1-dione derivatives (42) (Scheme 15). 
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Scheme 15 
1.2.7. Reaction of 4-Hydroxycoumarin with arylglyoxals 
N. N. Kolos' reported one-pot condensation of4-hydroxycoumarin (29) with arylglyoxals 
(43) and areas (44) to affords 4-aryl-5-(4-hydroxy-2-oxo-2H-clu•omcn-3-yl)-1H-imidazol-
2(3II)-ones (45) (Scheme 16). 
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Scheme 16 
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1.2.8. Synthesis of benzopyranopyrinridines via Biginelli reaction 
Kid\ ai et a12`' reported an environmentally benign method fbr the synthesis of 
benzopyranopyrimidines (48) via Biginelli reaction of 4-hydroxycoumarin (29), different 
aldehydes (46) and urea or thiourea (47) under microwave irradiation in excellent yields 
(Scheme 17). 
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48 
Scheme 17 
1.2.9. Synthesis o f 
A facile, one pot solvent- free condensation of 4-hydroxycoumarin (29) with active 
methylene esters (49) in refluxing pyridine give novel benzopyran derivatives (50). The 
reaction completed in I h and the product obtained in 88 % yield (Scheme 18).21 
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1.2.10. Synthesis of novel benzylarnino counrarin derivatives via Mannich type reaction 
Synthesis of benzylamino coumarin derivatives were reported by different researchers" 
under different conditions via Mannich type reaction. Rao et al reported a convenient and 
13 
practical method for the synthesis of u-benzylamino coumarin (53) in the presence of InCl3 
by the reaction of 4-hydroxycoutnarin (29), secondary amine (51) and aromatic aldehyde 
(52) in good yields. Kumar et al and Ghosh et ul.22 developed multicomponent green 
synthesis of benzylamino coumarin in the presence of non-ionic surfactant (Triton X- 100) 
and nano crystalline ZnO via a Mannich type reaction in aqueous media at room 
temperature (Scheme 19). 
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1.2.11. Synthesis of spire 2-nuttitto-3-cyanopyrano/3,2-cf chromette 
three component reaction employing 4-hydroxycoumarin (29), cyclic aliphatic ketones 
(55) and malononitrile (25) in boiling ethanol in the presence of morpholine (54) was 
reported by Yogesli T. Naliapara et al`' to affiord Spiro 2-amino-3-cyanopyrano[3,2- 
c]chromene derivatives (6(1). Initially, Knoevenagel reaction between cyclic ketones (55) 
and malononitrile (25) produces the unsaturated nitrile (56) which is followed by Michael 
reaction \ itli the base derived coumarin anion (57). The resulting Michael adduct (58) 
undergoes intramolecular cyclization producing the annelated iminopyran (59) which, 
undergoes a subsequent tautomeric [1,3]sigmatropic shift gives compound (60) (Scheme 
20). 
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It was found that with the substituted acetophenones (61), unsaturated nitriles (62) were 
Obtained rather than chromene derivatives (63) (Scheme 21). 
—R 
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Scheme 21 
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1.3. 3-Forrnvlchronione 
64 
Chromones constitute an important class of oxygen heterocycles and are widely distributed 
in plant lire, mostly as pigments in plant leaves, flowers, fruits, vegetables, nuts, seeds and 
barks.1-3 They are an integral part of the human diet and have been reported to exhibit a 
wide range of biological activvitics.4 ' Chromone is also part of pharmacophores of a large 
number of molecules of medicinal significance'`'" including anticancer agents such as 
psorospermin and pluramycin A. 
Chemistry of 3-formylchromone is arguably one of the most extensive and dynamic field 
of present-day chromone research. Since 1973 when first report on the synthesis of 3 
lonnvlchromonc was reported by the reaction of 2-hydroxyacetophenone under Vilsmeier 
Haack conditions (DMF-POCI3)15 it became a universal method and the potential of this 
compound in the construction of fused heterocyclic systems has attracted the attention of 
chemists world-wide. Thus, this part of the chapter covers the synthetic exploitation of 
nuelcophilic addition. cvcloaddition and other important reactions of 3-forniylchromone of 
the last ten years. 
18 
1.3.1. Synthesis of pyrazoles 
Trond Llven et al ly' reported the synthesis of pyrazole derivatives (66) by base-catalyzed 
condensation of 3-formylchromone (64) with arylhydrazines (65) in ethanolic KOH under 
microwave in-adiation. Further, alkylation of (66) with ethyl bromoacetate followed by 
alkaline 	hydrolysis 	with 	lithium 	hydroxide 	gave 	(2-(1 H-pyrazol-4- 
ylcarbonyl)phenoxy)acetic acids (68) as selective orally active CRTH2 antagonists for 
allergic inflammation treatment (Scheme 22). 
CHO 
/ 	I 	AOH• EtO 	\ 	y BrCIf1COOEt 	\ 	f 
UH '~ 	Acetone 	~ 0 N~ 
	
64 	 65  
Et000 67 
LiOH "I"HP, %cater 
N 
0 N~ 
ff 
L-1 WC 
68 
Scheme 22 
1.3.2. Reaction with binucleophiles 
An unexpected dithiazole derivative (71) in good yield has been reported by the reaction of 
3-formvlchromone (64) with 2-phenyl-4-dimethylatnino-l -thia-3-azabuta-1,3-diene (69) 
and thiobenzamide (70) as 1,3-NCS-binucleophiles in a sealed tube using toluene (5 mL) 
as the solvent at 120 °C (Scheme 23).17 
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1.3.3. Synthesis of 4-(2-hydroxybenzoy1)pyrro1es 
A novel synthesis of 4-(2-hydroxybenzoyl)pyrroles (73) is reported by the reaction of 
chromone-3-carboxaldehyde (64) and tosylmethylisocyanide (TOSMIC) (72) in the 
presence of DBU in THE at room temperature (Scheme 24).18 
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1.3.4. Slvtthe.~is of' :'s'ove! Chromone-Containing Peptidontitnetics 
Teimouri et al l s` developed an efficient and practical method for the diversity-oriented 
s,,lltlicsis of tripcptide chromone derivatives (77) via pseudo-five-component reaction 
between 3-fonnylchromone (64), meldrum acid (74), isocyanides (75) and primary 
aromatic amines (76) in dry CH2C12 at room temperature (Scheme 25). 
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The reaction may be rationalized by initial formation of conjugated electron-deficient 
heterodlene, by Knoevenagel condensation of the 3-formylchromonc (64) and meldrum 
acid (74), followed by [1-4} cycloaddition reaction with isocyanides to afford intermediate 
(78) which reacts with arylaininc followed by subsequent loss of acetone to give 
iminolactone (80). Finally. nucleophilic attack of the second molecule of arylamine to the 
activated carbonyl moiety of (80), yields final product (77) (Scheme 26). 
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1.3.5. Synthesis of Pyranodhroinene.s• and Pyruuothiazines 
Reaction of 3-fonnylchromone with 1,3-thiazines was reported by R. V. Shutov et al.2° 
Reaction of (64) with 2-phenyl-4-hydroxy-6H-1,3-thiazin-6-one (81) in THE in the 
presence of pyridine as a catalyst at 60 °C leads to formation of a mixture of novel N-
thiobenzovl-5-hydroxy-2-oxo-2H,5H-pvrano[3.2-c]-chromen-2-one-3-carboxamide (82), 
5-(4-oxo-4H-chromcn-3-yl)-2-phenyl-5,6-dihydro-4H,7H-pyrano[2,3-d}[ 1,33thiazine-4,7- 
dione (83) and (2E)-3-(4-oxo-4H-chroinen-3-yl)prop-2-enoic acid (89) (Scheme 27). 
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Because of the presence of two electrophilic sites on the chromone i.e. C-2 and CHO 
different types of products were formed. Initially, attack of the thiazine (81) at C-2 of the 
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Me_CO 
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chromone (64) results in the pyran ring-opening via 1,4-addition give intermediate (84) 
followed by the formation of (85) with further ring closure by way of the free formyl 
group. Addition of a water molecule allows enolization of the C-4 keto group to give (86) 
and subsequent cleavage of the thiazine ring form products (82). Alternatively, attack at 
the aldehyde group follows a Knoevenagel type reaction leading to ylidenothiazine 
(intermediate 87), which combines with a second molecule of (81) to form bis(thiazine- 5- 
yl)methane (88). Subsequent intramolecular cyclization and hydrolysis leads to 
pyranothiazinc (83). Fonnation of by product (89) occurs by direct hydrolysis of (87) 
(Scheme 28). 
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1.3.6. Diels Alder Reaction 
Perumal et al'' reported an aza Dicls—Alder reaction of 3-fonrsylcluomone (64), amines 
(90) and (91) for the synthesis of tetrahydroquinoline derivatives (92) mediated by CAN in 
an aqueous medium at room temperature stirring for 35-45 min which oxidized to the 
corresponding substituted quinolines (93) by reaction with 2.5 equiv of CAN in 
acetonitrile at 0 °C under \, atmosphere for 20 min (Scheme 29). 
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1.3.7. Synthesis of hydrovymethyl chromone 
Reduction of 3-formylchromone (64) in 2-propanol in the presence of basic alumina at 75 
°C was reported byAraya-\taturana et a122 to obtained 3-hydroxymethyl chromone (94) in 
good yield (61 `Yo) (Scheme 30). 
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1.3.8. Synthesis of hydroxymnethylphosphontate 
Shin-are and co-workers23 reported the synthesis of dialkyl-l-chromonyl-1 
hydroxyrnethylphosphonate (95) via Abramov reaction of 3-fonnyl chromone (64) and 
trialkylphosphite using TM Sc! under solvent-free microwave irradiation. The compound 
(95) was obtained in good yield within 5-6 min (Scheme 31). 
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1.3.9. Synthesis of 3-cyanochromones 
An efficient one step conversion of 3-formylchromone (64) into 3-cyanochromone (96) 
was reported by Reddy et a!24 on heating (64) with hydroxylamine hydrochloride 
(H,NOH.HC1) in refluxing acetonitrile in the presence of sodium iodide for 2 hrs (Scheme 
32). 
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1.3.10. Sl•nthesis of hydantoin derivatives 
Youssef' Lotfy Al? reported the condensation of 3-formylchromonc (64) with hydantoin 
(97) and 2-thiohydantoin (98) in acetic acid at reflux temperature in the presence of fused 
sodium acetate to afforded 5-chromonylidene-hydantoin and 2-thiohydantoin derivatives 
(99) and (100). Compound (100) undergoes Mannich reaction with formaldehyde and 
morpholine in methanol to give Mannich product (101) (Scheme 33). 
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1.3.11. Reactions with nucleophiles 
Knoevenagel reaction of 4-oxo-4H-benzopyran- 3-carbaldehyde (64) with 3-methyl-l-
phenyl-1H-pyrazol- -(4H)-one (102) was reported by Shingare et a126 in solid-state by 
grinding without solvent at room temperature. Reaction was completed within 2 min and 
product (103) was obtained in excellent yield (83 %) (Scheme 34). 
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They also reported the reaction of 3-formyl chromone (64) with meldrum acid (74) under 
microwave irradiation in the presence of acidic alumina27 or under grinding condition 
catalyzed by cellulose sulphuric acid28 to afford the product (104) in excellent yield 
(Scheme 35). 
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1.4. 5-Chloro-3-methy 1-1-phenyl-1H-pyyrazol-4-carboxaldehyde 
(105) 
Pyrazole derivatives are important nitrogen containing heterocyclic compounds and have 
attracted continued interest over the years due to use of this ring system as an important 
core structure in many drug substances, having a wide range of applications in 
pharmaceutical industry (e.g. Viagra,l Celebrex) as well as in the agrochemical field (e.g. 
Tebufenp)rad insecticide3).4 In recent years, 4-substituted pyrazole derivatives have been 
reported to show broad spectrum of biological activities such as herbicidal, antibacterial,6 
antioxidant, antiviral.' anti-HIV," anti-inflammatory and neuroprotcctive10 etc. In this 
regard 5-chloro-3-methyl- l-phenyl- I H-pyrazol-4-carboxaldehyde has been proved as a 
valuable synthon due to the presence of a halogen and aldehydic function in an ortho-
relationship for the synthesis of various heterocyclic compounds. This part of the chapter 
describes the synthesis, reactions and biological applications of -chloro-3-methyl-l-
phenyl-IH-pyrazol-4-carboxaldehyde from 2002 to the end of 2012. 
1.4.1. Nucleophilic substitution reactions with phenol and 2-itap/tthol 
Balakrishna Kalluraya and co-workers'' reported the nucleophilic substitution 
reaction of (105) with phenol (106a) and 2-naphthol (106b) in DMSO in the presence 
of potassium hydroxide at 60 °C to give substituted product (107) which undergoes 
Claisen-Schmidt condensation to give 1-substituted aryl-3-(5-aryloxy-3-methyl-1- 
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phenyl-1 H-pyrazol-4-yl)-2-propen- l -one (108). Further treatment of (108) with 
hydrazine hydrate in aceticipropionic acid at reflux temperature gave the 1- 
acetyl,rpropyl-3-aryl-5-(5-aryloxy-3-methyl-] -phenyl-1 H-pyrazol-4-yl)-2-pyrazolines 
(109) (Scheme 36). 
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1.4.2. Synthesis of'thiazolopyrimidine derivative 
The aldehyde (105) condenses with 2-amino-4-(3-coumarinyl)thiazole (110) in the 
presence of triethylarnine in DMF at reflux temperature for 48 hrs to afford 
thiazolopyrimidine derivative (111). 12 Compound (110) was obtained in good yield 
via Biginelli reaction of 3-acetylcoumarin (112) with thiourea and iodine (Scheme 37). 
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1.4.3. Synthesis of lleterou►u►ulated pyrido f l,?-bJf l,2,4/triazepine 
Magdy Ahmed Ibrahim et al l3 reported the synthesis of heteroannulated pyrido[1,2- 
b][l 2.4]triazepine (114) by the reaction of (105) with 1,6-diamninopyridone (113) in 
reflux ethanol containing few drops of acetic acid for 6 hrs. The synthesized compound 
was screened for their antimicrobial activity (Scheme 38). 
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Scheme 38 
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1.4.4. Synthesis of pyrimido thiazolo yuinoxaline 
b1.A. Gouda et al l ` synthesized pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivative 
(116) by the condensation of (105) with 2-aminopyrimido[2',1':2,3]thiazolo[4,5-b] 
quinoxaline-4-one (115) in glacial acetic acid. Reaction occurs at reflux temperature for 20 
h and the compound (116) was obtained in 76 % yield (Scheme 39). Compound 115 was 
obtained by refluxing a mixture of 2,3-dichloroquinoxaline (A) and 6-aminothiouracil (B) 
in DMF in the presence of catalytic amount of triethylamine. 
Clio 	 N 
\ \ Aao°C 	NII Ci N 
 H_N ~ ti 	S 	V  
CI 	N 
Ph 	I 	its 
105 Reilu41CHjc(0OR 	
li) 	 (A) 
N 	NSN  
nc ,. 
Scheme 39 
1.4.4. Si'jithesis of heterocyclic analogues ofxannthofie and xt1nthiOile 
Synthesis of lll-pyrano[2.3-c:6,5-c]dipyrazol-4(71-1)-ones (121a) and thiones (121b) were 
described by Barbara Datter and Wolfgang Holzer et al.1 ' Oxidation of 5-chloropyrazole-
4-carbaldehyde (105) with potassium permanganate furnished (117). Transformation of 
acid (117) with thionyl chloride in refluxing toluene afforded acid chloride (118). Reaction 
of (118) with I -substituted 2-pyrazolin-5-ones (119) in the presence of calcium hydroxide 
in refluxing 1,4-dioxane gave the corresponding 4-pyrazoloylpyrazol-5-ols (120), which 
0 	 0 
34 
were cyclized into ift-pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones (121 a) by treatment with 
K-)CO3 DMF. Compound (121a) was converted into the corresponding thiones (121b) 
upon reaction with Lawesson's reagent (Scheme 40). 
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1.4.5. Sj,nthesis gf'dihydropyritdnes 
Direct Hantzsch reaction of (105) with N-phenyl oxobutanamide (122) in the presence of 
ammonia in methanol-DMF under reflux condition for 7-10 hrs afforded dihydropyridine 
derivatives (123)1 `' (Scheme 41). 
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1.4.6. Synthesis of Schiff buses 
	
Knoevenagel condensation of (105) with ethylcyanoacetate 	at 0 °C results in the 
formation of ethyl-2-cyano-3-(5-chloro-3-methyl-l-phenyl-1H-pyrazole-4-yl)propionate, 
followed by the reaction with hydrazine hydrate at room temperature to give 5-amino-4- 
[(5-chloro- 3-methyl- I -phenyl- I H-pyrazol-4-yl)methylidine]-2,4-dihydro-31-l-pyrazo1-3- 
one (124). Further treatment of (124) with substituted benzldehyde (125) in the presence of 
a catalytic amount of acetic acid in ethanol at room temperature affords (126) (Scheme 
42),1- 
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1.4.7. Synthesis of dihydropyrirnidin-2(IH)-one via Biginelli reaction 
Synthesis of dihydropyrimidin-2(1H)-one derivatives (128) was achieved by the reaction 
of (105) with 13-keto ester or 13-diketone (127) and urea (or substituted urea) (47) in the 
presence of CuCl2iacetic acid, BF3.(OEt)2, in dry THE at reflux temperature in good yields 
(50-71 %) (Scheme 43).1 s' 
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1.4.8. Synthesis of pyrazolylquinolines 
A series of 4-pyrazolyl-N-arylquinoline-2,5-diones (130) has been synthesized by one pot 
cyclocondensation reaction of (105), meldrum acid (74) and 3-arylamino-5,5-disubstituted 
cyclohex-2-enones (129) in the presence of piperidine as basic catalyst in ethanol for 6 h l )` 
(Scheme 44). 
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1.4.9. Synthesis o f pyruzolopyrones 
A novel synthesis of pyrazolopyrones (133a), (133b) was achieved via Simonis 
condensation employing 105 and triacetic acid lactone (131) /4-hydroxycoumarin (132) in 
the presence of anhydrous sodium acetate in refluxing ethanol °` (Scheme 45). 
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They also reported the synthesis of pyrazolyl chalcones (135) and pyrazolines (136) from 
(105) and different heterocyclic active methyl compounds (134) (Scheme 46). 
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1.5. 	3-Formylindole 
CHO 
H 
137 
In the family of heterocyclic compounds, nitrogen containing heterocycles are important 
from medicinal chemistry point of view and also have contributed to the society from 
biological and industrial points and thus which helped to understand life processes.[ 
Among various nitrogen heterocycles, indole nucleus is one of the most ubiquitous 
scaffolds found in natural products, pharmaceuticals, functional materials, and 
agrochemicals -`1 Indole derivatives that occur in nature have occupied a unique place in 
the chemistry because of its varied biodynamic properties such as antimicrobial,' 
antidepressant,6 antihistamine.7 antidiabetic,8 anti-inflammatory,9 anthelmintic,10 
antiallergic,1I cardiovascular 2 and also play a vital role in the immune system. i3 The 
important 	known bioactive alkaloids having indole moiety include uleine, 
aspidospermidine, ibophyllidine, brevicolline which exhibit remarkable biological 
activities.14 An indole core is also central component of many drugs like Sumatriptan, 
Ondansetron which are used in the treatment of migraine, suppression of the nausea and 
vomiting, caused by cancer chemotherapy and radiotherapy," Indomethacin is used for 
the treatment of rheumatoid arthritis and LSD with high hallucinogenic activity.'6 
Therefore, the development of new strategies to synthesize indole derivatives have been 
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the focus of active research in the present days. Among the various indole derivatives 3- 
formyl indole is widely used as a starting material for the synthesis of biologically active 
compounds. A review of the literature about 3-formyl indole is described below: 
1.5.1. Sv,►thesis of symmetrical and ulzvyon»•tetricaI biv(iiidolyI)alkanes 
Bis(indalvl)alkanes and their derivatives constitute an important group of bioactive 
metabolites of terrestrial and marine origin. Various methods for the synthesis of 
kiis(indolyl)alkanes have been reported in the literature. Kumar et al l ' investigated the 
ternary reaction of indole-3-carboxaldehyde (137) and indoles (138) with allyl bromide in 
THE-water (2: 1) in a suspension of indium metal for the synthesis of symmetrical and 
unsymmetrical bis(indolyl) alkanes (139) in excellent yields (Scheme 47). 
THE
[n 
 li•0 2 I)  
R 	 , C. Stir 	 1f 	1  
137 	138 139 R 
R H. CH;  
(89-94 ) 
Scheme 47 
Further. In order to broaden the scope of this ternary reaction, the reactions of indole- 3- 
carboxaldehyde (137) and allyl bromide with other heterocyclic enamines such as 3,5- 
dimethylpyrazole (140 a). l-benzyl-2,5-dimethylpyrrole (140 b), 6-aminouracil (140 c), 
pyrazole (140 d), imidazole (14() e) was carried out to provide the corresponding indolyl-
heterocyclic alkane derivatives (141 a-e) (Scheme 48). 
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1.5.2. Synthesis of'a-usnhzophospIiiwtes by Kabachnik—Fields reaction 
C. S. Reddy et al{8 reported one-pot reaction of indole-3-carboxaldehyde (137) with 2- 
alninobenzothiazole, 	3-amino- -methylisoxazole, phenylglycine ethyl ester, or 
cyclohexylamine, and dimethyl-, diethyl-, or diphenyl phosphite (142) in the presence of 
tetra methyl guanidine (TMG) (10 mole %) as catalyst in toluene at reflux temperature to 
afford u-aminophosphonates (143) in high yields (Scheme 49). 
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1.5.3. Synthesis of Indolyl chalcone and their derivati,ation 
J.S. Biradar et al synthesized a novel series of indolyl pyrimidine derivatives (146) by the 
direct condensation of indolyl chalcone (144) and barbituric acid (145) in acetic acid in 55-
69 °.o yield and evaluated their antioxidant and DNA cleavage activities (Scheme 50). 
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P. Venkatcsan et al20 reported the reaction of indole-3-carbaldehyde (137) with o-hydroxy 
acetophenones (147) for synthesis of indolyl chalcones (148) in ethanol using piperidine as 
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a basic catalyst. Further oxidative cyclization of these 2-hydroxy chalcones (148) were 
carried out using different reaction conditions such as DDQ,/DMSO-I2/diphenyl disulfide 
to obtained the indolyl flavones (149) in varied yield. Results showed that DMSO/12 gives 
comparably high yield with short time among the other methods (Scheme 51). 
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A. Agarwal et al.21 synthesized indolyl chalcones (151) by reacting indole  
(137) with different substituted acetophenones (150) by refluxing in methanol in the 
presence of piperidine. These chalcones (151) were further cyclized with amidine 
hydrochlorides (152) in the presence of sodium isopropoxide (153) to afford the 
substituted indole derivatives (154) and evaluated their antimalarial activities (Scheme 
52). 
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1.5.4. S}enthesis of beW;,eHesoIfDholtydrazide 
S. M. Sandhi et al.'-' reported the condensation of indole-3-carbaldehyde (137) and 
sulfonvlhydrazide (155) in acetic acid to obtain the benzenesulfonohydrazide derivatives 
(156) in 37-57 % yield (Scheme 53). 
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1.5.5. Reaction of•ittdole-3-ecn•Galdehyde rtwith 2-acetyl bett:ofut•an 
\laeadv et al ' reported the reaction of 2-acetyl benzofuran (157) with (137) and 
cthvlc\anuacctate (158) in refluxing n-butanol in the presence of excess of anhydrous 
ammonium acetate (159) to afford 6-(henzofura21 ?-yl) I.2-dihsdro-1-(11i-Indol- -y)-2 
oxopvndine- 3-carhonitrile (160) (Scheme 54). 
Ncc•II:(OOC:IL; -(lI,CO)Iiwt, —. 
13' 	I :' I :Ss 159 
Scheme 54 
1.5.6. Reaction of iudo/e- c urbuldelr}'cic' and amino pyrazoles 
Indole ring, acts as a biclelectrophiles by introducing an aldehyde moiety at the C-3 
position and reacts with binucleophiles such as aminopyrazoles and hydrazines. Seung 
Bum Park et a1'4 reported an efficient one-step synthesis of heterobiaryl p)razolo[3.4- 
h]pyridines (162) by the reaction of indole-3-carbaldehyde (137) and amlllo pyrazoles 
(161) as binucleophiles in the presence of acidic catalyst in reflux methanol (Scheme 55). 
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Scheme 55 
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1.5.7. Stwthe.sis of Triindolt-/ntet apes 
Triindolvlmethancs were firstly synthesized by treatment of indolc-3-carboxaldehyde 
(137) with two equivalents of indole in acetic acid and ethanol with unsatisfactory yields.25 
In 1984, another synthetic method was developed by Mueller and co-workers,26 in which 
triindolvlmethanes were prepared by treatment of 3-substituted indoles with ethyl 
orthotormate in acidic media but only symmetric triindolylmethanes prepared by this 
method and the yields were low. Chakrabarty and co-workers27 catalyzed this reaction in 
the presence of clay under solvent-free conditions and the yield could reach 78%, but 
when indole was substituted, several kinds of triindolylmethanes were formed by side 
reaction. Guolin Zhang et al-' reported the synthesis of triindolylnicthanes (165) in high 
yields by treating indoles (163) with indole-3-carboxaldehyde (137) in acetic acid and 
acetic anhydride under N, atmosphere at room temperature and in the presence of solid 
acid catalyst zeolite [SO;H]-MSU) (164) in refluxinb ethanol (Scheme 56). 
Further. GU. Da-Gong and J1, Shun-June reprted an improved method for the synthesis of 
symmetrical and unsymmetrical triindolylmethanes (165) using acidic ionic liquids 
[hmim}HSO4; EtOH as an efficient and green catalyst system. 
	
K1 	 K 	- 
l3 	 163 	 t65 
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Scheme 56 
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1.5-8 . Reaction of 3 fornrylindole with the active htethylene compounds 
M. Veakatanarayana ° reported the Knoevenavel condensation of 3-formylindole (137) 
and their N-methyl dcrivativcs (166) with ethyl cyanoacetate in the presence of 40 mol% 
of L-proline in ethanol at room temperature for 30 min resulted in the formation of (E)-
ethyl 2-cyano-3-(1 H-indol-3-yl)acrylates (167) and (168) respectively. Treatment of (167) 
and (168) with 5 % aqueous NaOH under reflex for 30 min resulted in the formation of 
(E)-3-(1H-indol-3-yl)acrylonitriles (169) and (E)-3-(1-methyl-lH-indol-3-yl)acrylonitrilcs 
(170) in 84-90% yields. Each of the compounds (137), (167), and (169) could be smoothly 
transformed into their corresponding N-methyl derivatives (166), (168), and (170) 
respectively in excellent yields by heating for I hat different temperatures with DMS in 
PEG-600 as a facile and versatile reaction medium (Scheme 57). 
0 
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1.5.9. Stvrthesis of 3,4-dih}?lropyri►uidinre-2(1 H)-ones via Biginelli reaction 
P. B. Chaudliari et al reported synthesis of 3,4-dihydropyrimidine-2(1 H)-ones (172) in 
excellent yields via the Biginelli three-component condensation of 3-formylindole (137), 
urea. thiourea and ethyl acetoacctatc in the presence of acidic catalyst in ethanol at retlux 
temperature (Scheme 58). 
13 	\ 	. > I'2 
Scheme 58 
1.5.10. Sj•►tthesis of'4H-clu•ontene derivative 
An ctiicient multicomponent synthesis of 4H-chromene derivative (173) has been reported 
by the reaction of' malononitrilc (25) diinedone (41) and indole-3-carbaldehyde (137) in 
water at retlux temperature in the presence of catalytic amount of tetrabutylannmonium 
fluoride (TB.AF=) as a catalyst. Reaction was completed in 150 min and the product was 
obtained in 70 "'0 yield (Scheme 59).32 
I1 	 0 
13- 
173 
Scheme 59 
50 
REFERENCES 
I. 	Gracia, M.; Valverde.; Torroba, T. Molecules, 2005, 10, 318. 
2. 	Joshi, K.C.; Chanel, P. Pharmazie 1982, 37, 1. 
3. Joshi, K.C.: Chand, P. Ileterocycles 1985, 23, 957. 
4. Scribner, A.; Moore, J.A.; Ouvry, G.; Fisher, M.; Wyvratt, M.; Leavitt, P.; 
Liberator, P.; Gurnett, A.; Brown. C.; Mathew, J.; Thompson, D.; Schmatz, D.; 
Biftu, T. Bioorg Med Chem. Lett. 2009, 19, 1517. 
5. Germisk, D. L.; Parks, G.Y.; Plotnikof, N. P. US Pat. 3, 705902, 1971, C.A. 78, 
72103 1973. 
6. Kosta AN., Vinogradova E.V., Trofimov F.A., Mukhanova T.I. et al.: Khim. 
Farm. Zh. 1, 25 1965, Chem. Abstr. 1968, 68, 39516. 
7. Young. G. A.; Date, Sin J. C.; Tanis, S. PCT Int. Ap. 1009005, 1921, C.A. 
211831m,113,1990. 
8. Barry, A. L. Ed. The antibiotics succeptibility test: Principles and practices, IV 
edn., p. 180, Lea and Febiger, Philadelphia PA 1976. 
9. Crawtazd C., Reiter L.A., Faming Z.S., Gongkal S.: CN 1,041,938, C.A., 143136q. 
144, 1991. 
10. Kumar, P.; Agarwal, S. K. Indian] Chem. 1990, 29, 1077. 
11. Matsui, S.; Kamiva. S.; Shirahase, II.; Morihisa. R.; Nishimura, K.; Kakeya, N.: 
PCT Int. Ap., I. 912009, C.A., 143418a, 114, 1991. 
12. Abdel-Rahman, A. H.; Farghaly J. Chinese Chem. Soc. 2004, 51, 147. 
13. Page. D.; Yang, H.; Brown, W.; Walpole, C.; Fleurent, M.; Fyfe, M.; Gaudreault, 
F.; Onge, S.S.; Bioorg. Med. Chem. Lett. 2007, 22, 6183. 
51 
14. (a)Fukuyama, T.; Chen. X. J Am. Chem. Sec. 1994, 116, 3125. 
(b) Moore, R.E.; Cheuk, C.; Yang, X.Q.G.; Patterson, G.M.L.; Bonjouklian, R.; 
Smitka, T.A.; Mynderse, J.S.; Foster, R.S.; Jones, N.D. J Org. Chern. 1987, 52, 
1036. 
(c). Moore, R.E.; Cheuk, C.; Patterson, G.M.L. J Am. Chem, Soc. 1984, 106, 6456. 
15. (a) Tan, M.; Xu, R.; and Seth, R.; Curr. Med. Res. Opin., 2004, 20, 879. 
(b) Eisenberg, P.; Figueroa-Vadillo, J., Zamora, R.; Charu, V.; Hajdenberg. J.; 
Cartmell. A.; Macciocchi, A.; and Grunberg, S. Cancer 2003, 98, 2473. 
(c) van Niel, M. B.; Collins, 1.; Beer, M. S.: Broughton. H. B.; Cheng, S. K. F.; 
Goodacre, S. C.; Heald, A.; Locker, K. L.; MacLeod, A. M.; Morrison, D.; Moyes, 
C. R.; O'Connor. D.; Pike, A.; Rowley, M.; Russell, M. G. N.; Sohal, B.; Stanton, 
J. A.; Thomas, S.; Verrier, H.; Watt A. P.; and Castro, J. L.; J .Lied. Chem. 1999, 
42. 2087. 
16.  Huskisson, F. C. Taylor, R. T.; Burston, D.; Chuter, P. J. Dudley, F. Hart Ann. 
rheum. Dis.1970, 29, 393. 
17.  Kumar, S.; Kumar V.; Chimni S. S. Tetrahedron Lett. 2003, 44, 2101. 
I. Redd, M. V. N.; Kumar, B. S.; Balakrishna, A.; 	Reddy. C. S.; 	Nayak, S. K.; 
Reddya C. D. Arkivoc 2007, 15, 246. 
19. Biradar. J.S.; Sasidhar, B.S.; Parveen R.; Cur. J. Med. Chem. 2010,45. 4074. 
20.  Venkatesan. P.; Maruthavanan,T. Bull. Chem. Soc. Ethiop. 2011. 25, 419. 
21.  Agarwal, A.; Srivastava, K.; Puri, S. K.; Chauhan, P. M. S. Bioorg. Med. Chem. 
Lerc 2005. 15, 3133. 
22. Sondhi, S. M.; Dinodia, M.; Kumar, A. Bioorg. Med. Chern. 2006, 14, 4657. 
52 
	23. 	Magdy, I.; El-Zahar, Somania, S.; Abd El-Karim.; }iabiba. M. E. World J Chem, 
2009..4, 182. 
24. 	Lee, S.; Park, S. B.; Org. Lett. 2009, II, 5214. 
25. 	(a) Armand, C; Robert, P. Comps. Rend. 1964, 258. 609. 
(b) Bergman, J..1 Heterocyc!. Chem., 1971, 8, 329. 
(c) Sheitdanan. A. K.; Stupnikova, T. V. Khim. Geterotsikl. Soedin.1978, 7, 904. 
26. 	Mueller, J.; Pindur, U. Arch. Pharm. 1984, 317, 555. 
27. 	Chakrabarty, M.: Sarkar, S. Tetrahedron Lett, 43, 2002, 1351. 
28. 	(a) Li, J.; Guang, B.; Wang, L.; Li, B.; Zhang, G. Heterocycles 2003, 60, 1307. 
(b)Lia, Jun.; 7houa, M.: Li, B.; Zhanga, G. Synth. Commun. 2004, 34, 275 
29. 	Da-Gong, G.U.; Shun-Jun, J. 1. Chinese J Chetn. 2008, 26, 578. 
30. 	Venkatanarayana, M.: Dubey, P. K. Synth. Comrnun. 2012, 42, 1746. 
31. 	Heda, L. C.; Sharma, R.; Pareek, C.; Chaudhari, P. B.; E-J Chern. 2009. 6, 770. 
32. 	Gao S.; Tsai, C. H.; Tseng C.; Yao C. Tetrahedron 2008, 64, 9143. 
I*1 
CHAPTER 2 
(3-ENAMTNONES: SYNTHESIS AND ITS TRANSFORMATION TO 
NOVEL HETEROCYCLES EMPLOYING NaHSO4-SiO2 AS 
HETEROGENEOUS CATALYST UNDER SOLVENT-FREE 
CONDITION 
(Journal of Molecular Catalysis A: Chemical 363— 364 (2012) 451— 459) 
2.1. REVIEW AND LITERATURE 
Chemistry of p-enaminones has been recognized as a significant field of study as they are 
composite of an a, n-unsaturated system with enone and enamine sub-units. As a result, 
these compounds have pronounced ambient character and can react both as nucleophiles 
and electrophiles. I An interesting feature of enaminones is that they serve as valuable starting 
materials for the synthesis of various heterocyclic compounds of therapeutic importance such 
as pyranones,z 2-isoxaaolcs,3 pyridines,4 pyrimidines,5 tetrahydropyrimidincs,° pvrazoles,7 
isoquinolines,s dihydropyridines, triacylbenzcnes and naphthofurans9 etc. Thus, in spite of 
their importance in organic synthesis as intermediates and in pharmaceuticals, several 
methods for the preparation of (3-enaminones have been reported. The most common and 
convenient method for the synthesis of enaminones involves the direct condensation of (i- 
dicarbonyl compounds with amines in an aromatic solvent under reflux.10 Several 
catalysts have been also applied to achieve this transformation including cerric ammonium 
nitrate.' heteropolyacids,'2 BF3—Et20,13 ytterbium triflate,14 zirconium chloride, is 
alumina. montmorillonite, P205/SiO2,''  direct condensation of amines with diketones in 
water.1e Bi(TFA),,19 etc. Other synthetic approaches to p-enaminones include the 
cyclization of amino acids-0 reductive cleavage of isoxazoles; ' substitution of the 
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imidoylbenzotriazoles with trimethylsilyl (TMS) enol ethers22 and copper'aLetateffffediated 
aminolysis of dithioaceta1s.23 j3-Enaminones have been also synthesized by condensation 
of active methyl and active methylene compounds with DMF-DMA under reilux condition 
or by using microwave irradiation 24 These methods suffer from drawbacks such as higher 
temperature and longer reaction time to achieve moderate to high yields of the products. 
Martins et.al. reported an efficient ionic liquid catalyzed synthesis of enaminones using 
[Bmim].BF4 and [Omim].BF4 as catalysts under solvent-free conditions.2 However, ionic 
liquids especially imidazolium based systems containing BF4 anions are toxic in nature as 
they produce hazardous HF and their high cost and disposability make their utility 
limited2' Taking into consideration of all these limitations there is a stilt chance to 
develop a simpler and clean method for the synthesis of (3-enaminones at lower 
temperature. 
In recent years the applications of catalysts to reduced toxicity systems, benign and 
renewable energy systems, and efficiency of reaction makes it a central focus area for 
green chemistry research." Among them heterogeneous catalysts have gained much 
importance in organic synthesis due to their inherent economic and environmental 
consideration. These catalysts make synthetic processes safe, clean, inexpensive as well as 
high yielding. A tremendous impact has sparked in various chemical transformations 
promoted by catalysts under heterogeneous conditions. These catalysts are advantageous 
over homogeneous catalysts as they are cheap, non toxic, easily available and can be easily 
recovered from the reaction mixture by simple filtration or precipitation through adding 
precipitating agents to the reaction medium, thereby making the process economically 
viable. Therefore, to maintain economic viability, a suitable heterogeneous system must 
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not only minimize the production of waste, but should also exhibit activities and 
selectivities comparable or superior to existing homogeneous routes. IV, 29,30 
Literature survey reveals that silica supported sodium bisulphate (NaHSO4—SiO2) has 
been found to be an efficient, inexpensive, non toxic, recyclable and ecofriendly 
heterogeneous catalyst in various useful chemical transformations such as protection and 
deprotection; 1 Friedlander condensation,32 Knovenagel condensation," and Biginelli 
reaction." It is also used in the synthesis of napthols; ' dihydropyridines,36 xanthenes" 
homoallylic amines, pyrazolines,J9 amides, 40 yuinazolinones,41 and imidazoles.s' 
2.2. PRESENT WORK 
Due to increasing concern of the harmful effects of organic solvents on the environment, 
organic reactions that are operated under solvent-free condition have aroused the attention 
of organic and medicinal chemists. In recent years, the application of solvent-free reactions 
in organic synthesis is a widely accepted tool and it is often claimed that the best solvent is 
no solvent43 Researchers have demonstrated that the solvent-free organic syntheses are 
generally faster, cost savings, decreased energy consumption, reduced reaction times 
selective, higher yielding with cleaner products, environmentally benign and involve 
simple operational procedure as compared to the classical reaction.44 
Therefore, based on the above findings, in this chapter, we describe the use of silica 
supported sodium bisulfate (NaHSOn—SiOz) as a mild, highly efficient, and recyclable 
heterogeneous catalyst for the synthesis of pyrazole and pyranyl pyridine derivatives by 
the reaction of p-enaminone with different hydrazines and active methylene compounds 
respectively under thermal solvent-free condition in excellent yields. The catalyst shows 
excellent activity and was recyclable up to four cycles. The structure and morphology of 
the catalyst was established for the first time with the help of powder XRD, scanning 
electron microscopy (SEM) and energy dispersion analytical X-ray (EDX). 
2.3. RESULTS AND DISCUSSION 
2.3.1. )Synthesis of heteroc j elic ft-enaminwnes 
Initially. synthesis of hetercyclic 13-enaminones (176a-d) was investigated by condensation 
of hetercyclic methyl ketones (174a-d) with DMF-DMA (175) by thermal heating under 
solvent- and catalyst-free reaction at 70 °C for 5-10 min. The corresponding enarninones 
(176a-d) were obtained in excellent yields (89-93%) (Table 1). The structure of the 
isolated enaminones (176a-d) (Scheme 60) was confirmed by elemental and spectroscopic 
data (I R. 'Fl NMR, 'C \MR and NIS). 
Table I Synthesis of heterocyclic (i-cnaminones. 
Entr\ 	 HET 	 Product 
	
Time (min) 
	
Yield (%) 
176a 
	J 
	 93 
176b 
	
5 
	 92 
176c 
	 89 
176d 
	
10 
	
92 
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Scheme 60. .Si - nthesi.s of heterocyclic• /J-enanrinoncs (1 76a-d, 
The IR spectrum of (176a) (Fig. 1) exhibited the broad hand for OH group at 3429 cm-1 
and a sharp strong band at 1712 cm-1 for lactone carbonyl group. Another absorbtion bands 
at 1609 cm along with a shoulder at 1649 cm•' was due to C=C and CO of a, 13-
unsaturated carbonyl system. The ' H N MR spectrum (Fig. 2) displayed two doublets at 
6.65 and h.0D with coupling constant] = 12.3 Hz assignable to the two olelinic protons Ha 
and IIb respectively. The coupling constant value indicates that the enaminones existed 
predominantly in the L•--configuration (Scheme 60). The six protons of the two methyl 
groups of —N(CH„), group appeared as two singlets at i'i 3.24 and 3.05. The remaining 
protons of lactone moiety were present at their normal values. The °C NMR spectrum 
(hg. 3) showed signal at d 155.9 for a, 13 unsaturated carbonyl group whereas olefinic 
carbons C-2' and C-3' were present at 6 91.5 and 156.1 respectively. The signals for two 
N-CI1: carbons were discernible at 37.6 and 45.6 respectively, whereas signals for other 
carbons appeared at their appropriate positions. Further, evidence for the formation of” 
(176a) was obtained by mass spectrum (Fig. 4) which showed molecular ion peak at rn/z  
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223. The spectral studies of the other compounds followed similar pattern and are given in 
experimental section. 
2.3.2. Characterization of the catalyst 
23.2a. Powder X-raydiffraction (XRD) analysis oft/re catalyst 
The structure of the prepared catalyst (NaHSO4-S102) was identified by powder XRD. 
X-ray patterns of the catalyst was recorded at 20 = 10-70° range (Fig 5). A broad peak 
centered at 20 angle in the range 18-30° confirmed the formation of amorphous silica- 
NaHSO4 matrix.45  
2 Sore.)  
Fig 5. The powder XRD pattern q[Jresh caralysi. 
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2.3.2b. SE_ll-ED a,,altv.~is of the cutah'st 
I o stud\ the surface morphology of the catalyst, SE1VI micrographs of the catalyst was 
employed. l'he SE\l intaL-cs of the catalyst (Fig. 6) showed an even distribution of 
\al-lSO on the surface of the silica gel_ No conglomeration or layering of NaHSO4 was 
observed on the surface of silica gel. 
Fig. 6. SL•:11 itrrcr<,c. ul the catalyst (.Va1TSO4 -SiO2) at dijferent uugnifXtrtiwns. 
Further. [DX analysis tFig. 7) of the catalyst showed the presence of Na. S. 0 and Si 
elements suggestin the l'brmation of expected catalytic system. The presence of C' 
elements in the spectrum I. due to coating of the sample by carbons during the analysis. 
0 	2 	4 	6 	8 	10 	12 	14 	16 	18 
Fiji Scale 295 cis Cursor D 000 hey 
Fig. 7. EDX analysis of'the catalyst (NaHSO4-5i02). 
The increased reactivity of NaHSO4 supported on silica material may be due to the catalyst 
and support interactions resulting in the changes in surface properties of reactive sites. 
2.4. Synthesis of pyrazoles 
The pyrazole derivatives are well known five member heterocyclic compounds found 
wide applications in pharmaceutical and agrochemical industry. Therefore, several 
methods for its synthesis have been developed in recent years, the most widespread 
synthetic strategies for the synthesis of pyrazoles includes the 1,3-dipolar cycloadditions 
of diazo compounds,46 reaction of chalcones and hydrazines,47 a four-component reaction 
of terminal alkynes, hydrazine, carbon monoxide and aryl iodidesd8 and the direct 
condensation of 1,3-diketones and hydrazines in fluoroalcohol,49 reaction ofaldehydes and 
diethoxy phosphoryl acetaldehyde tosylhydrazone.50 A variety of catalysts such as 
H2SO4,51  polystyrene supported sulfonic acid,52 zirconium sulfophenyl phosphonates' Sc 
(OTt) 3,54 Y-zcolite,55 Mg(C104)56 have been also reported in the literature. 
In our initial investigations for optimization of appropriate reaction conditions, at first the 
synthesis of compound (178a) was selected as a model reaction. Thus, an equimolar 
mixture of (i-enaminone (176a) and hydrazine hydrate (177x) was heated at 70 °C under 
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solvent-free condition. The reaction proceeded very slowly and product was obtained in 
lower yield even after prolonged heating demonstrating the need of a catalyst. When the 
model reaction was performed in the presence of NaHSO4-SiO2 (1(10 mg) under solvent-
free condition, product (178a) was obtained in excellent yield (94 %) within shorter time 
period (5 min) (Table 2). 
Table 2 Synthesis of pyrazoles 178a-h. 
Entry 	Product 	R 	Time (min) 	Yield (%) 
1 	178a H 5 94 
2 	1786 Ph 5 90 
3 	178c H 5 92 
4 	178d Ph 10 92 
5 	178e H 15 87 
6 	178f Ph 20 85 
7 	178g H 15 90 
8 	178h Ph 20 89 
2.4.1. Effect of different supports 
To establish the use of silica as the best support for NaHSO4, other supports were also 
investigated (Table 3). The model reaction, thus, when carried out with NaHSO4-alumina 
(acidic, basic, neutral). the TLC showed formation of product but the reaction did not 
complete even after longer reaction time (entry 3,4,5). Further, when the silica gel alone 
was employed in lieu of NaHSOa— Si02, no measurable product was obtained (entry 6) 
while with NaHSO4 in pure form the reaction was again not successful (entry 7). Among 
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the examined supports, for Na1I504 silica gel showed the best results. Therefore, silica-
supported t aHSO4 was used as catalyst for all reactions. The increase in rate of reaction 
employing NaHSO4-SiO2 may be due to increased surface area of the catalyst. 
Table 3 The screening of different support on the model reaction 
Entry Support Time Yield (%) 
1 No catalyst 4 h 43 
2 NaHSO,-SiO2 5 min 94 
3 Nat 1SO4-allunina (acidic) - incomplete 
4 NaHSO4-alumina (basic) - incomplete 
5 NaHSO4-alumina (neutral) - incomplete 
6 5i02 3.5 h trace 
7 NaHSO.r 3 h 52 
A plausible mechanism for the formation of 178a in the presence of NaHSO4-Si02 has 
been shown in Scheme 61. 
-Z Q 	 "r 
: 	Z NaBSOa 91O, 	" 	 pH NH, 	 O N—NH 
RD " N(Cth IIFI 	^:(Cn -HET 	g(LHl+ 
rlfv  
¢O 
HFI 
HN N 	Z0H 	TT1 -NH 	~~ N—NH 
	
H 	
OH 
HET 	 NHfCH;I• 
f3 
I 'h
HE. 	~(CI1t FT N(CH3)1 
H 
Scheme 61 
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2.4 2. Effect of .olve,i ts 
In order to established the superiority of solvent-tree reactions, the model reaction was 
carried out in different polar and non polar solvents such as acetic acid (CEI;COOE-l). 
dichloronlethane (CH,C I, ). acctonitrile (CHICN), methanol (MeOH), ethanol (EtOH) and 
isopropanol (Table 4). \'hell the reaction was performed in McOH. EtOH. iso-propanol 
lower yield of the product (178a) was obtained after longer time period (entry 3, 4. 5) 
whereas in Cl-I,CI, and Cl-i;CN, only trace amounts of the product was obtained (entry 6, 
7). Using.; acetic acid relatively high yield of the product was obtained (entry 2) but 
reaction took longer time period for completion. Interestingly, when the reaction was 
carried out under solvent-free conditions, both the yield and reaction time Were 
significantly Improved (entry I). 
Tahle 4 Comparative stud v of compound (178a) using solution conditions versus the 
solv cnt-free method. 
Entry 	 Solvent 	Temperature 	Time 	Yield (%) 
I 	 Solvent-free 	70 "C 	 5 mill 	94 
2 	 Acetic acid 	Reflux 	 7 h 	76 
EtOH 	 Reblux 	 3 h 	68 
4 	 McOH 	 Reilux 	 6 h 	64 
5 	 Isopropanol 	Reflux 	 8 h 	58 
6 	 CH,C1, 	Reflux 	 48 h 	35 
7 	 CII1,C'\ 	 Reflux 	 48 h 	38 
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2.4.3. Loadin, of the catalyst 
In order to optimize the amount of catalyst used for the catalysis of the reaction to form 
the desired product (178a) we analyzed the reaction by varying the loading amount to 40, 
60. S0. 100 and 120 mg of NaHSO4-Si02. Generally, the rate of reaction and yield 
increases over the amount of catalyst. It was found that the optimum amount of catalyst 
turned out to be 100 im-, in order to obtain the best result. No such significant improvement 
in the yield was observed on increasing the loading to 120 mg. whereas, decreasing the 
amount of catalyst to 40 m- resulted in lowering of the yield (Table 5). Therefore, 100 mg 
of catalyst was chosen for further studies because of satisfactory yield of the product in 
reasonabl\ short time. 
Table 5 Effect of catalyst loading on the synthesis of (178a). 
Entry 	Catalyst (mu) 	Time (min) 	 Yield (%) 
	
40 	 45 	 58 
2 	 60 35 74 
i 80 	 10 	 89 
4 	 100 5 94 
5 120 	 5 	 94 
2.4.4. Recycling study of 'the catalyst 
We also investigated the reusability of the catalyst under solvent-free conditions using 
model reaction of fi-enaminone (176a) with hydrazine hydrate (177a) in the presence of 
'.oaf 1SO4-Si02 (100 m`,) (Taf)le 6). After completion of the reaction, the mixture was 
cooled to room temperature, and the organic part was dissolved in ethyl acetate (10 niL). 
The mixture was filtered for separation of the catalyst. The recovered catalyst was washed 
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with ethyl acetate (3x 10 mL), dried in oven at 100 °C for 3 h and used for the subsequent 
catalytic runs. The results (Table 6) showed that the catalyst was active up to four cycles. 
Table 6 Recycling data of the catalyst for the model reaction. 
Catalyst recycles 	 Time 	 Yield (%) 
I 	 5 min 94 
11 5 min 	 94 
[Il 	 5 min 94 
IV 5 min 	 94 
V 	 10min 89 
The recyclability of the recovered catalyst after four runs was checked by powder XRD 
(Fig. 8) and SEM analysis (Fig. 9). It was observed that peaks remained the same, and 
there was no change in the morphology of the catalyst as compared to that of the fresh 
catalyst. 
d  
10 	20 	30 	40 	50 	60 
2$ (degree) 
Fig. 8. The powder XRD pattern of recovered ca1alusl after four runs. 
Fig. 9. "l ire' SE.%J image of rec o erecl catalyst after four runs. 
Under these optimized reaction conditions the scope and generality of the present method 
was further demonstrated by reaction of different heterocyclic -enaminones (176a-d) with 
various hvdrazine derivatives (177a-b) under same reaction conditions. All the reactions 
proceeded smoothly and the reaction was completed within 5-10 mite to afford the 
products (178a-h) in excellent yields (85-94%%i,) (Table 2). The structure of products 178a-
h (Scheme 62) was deduced from their elemental analysis and spectral data (IR. 1 1-I NMR, 
1 'C-\\lR and e1S). 
\alIso,SK 	HN—N I. ICI 
 
Nit l l i, kNII\I 	Solvent- lice 
1-6a-d 	'U ='C 	III. 1-- 
Il;c . .Uu 	o 0 
t Ii 	 1)1 
1 -6;i 	 1-6h 
I?"a:K=fl 
i1 	 ('II, 
II, 
(~ 	U 
1?6c 1"6d 
Scheme 62 Vn1iSO-;-SiO CitCtiv:etl svothe.ris of 1VrCzotes lmcler thC1•/iiQl solvent free 
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The AR spectrum of (178a) (Fig. 10) showed two broad absorption bands at 3171 cni t and 
3045 cnf t due to the presence of OH, NH groups of lactone and pyrazole moieties 
respectively. A sharp and strong absorption hand for the lactone carbonyl group was 
discernible at 1696 cm '. In the 'H NMR spectrum (Fig. 11) the presence of pyrazole 
moiety was inferred by two doublets at 66.9! (J= 3 Hz) and a 7.89 (J= 3 Hz) for C-4', C-
3' protons respectively and a broad singlet for NH proton at a 13.36. The 13C NMR 
spectrum (Fig. 12) showed signal at r) 145.6, 100.6, and 130.1 for C-3'. U4'. and C-5' 
carbons of pyrazole moiety. The other peaks were present at their normal values and are 
mentioned in the experimental section. The structure of compound (178a) was further 
confirmed by mass spectrum (Fig. 13) which showed Mt at miz 192. 
2.5. Synthesis of pyranyl pyridine derivatives 
Pyridine is one of the most prevalent heterocycle being the core fragment of different 
natural products and pharmaceutical active agents"' The pyridine ring is also an integral 
part of agrochemicals,s8 preparative organic chemistry,59 and in coordination chemistry 60 
In addition to classical pyridine syntheses such as the Krohnkc reaction, many new 
approaches have been also reported in the literature including condensation of amines and 
carbonyl compounds, cycloaddition reactions. multicomponcnt 	 etc. Due to the 
remarkable biological activities of the pyran derivatives either in the form of substituents 
or as a fused component°  efforts were also made to synthesize pyranyl pyridine 
derivatives (180a-h) employing (176a), different cycliclacyclic active methylene 
compounds (179a-h) and ammonium acetate in the presence of NaHSO4-SiO2 under same 
reaction conditions (Scheme 63). 
m 
zN 
I. O11 yi 	o  
< -  
011 N 
II ;C 	O 	O /"C) 	 180c1;1=0 
IRUa; R. 	('l I R_ COOC',11, 	 0 
18(1h: 1" =C1 I ; 1:,= COCII ; O11 	O 
C) 	O 	> 	 I 	N 
(179f-h) 
I8(k) 
Scheme 63. Reaction of (1760 with c/1fB1E'/1t active lNC'1hvlL'I1E compounds (179a-{l), 
cnlr1nulri!1/?1 acetate (3.00 /!/nul) and ,VaHSO,-SiO, (100 ing) ufuler solvent-free heating at 
71) _:( • 
All reactions proceeded ettiClentiv and the desired products were obtained in excellent 
yields (S 1-9 °o) in short reaction times (5-25 min) (Table 7). 
II ;C 	O 0  
(180f-h) 
18(If; X-O Y- II 
180g: \ = 0 y  
180h; \-S )' - II 
)(II,CI-1; 
180a 
180b 
180c 
Table 7 Synthesis of compounds 180a-h 
Entry 	 Product 	 Time (min) 	Yield (%) 	M.P.(°C) 
E 
	
93 
	
129-13 1 
5 
	
8S 
	
?01-205 
89 
	>300 
;0113 
y 	4 
O1-1 N 	1p U 
180(1 	 n 0 
	
10 
	
84 
	
>300 
S 
9 / 7 
O \ 6 
(A `~ O 
180c 	Off() 
	
15 
	
M 
	
>300 
FEB 
IXOf 
l80g 
180h 
25 
IS 
20 
89 
93 
90 
>300 
239-241 
>300 
The structure of compounds (1K(la-h) was deduced on the basis of IR, I H NMR. '3C N\4R 
and mass spectrometr.. The IR spectrum (Fig. 14) of the newly synthesized compound 
(180a) exhibited characteristic abu»1ntion hands at 3065, 1717 and 1697 cm' due to the 
presence of Oil, ester, and lactonc carbonyl groups respectively. 'H NMR (Fig. 15) 
exhibited two doublets at () 8.85 and 8.44 for H4 and H5 proton of pyridine moiety. 
Presence of ester group was in!Crrcd by quartet at o. 4.44 (J = 7.2 Hz) and triplet at O 1.42 
(.1 — 6.9 Hz) ti,r OCH, and ('11; protons respectively. The ' 3C NMR spectrum (Fig. 16) 
showed characteristic signals at r) 142.2 and 1 19.7 for C4 and C> carbons of pyridine 
moiety respectively. Other peaks were at their normal values and discussed in the 
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experimental section. Further confirmation for the structure (180a) was provided by mass 
spectrometry (Fig. 17) which showed M' at m/z 289.15 as base peak. 
2.6. EXPERIMENTAL 
Melting points of all synthesized compounds were taken in a Riechert Thermover 
instrument and are uncorrected. I he 1R spectra (KBr) were recorded on Perkin Elmer RXI 
spectrometer. 'H NMR and ''C NMR spectra were recorded on a Bruker DRX-300 and 
Broker Avance II 400 spectrometer using tetramethylsilane (TMS) as an internal standard 
and DMSO-db/CDCI3 as solvent. DART-MS were recorded on a JEOL-Accu TOF JMS-
TI 00LC mass spectrometer having a DART source. Elemental analyses (C, H and N) were 
conducted using the Elemental vario El. III elemental analyzer and their results were 
found to be in agreement with the calculated values. 5-Acetyl-barbituric acid, S-acetyl-l.3- 
dimethylbarbituric acid. 3-acetyl-4-hydroxy coumarin were synthesized by reported 
procedures.bb Other chemicals were of commercial grade and used without further 
purification. The homogeneity of the compounds was checked by thin layer 
chromatography (TLC) on glass plates coated with silica gel G254 (h. Merck) using 
chloroform-methanol (3:1) mixture as mobile phase and visualized using iodine vapors. X-
ray diffraetoerams (XRD) of the catalyst were recorded in the 20 range of 10-70° with 
scan rate of 4°/ min on a Rigaku Minifax X- ray diffractometer with Ni-filtered Cu Ka 
radiation at a wavelength of 1.54060° A. The SEM-EDX characterization of the catalyst 
was performed on a JEOL JSM-6510 scanning electron microscope equipped with energy 
dispersive X-ray spectrometer operating at 20 kV. The catalyst Silica-supported sodium 
hydrogen sulfate (NaTIS04-SiO2) was prepared by reported procedure. h7 
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2.6.1. General procedure for the synthesis of heteroaryl /J-enanrinones under thermal 
so/vent—free condition 
A mixture of dehydroacetic acid/ 3-acetyl-4-hydroxycoumarin/ 5- acetylbarbituric 
acid i 5-acetyl-1,3-dimethylbarbituric acid (174a-d) (1.00 rumol) and DMF-DMA (175) 
(1.00 mmnl) was added into a round bottom flask. The resulting mixture was heated at 70 
°C in an oil bath for specified time. The progress of reaction was monitored by TLC. The 
reaction mixture (after being cooled to room temperature) was poured into ice cold water 
(20 mL) and stirred for 5-10 min. The bright yellow solid, thus, obtained was filtered, 
washed with water, dried and recrystallized from ethanol to afford pure products (176a-d). 
2.6.2. General procedure for the synthesis ofpyrazoles under thermal solvent-free 
condition 
To a mixture of (176a-d) (1.00 mmol) and hydrazine hydrate (177a) ;phenyl hydrazine 
(177b) (1.00 minol), Na1SO4—Si02 (100 mg) was added. The reaction mixture was heated 
at 70 °C for specified time. After completion of the reaction (checked by TLC), the 
reaction mixture was cooled to room temperature and mixed thoroughly with 10 mL of 
ethyl acetate. The solid inorganic material was filtered off. After separation of solid, the 
solvent was evaporated under reduced pressure. The white solid, thus, obtained was 
washed with water and dried. Further purification was made by recrystallization from 
suitable solvents to afford pure products (178a-It). 
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2.6.3. General Procedure for the syntheses of pyranyl pyridine derivatives under solvent-
free condition 
lo a mixture of (3-enaminone (176a) (1.00 mmol), active methylene compounds (179a-h) 
(I.00 mmol). ammonium acetate (3.00 mmol), NaHSOI-SiO? (1)0 mg) was added. The 
reaction mixture was heated at 70 °C over a heating mantle for specified time. After 
completion the reaction mixture, (monitored by TLC) the contents were cooled to room 
temperature and mixed thoroughly with (10 mL) or ethyl acetate. The catalyst was 
removed by filtration and reused. After separation of catalyst, the solvent was evaporated 
under reduced pressure. The resulting solid residue was washed with cold water to remove 
any unreacted ammonium acetate, filtered and dried to afford the crude products. The pure 
product (1811a-h) was obtained by recrystall ization from suitable solvents. 
2.7. Spectral data of the compounds 
3-[(E)-3-(N,N—dime0iylamino)acrylolyl)-l-(4-Aldroxy-6-merhyl-2-oxo-2H-1 pyran-3 yl) 
(I76a) 
Purified by recrystallization from ethanol.  
Orange solid. 
M.p- 	 199-202 °C. 
IR (KHr) v,n„/cni t 	 3429 (OH), 1712 (C=O), 1649 (CO), 1609 
(C=C). 
H NMR (30(1 MHz, (:DCl3) 	O (ppm) 2.18 (s, 3H, C113).3.05 (s, 3H, N- 
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CFI), 3 24 (s. 3H, N-CH), 5.79 (s, I H. H-5), 
6.65 (d, J = 12.3 Hz, 1 Ha), 8.05 (d, J = 12.3 
Hz, I Hb), 18.8 (s, 1H. OH). 
'(' N\IR (100 MHz., CDCi ; ) 	 <> 19.9 (C113), 37.6 (N-CH;), 45.6 (N-CH ;), 
91.5 (C-2'), 95.5 (C-3), 104.4 (('-5) 156.8 
(C-3'), 162.5 (C-6), 164.4 (C-2), 184.3 (C-4), 
185.9 (C-1'). 
ESI-\IS 	 : 	(nr/) 223.08. 
Elemental analysis for C1 i H 1 3N04 	: 	Calculated C, 59.24; H, 5.87 N, 6.28. 
Found C. 58. 95; H, 5.63, N, 6.58. 
3-/( E)-3-(\,.V-ditmretht'lwrnninn)ac:ylolyl)/-1-(4-hydroxy-l-benzapyranr-2-one-3 yl) 
(176b) 
Purified by recrystallization from ethanol. 
Li.ttht yellowy solid. 
M.p. 	 : 	254-258 (dec) "C. 
IR (KBr) cm-1 	 : 	3400 (OH), 1699 (C=O), 165l(C=0), 1607 
(C=C). 
'H N\IR (300 MIIz. ('DCI3) 	v (pprn) 3.11 (s, 3H, N-CH;), 3.29 (s. 3H, N- 
CH;), 6.82 (d, J = 12.3 Hz, IHa), 7.23- 8.06 
(m. 4H. Ar- H), 8.16 (d, J = 12.3 Hz, l Hb). 
18.8 (s. l H, OH). 
''C NMR (100 MHz, CDC13) 	 6 (ppm) 38.0 (N-CH3), 46.0 (N-CH3), 92.1(C- 
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ESI-NIS 
Elemental analysis for C 14H 1 NO4 
3), 96.6 (C-2'), 116.5, 118.6, 123.5, 125.4, 
134.1, 154.0, (C-Ar), 156.9 (C-3). 161.6 (C-
2), 182.0 (C-4). 185.8 (C-I'). 
(m/-) 259.1 1. 
Calculated C, 64.92; H, 5.05; N, 5.40. 
Found: C, 64.67; H. 5.31: N, 5.14. 
3-/(E,-3-(V', :\'—diiiiethl ,laiizuzo)aciylolyl)-1-(2,1,6 pyi-iiiiitlittetrioize-3 yl) (1 76c) 
Purified by recrystallization trom ethanol-DMF (8:2) mixture. 
VL11Ovv solid. 
X1.11. 
IR (IKBr) cin 
1 'C N \ IR (100 MI-Iz. ('DCI;) 
218-222 °C. 
3200 (OH), 3100 (NH), 1719 (C—O), 1655 
(C=O). 1611 (C=C). 
(300 MHz, DMSO-d6 ): 6 = 2.97 (s, 3H, N-
CH). 3.26 (s, 31-1, N-C1-I;), 6.72 (d, J = 12.0 
Hz, 8.13 (d, J = 12.0 Hz, 11-Ib), 10.48 (s, I1-1, 
NH), 10. 94 (s, IH, NH). 
ri (ppm) 37.5 (N-CH 3 ), 45.4 (N-CH ; ), 86.9 
(C-5). 88.9 (C- 2'), 149.4 (C-3'). 156.2, (C-
2), 163.5 (C-4, C-6), 180.0 (C- I ' ). 
(nz-) 225.13. 
Calculated C, 48.04: H. 4.92; N,18.67. 
Found: C, 48.26; H. 5.22: N. 18.91. 
ES1-MS 
Elemental analysis for GH It N:O4 
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3-f(E)-3-(.Y,:V-diinetlirlwnuwciylolyl)-1-(1,3-dimethyl-2,4,6 -pyrimidiizetrione-3-yl)  
(1 764) 
Purified by recrystallization from ethanol. 
Yellow solid. 
M.p 	 : 230-232 °C. 
IR (KBr) cm"' 	 : 1690 (C=O), 1662 (C=O), 1623 (C=C). 
1 H N v1R 	 : (300 MHz, CDC13): 5= 3.05 (s, 6H, N-CH3), 
3.33 (s, 6H, N-CH3), 6.96 (d, J = 12.0 Hz, 
I Ha), 8.04 (d, J = 12.0 Hz, 1 Hb). 
''C NMR (100 MHz. CDC1;) 	: 6 27.4 (N-CH3), 27.7 (N-CH3), 37.7 (N-CH3), 
45.8 (N-CH3), 88.4 (C-5), 90.5 (C-2'), 151.0 
(C-3'), 	162.2 (C-4), 168.9 (C-6), 156.0 (C-2), 
181.8 (C-1'). 
ESI-MS 	 : (niiz) 253.08. 
Elemental analysis for C11 H15N3O4 	: Calculated C, 52.22; H, 5.97; N, 16.60. 
Found: C, 52.51; H, 6.26; N, 16.29. 
4-Ht-drox}y-6-iiiet/zy1-3-(2H pyrazol-3 y1) pyray:-2-oi:e (178a) 
Purified by recrystallization from ethanol. 
White solid. 
M.h. 	 : 	>300°C. 
IR (KBr) cni1 	 : 	3171 (OH), 3045 (NH), 1696 (C=O). 
'H N\1R (300 MHz. D\1SO-J,) 	: 	(>2.23 (s, 3H. CH;), 6.91 (d, J= 3.0 Hz, H- 
77 
4'). 6.25 (s, Ill. H-5). 13.36 (s, 11-1, NI I), 7.89 
(d. J= 3.0 Hz, 1-1-3'). 
'''C NMR (100 MI 1z, DMSO-d6) 	: 	O> 19.3 (C113). 93.1(C-3), 100.6 (C-4'). 103.5 
(C-5), 130.1 ((-5'). 145.6 (C-3'), 161.6 (C-6). 
161.8 (C-2), 167.8 (C-4). 
ESI-MS 	 : 	(m%) 192.06. 
Elemental analysis for C9l IQN,03 	: 	Calculated C, 56.30: H. 4.19; N. 14.59. 
Found: C, 56.07; H, 4.43; N, 14.34. 
4-Hh'droxt'-6-methyl-3-(2-PhenvI pyrazo/-3-~,1) pvran-2-one (178h) 
Purified by recrystallization from ethanol. 
White solid. 
 M.P. 
IR (KBr) cm- ' 
'II NMR (300 MI-Iz. DMSO-d(;) 
''C NMR (100 Ml-lz. DMSO-c/6) 
ESI-!~1S 
>300 °C. 
3039 (OH), 1678 (C=O). 
r) 2.19 (s, 3H, CH3), 6.03 (s, 111, H-5). 6.38 
(d..1 = 2.4 Hz, H-4'). 7.31- 7.43 (m, 5H. Ar- 
H), 7.68 (d, J = 2.4 Hz, 1-1-3'), 11.92 (s. 1 H, 
OH). 
O> (ppm) 19.4 (CH3). 92.5 (C-3), 99.6 (C-
4').109.6 (C-5), 139.6 (C-1"), 133.6 (C-5'), 
123.0. 127.0, 128.8 (C-Ar), 140.4 (C-3'), 
162.3 (C-6), 163.4(C-2), 167.9 (C-4). 
(ni/) 268.08. 
I:Iemental analysis for Ci f-11 2N,O; : 	Calculated C. 67.22: H, 4.51; N. 10.4.5. 
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Found: C, 66.94; H. 4.29: N. 10.19. 
4-1I1'Arw.a•-3-(2H lA•ra; ol-3a'1)—beMzopt'vaff-2-onee (1.78c) 
Pun tied by recrystallization from ethanol-chlorotbnn (4:lviv) mixture. 
\\Iinc Solid. 
N.I.P. 
IR (K13r) cm- ' 
'FT \AIR(300Vll-lz.CDCb) 
'C \MR (100 MHz, DMSO-i,,) 
ESI-\1S 
Elemental analysis for C l  H,N,O;  
>300 °C. 
318 (OH), 3054 (NH). 1684 (C=O). 
ô7.70 (d,.1 3.0 Hz, H-4'), 7.14- 7.57 (in. 
4H, Ar-H), 8.04 (d. J= 3.0 Hz, H-3'), 10.58 
(s, 1H• NH), 11.8 (s, 1 H, 011). 
(> (ppm) 94.5 (C-3), 104.1 (C-4'). 152.1, 
132.6. 124.1, 123.6, 116 2, 116.1 (C-Ar). 
130.0 (C-5'). 146.4 (C-3'). 160.1 (C-2), 
164.1 (C-4). 
(,n/_-) 22$.12. 
Calculated C. 63.21: H, 3.53; N, 12.28. 
Found: C, 62.91: H. 3.28; N. 12.49. 
1- f /yrlro. -3-(2 p/u'nl'1- ptiaazo1-3 }yl)—be»; op1'tau-2-olte (178d) 
Purified b' recrystallization From ethanol-chloroform (8:2 v;v) mixture. 
Light yellow' solid. 
M.p. 	 : 	260-263 "C. 
IR (KBr1 em- ' 	 : 	3384 (OH), 1695 (C—Q). 
I II NMR (300 v11-lz, DMSO-i,) 	: 	o6.55 (d, J= 3.0 Hz, H-4'), 7.2-7.9 (m, 9H, 
Ar- H). 7.80 (d. J = 3.0 Hz, H-3'). 
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''C NMR (100 Ml-lz. DMSO-d6) 
ESI-MS 
Elemental analysis For C 1 I 11 N2O 3 
O 96.1(C-3). 1 10.4 (C-4'), 115.6, 116.4, 
123.2. 123.9. 124.2, 127.2, 128.8. 133.1, 
152.7. (C-Ar). 133.0 (C-5'), 139.9 (C-1"), 
140.1 (C-3'). 160.5 (C- 2), 163.4 (C-4). 
(in/:) 304.12. 
Calculated C, 71.11; H. 3.97; N, 9.21. 
Found: C, 70.86; H, 3.74, N, 9.45. 
5-(2H-pt•razol-3-y/)ntrinzidinre-2,4,6Irioee (1 78e) 
Purified by recrystallization from ethanol-DNMF (8:2 v/v) mixture. 
White solid. 
M.p. 
IR (KBr) cm- ' 
' I 1 N\MMR (300 M11 , DMSO-d6) 
13C NMR (100 MHz, DMSO-d) 
>300°C. 
3372 (01-1), 3316 (NH), 3148 (NI-1), 1719 
(C=O). 
O6.65 (d, J = 33 Hz. H-4'). 7.31 (d, 1= 3.3 
llz, 1-1-3'). 9.59 (s. 1H, NII), 10.38 (s, 111. 
NH). 1325 (s, I H, NH). 
()72.2  (C-5), 104.6 (C-4'). 135.1 (C-5'), 
145.7 (C- 3'). 153.7 (C-2), 161.0 (C-4. C-6). 
(m%:) 194.07. 
Calculated C, 43.33: H. 3.11: N, 28.87; 
Found: C, 43.04; H. 2.81; N, 28.59. 
ESI-MS 
Elemental analysis for C7HNO; 
I-H 
5-(2-Phenyl-pyrazol-3-9Q-pyrimidine-2,4,6 (none (178f) 
Purified by recrystallization from ethanol-DMF (8:2 v/v) mixture 
Yellow solid. 
M.p. 
IR (K1r) can 
'El NMR (300 MHz. DMSO-d6) 
'3C NMR (100 MHz, DMSO-dr) 
ESI-MS  
>300 "C. 
3189 (NH), 3018 (NH), 1716 (C=0). 
6 6.76 (d, J= 2.7 Hz, 1I-4'), 7.14 - 7.52 (m, 
5H, Ar-H), 7.81(d, J 	2.7 Hz, H-3'), 10.64 
(s, (H, NH), 11.33 (s, IH, NH). 
ô79.8 (C-5), 104.5 (C-4'), 139.9 (C-I"). 131. 
(C-5'), 117.4, 127.2, 128.1, (C-Ar), 141.2 (C- 
3'), 160.5 (C-2), 164.4 (C-4, C-6). 
m./z 270.04. 
Elemental analysis for C i ~H j,N401 	Calculated: C, 57.82; H, 3.73; N, 20.74. 
Found: C, 57.53; H, 3.43; N, 21.12. 
1,3-Dimethyl-5 -(2H pyrazol-3-y7) pyrimidine-2,4,6 trione (178g) 
Purified by recrystallization from ethanol-chloroform (8:2 v/v) mixture. 
White solid. 
M.p. 
IR (KBr) cm ' 
'H NMR (300 MHz, DMSO-d6) 
13C NMR (100 MHz, DMSO-d6) 
>300 °C. 
3084 (NH), 1684 (C=O). 
d 3.19 (s. 6H, 2 N-CH3), 7.18 (d, J= 3 Hz, H-
4'), 8.01 (d,.7=2.7 Hz, H-3'), 11.59 (s, (H, 
NH) 
S 26.9 (N-CI1,), 79.2 (C-5), 101.6 (C-4'), 
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132.1 (C-5'), 145.8 (C-3'), 151.7 (C-2), 
161.5 (C-4, C-6'. 
ESI-NIS 
	
(in') 222.13. 
Elemental analysis for CHi,,N4U; 	Calculated C, 48.09; II. 4.54: N, 25.23. 
Found: C. 48.92: 11.4.26; N. 24.91. 
1,3-l)inie[/rl!-5-(2 -pllen►'I-h►'i'uzol-3-►y!) /a'Y!oodiWe-2,4,6 triune (I78h) 
f'uritiocl by rccrystalllzation from ethanol-chloroform (8:2 v:'v) mixture 
\fhite solid. 
Ni. p. 	 >300 °C. 
IR (KBr) cin- ' 
	
1697 (C=O). 
1-1 \\IR (300 MI 17, 1)N1SO-d,,) 
13C N\IR (100 MI Iz. I)`ISO-d,) 
O 3.07 (s, 61-1, 2 N-Cl I;), 7.81 (d. .1 = 3.0 Hz, 
1-I- 4'). 7.26 — 7.81 (m, 51-1, Ar-H), 8.65 (d, .1-
3.0  Hz. H-3'). 
v 27.9 (N-C1-l;), 82.6 (C-5), 105.7 (C-4'), 
117.6, 118.3. 126.8, (C-Ar), 129.8 (C-5'), 
141.5 (C-1"), 142.6 (C-3'), 157.8 (C-2), 
160.4 (C-4, C-6). 
ESI-'CIS 
Elemental analysis for C 1;H l.,N.Oz : 
(nl/) 298.09. 
Calculated C, 60.45; 1-1, 4.73; N, 18.80. 
Found: C, 60.25; H, 4.49; N, 18.54. 
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3-F_t/rniucurfio►itl-(--(/-Irvcruxv-6-arct!lvl-2-uxu-2H-1 pyf'un-3 yl)-2-nretlit,,I pyridine 
(180a) 
Purified by rerrytalHstion from ethanol. 
Li,ht vet lo v solid. 
\.p. 	 129-131 °C. 
IR (KBr) ci n" 	 : 	3065 (OH), 1717 (C=0), 1697 (C=0), 1614 
(C=N). 
'H \NIR (300 MHz. CDC1:) 	 J 1.42 (t, 3H, 6.9 Hz, 0CH 2CH3 ), 2.22 (s, 
3H, C1-1-), 2.92 (s, 3H, CH), 4.44 (q, .I = 7.2 
Hz, 211, OCfi, ), 5.86 (s. 1H, 11-5'), 8.44 (d, J 
= 9.3 Hz, I H, pyridine H-5), 8.85 (d, J = 9.3 
I Iz, 111. pyridine 11-4). 
C XMR (1(1) MHz, DMMSO-cJ,,) 	: 	O 14.2 (CHI), 20.0 (C-3"), 21.5 (CH;). 61.7 
(C -2"), 91.9 (C -3'), 106.2(C-5'), 119.7 (C-5), 
120.2(C-3). 1422(C-4), 151.2 (C-2). 156.19 
(C-6), 163 2, (C-6'), 163.4 (C-2'), 164.4 (C-
1"), 1$2.5 (C-4'). 
[Si-MS 	 : 	(m/:) 289.15. 
Elemental analysis for C,<1INO 	Calculated C, 62.34; H, 5.23: N, 4.84; 
Found: C. 62.22; H, 5.14, N, 4.71. 
83 
3-. I cett'I-6-(!-lyrfro•11-6-metlzrl-2-oxo- II-1 -pyrun-3-y1)-2-»ictlr} 1 	ridi,ze (180 b) 
Purified by recrystallization from ethanol-chloroform (3:2 v/v) mixture. 
Light VL'llo\v solid. 
N1.1i. 	 201-205 °C. 
IR (KRr) cm - ' 
	
3336 (011), 1695 (C=O), 1672 (C=O), 1621 
(C=N). 
1-I N.IR i; 30O NIIIz. CD('I:) 
C \\IR ( 100 Mllz. MISO-4l(;) 
r) 2.17 (s, 3I-I, C1-I 3), 2.69 (s, 311, CH). 2.75 
(s, 31-1, COCI-I,), 5.96 (s, I H, H-5'), 8.62 (d, J 
= 9.0 Hz, 1H, pyridine H-5), 8.68 (d, J = 9.3 
Hz, 1 H. pyridine H-4). 
O 14.3 (CH3), 20.2 (C-2•).21.7 (CH;), 92.4 
(C-3'), 105.27 (C-5')• 120.0 (C-5), 121.5 (C-
3), 142.3 (C-4), 151.2 (C-2), 156.2 (C-6), 
163.2 (C-6'), 163.4 (C-2'), 180.29 (C-4'), 
196.76 (C-I"). 
(ES!-\1S) 	 (ml) 259.12. 
Elcmcatal analysis for C'141K;NO4 : 	Calculated C, 64.92; H, 5.05; N. 5.40: 
Found: C, 64.81; H, 4.92, N, 5.28. 
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-I)inretlrvl-5-oxo-2-(d-/ndroty-6-methyl-2-oxo-2H-1 pyran-3-y1)-5,6,7,8 
tetralivdr•oquinoline (I 81)c 
Pusif 26 by re crystallization from eth rnol. 
Light v ello%% solid. 
Nip. 	 : 	==300 T. 
3088 (011), 1692 (C=0), 1616 (C-N). 
v 1.17 (s, 6H, 2XCH3). 2.22 (s, 3H, CH,), 
2.57 (s. 21-1, CH,), 3.02 (s, 2H, Cl-1,), 5.93 (s, 
) H, 1-1-5'), 8.42 (d, J = 9.0 Hz, ) H, pyridine 
H-3), 8.93 (d, J= 9.9 Hz, 1H, pyridine 11-4). 
()20.10  (CH3), 28.2 (CH3), 30.9 (CH3), 33.2 
(Cl-!;). 42.6 (C-8), 51.3 (C-6), 92.9 (C-3'), 
105.7 (C-5'), 120.7 (C-3), 	122.9 (C-10). 
137.8 (C-4),153.2 (C-2), 157.9 (C-9), 163.0 
(C-6"), 163.7 (C-2'), 182.2 (C-4'), 194.0 (C-
6). 
(ml) 299.16. 
Calculated C, 68.28; H, 5.73, N, 4.54. 
Found: C. 6$.15, H, 5.61, N. 4.54. 
IR KBr) cni 
'II N\iR (300 Mlllz. ('DC1;) 
1 'C' NN1R (100 \)Il lz. DNISO-d';) 
ESI-NIS 
Elemental analysis for C: -Hi-NO4 
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-(.J-IIydI y-6aa iet{•(-2-oxa-2II-pyran-3- I)-2,2-dh;wthyi-l,3-dloxu-8-u u-quinoline_4- 
one (IS'Od) 
Purified by rectystallization from ethanol-chloroform (4:1 viv) mixture. 
Brown solid. 
M.p. 
IR (KBr) cm-1 
H \\IR (300 %11Iz. C1)(1:) 
1 C \\ I R ( 100 M 11 . 1)\ ISO-c1,) 
ESI-\lS 
1::I.mentaI analysis f or C r 4 I ::~O~,  
>300 "C'. 
3283 (01-1), 1735 (C=O), 1688 (C=O), 1616 
(C—N). 
O 1.61 (s, 6H, 2XCH;), 2.22 (s, 3H, CH3), 
5.89 (s, IH, H-5'), 8.45 (d, J = 9.0 Hz, 1H, 
pyridine H-6), 9.06 (d, J = 9.0 llz, 111, 
pyridine 1-1-5). 
620.1 (CHI), 27.1(CH;). 27.8 (CH). 92.9 (C-
3'), 105.7 (C-5'), 106.0 (C-2), 115.5 (C-10), 
119.4 (C-6), 138.4 (C-5), 151.2 (C-7), 153.4 
(('-9). 163.1 (C-6'), 163.5 (C-2'), 164.0 (C-
4), 183.2 (C-4') 
(,n.ih) 303.11. 
Calculated: C. 59.40: 1-1, 4.29: N, 4.60; 
Found: C, 59.53; H, 4.13, N, 4.72. 
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2-(1-1{t'1ruxt -G-nretht'! Z-uxo-21I-1-pti run-3 y!)-p}'rldu/2,3-G/-ctiruncuri- -uiie (180ee) 
Purified bv- recrvstallization from ethanol-DMF (8:2 v/') mixture. 
White solid. 
Nip. 	 : 	>300'C'. 
IR (KBr) cm1 	 3445 (OH), 3085 (OH), 1707 (C=O), 1670 
((=0), 1612 (C=N). 
11 NAIR (300 v1Hz. CDCI:) 	: 	ri 2.22 (s, 3H, CH;), 5.94 (s, 1H, H-5'), 7.41- 
8.10 (m, 4H, Ar-H), 8.57 (d, J = 9.6 Hz, 1H, 
pyridine H-3), 8.92 (d, J = 9.0 Hz, 1H, 
pyridine 11-4). 
'C N\IR (100 MHz. 1)\iSO-d,,) 	ri 19.4 (CH3), 94.9 (C-3'). 105.9 (C-5'). 1 18.4 
(C-4a), 117.8 (C-6), 120.1 (C-3), 127.5 (C-
Sa), 129.8 (C-7), 137.7 (C-8), 138.7 (C-9), 
139.9 (C-4), 152.5 (C-1), 154.4 (C-9a). 162.1 
(C-2'), 162.7 (C-lOa), 164.5 (C-6'),172.7 (C'-
5). 180.2 (C-4') 
F:SI-\IS 	 : 	(rni_) 321.30. 
1lemcntal analysis for 01 ,111 i N0 	: 	Calculated C, 67.35; 1-1, 3.45. N; 4.35. 
Found: C, 67.20; H, 3.56, N. 4.48. 
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-(I-)Idray►-6-nrct1t►'1-2-o.vo-3H-1 pl'run-3 .rl)-I 1I,31I p vrido/2,3-dJpt-rinriditte-2,4- 
dione (180J) 
I'Lu I l d by recrystaIIIzation ti,om ethanol-chloroform (8:2 v: v) mixture. 
( )rari.e "Aid. 
\l n. 
lR KBrI ctu 
II N\iR (30O MIIz. CD('l;) 
C NNIR I 100 Nillz. I)\ISO-(/,,) 
F l-\lS 
Elemental analysis for C ; :I I.,NIM  
>300 T. 
3396 (011), 322 (NH). 3038 (NH), 1684 
(C=O), 1620((.'-N). 
J2.12 (s, 3H, CH;), 5.83 (s. 1H, H-5'). 8.07 
(d, J = 10.9 Hz, pyridine H-6), 8.48 (d, J = 
1().9 1 Iz. pyridine 11-5), 9.97 (s, 1 H. NI-I), 
10.10 (s, III. NI1). 
,> 19.5 (CI-I3), 96.1 (C-3'). 104.6 (C-5'), 119.6 
(C-10). 125.6 (C-6), 147.6 (C-5), 151.1 (C-9). 
153.8 (C-7), 155.5 (C-2), (163.6 (('-4). 161.7 
(C-2't. 164.6 (C-6'). 194.4 (C-4') 
(nriz) 287.13. 
Calculated C, 54.40; 1-1, 3.16: N. 14.64; 
Found: C. 54.26.: F1, 3.08, N. 14.51. 
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1,3-/)iWzsdzt•/-7-(4-/r;•drox v-6-»ret/z v/-2-uxu-211-1-pav-an-3 yI)-111,311-pyrido[2,3-dj 
j,yiurIciric-2,-l-diU!le (18(h) 
lwitkd b\ rervs11izition from ethanol-chlorotbrm (8:2 v v) mixture. 
Oratt'c solid. 
NI h. 
I R KBr) em 
II \\IR 03O0 %I11i. C1-)(1:) 
C \NIR (I00 MitIz. D\1SO-~1,.) 
E1en natal analysis for C: -ll ; ,.H;OS 
239-241 °C. 
3169 (OH), 1700 (C=O), 1620 (C=N). 
a 2.13 (s, 31-1, CII;), 3.14 (s, 611, 2xNCH3), 
5.86 (s. H. H-5'), 8.20 (d. .1 = 9.6 Hz. IH. 
pyridine H-6), 8.57 (d, J = 9.6 Hz, 1H. 
pyridine 11-5). 
O19.6 (C113), 27.0 (2N-CIh). 95.9 (C-3'), 
105.0 (C-5'), 124.4 (C-6), 125.2 (C-10), 
148.3 (('-5), 151.9 (C-9), 154.6 (C-7), 160.9 
(C-6'), 163.9 (C-2'), 164.8 (C-2), 164.9 (C-
4). 182.4(C-4') 
(mi) 315.16. 
Calculated C. 5.19: 1-1, 4.16: N. 3.31. 
Found: C. 57.08; H, 4.04, N, 3.18. 
TI: ioxo-"-(4-!rt•droxt•-h-nretht'1-2-oxo-211-1 pyran-3 _yl)-1H,311 pi'ridof2,3 
d/pFrimidinc!--1-otiC (1(S'(lli) 
Purified by rcovsiallization from ethanol-DMF (8:2 viv) mixture. 
\I. 	 . 
II. (I'Br)em 
H \\IR ( 00 \11-1i. ("D('l:) 
: IC N\1R (I ((0 \illz. D\ISO-J .,) 
FS1-\1S  
>300 °C. 
3392 (O11), 3201 (NH), 3026 (NI-I), 1707 
(('-=0). 1620 (C—N). 
Ji 1.15 (s, 31-I, CH). 5.90 (s, 1H, H-5'). 8.20 
(d. J = 9.9 Hz, I H, pyridine H-6), 8.46 (d. J = 
11).4 Hz. 111, pyridine 1-1-5), 10.20 (s, IH, NH). 
10.92 (s, IH, N11). 
r) 19.6 (Cl-h), 97.0 (C-3'). 104.1(C-5'). 121.1 
(('-10), 123.2 (C-6), 146.4 (C-5), 151.6 (C-9), 
154.2 (C-7), 161.3 (C-6'), 162.0 (C-2'), 164.6 
(('-4). 175.6 (C=S). 184.4 (C-4). 
(nil) 303.15. 
Elemental analysis for C 	;N;U.4S : 	Calculated C. 51.53: H. 2.99. N. 1-1.`2; 
Found: C, 51.39: H, 3.14, N, 13.65. 
Mo 
2.8. (oXCLIS10N 
In conclusion. in this chapter we have described it convenient and efficient process fir 
the >\ titkesis of novel py raurle and pyranyl pyridine derivatives from -enaminones under 
thermal solvent-tree condition usine NaHSO4—Si02 as an efficient catalyst. Present 
niethodologv offers very attractive features as excellent yields of the product in shorter 
reaction time, simple work-up procedure. economic viability and reusability of the 
catalyst. \Ve believe that this method has provided a better scope for the synthesis of 
pN riclinc and pyrazole derivatives and will be a more practical alternative to the other 
exiStin-, methods. 
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CHAPTER 3 
Zn[(L)PROLINE]1-WATER: A GREEN CATALYTIC SYSTEM FOR 
THE SYNTHESIS OF BENZOPYRAN RING SYSTEMS 
Catalysis Science and Technology, 1, 2011, 810-816. 
Journal of Chemical Sciences, 124, 2012, 1097-1105. 
3.1. REVIEW & LITERATURE 
the design of chemical products and processes that reduce or eliminate the use and 
generation of hazardous substances has led to the design and application of catalysts and 
catalytic systems to achieve the dual goals of environmental protection and economic 
benefit.' Catalysts are distinguished into homogeneous and heterogeneous catalyst. 
Homogeneous catalysis play a key role in the development of greener, more sustainable 
chemical processes and are powerful tools for the synthesis of tine chemicals, 
pharmaceuticals and materials. Homogeneous catalysts offer a number of important 
advantages over their heterogeneous counterparts. For example, in homogeneous catalysis 
all catalytic sites for reactants are accessible. Therefore, they are higher yielding, more 
selective, reactive and easily studied from chemical mechanistic aspects for a single 
product, and more easily modified for optimizing selectivity. However, their exploitation 
on an industrial scale is often held back due to the challenges of separating and recycling 
the catalyst. Therefore, development of new recoverable, and recyclable homogeneous 
catalysts is an important area of research for both industry and academia alike.2 
To reduce the dependence on ecologically unsafe chemicals, it is advantageous to carry out 
reactions in water? In recent years, water-mediated organic synthesis without using 
organic solvents has been accepted for wide range of organic transformation including 
stereoselective Diels-Alder reaction,4 Clasien rearrangement 5 Aldol reaction,6 allylation 
reaction.7 oxidation including asymmetric epoxydation. hydrogenation of alkenesv etc. 
This strategy becomes more attractive if such reactions could be carried out using 
recyclable catalyst. So there is an urgent need to develop such methodologies which can 
fulfill both these requirements efficiently. 
On the other hand, Lewis-acid catalyzed organic reactions in water are currently one of the 
most challenging topics in organic synthesis because they allow environmentally friendly 
processes under mild conditions. 10 Over recent years, Zn[(L)proline]2 mediated Lewis acid 
catalyzed reactions have attracted tremendous interest throughout scientific communities 
due to their low toxicity, ease of handling, low cost, stability and easy recoverability from 
water' 'This complex is soluble in water but insoluble in organic solvents, which allows 
simple and quantitative recovery of the catalyst.12 Its ability to work both in a solvent and 
under solvent-free conditions is also the salient feature of this catalyst.Thus, 
Zn[(L)proline]2 has emerged as powerful catalyst for a wide range of organic 
transtormations. 
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3.1.1. Some recent examples of Zn~(L)proline]2 catalyzed organic reactions under 
green environment 
3.11a. Zn((L,iprolinej2 catalyzed direct aqueous aldol reactions of aldehydes and ketones 
for the synthesis of carbohydrates 
llarbe et.al in 2005 first time report the Zn[(L)proline]2 catalyzed synthesis of 
carbohydrate by the reaction of a-hydroxy aldehydes and ketones via aldol condensation in 
water in varied yields. 13 
O 	OH 0 
Xt 	H Zn[(LlProlineJ l 
	
~~ 	>mal%,Water 
X 
X= 2-NO7, 4-NO2, 2 Br, 4-F, 4-CN, 2-CL 4-CL 2-CHI, 2-OCH3, 4-OCR3, 3-OCH3, 4-CF3. 
n,htlryl 
3.1.1 b. Znffl)prnlinj2 as a reusable catalyst for the synthesis of pyrirzoles. 
An efficient synthesis of pyrazole derivatives in pure water at room temperature in the 
presence of 2 mol % of Zn[(L)proline]2 catalyst is reported . This reaction proceeds 
smoothly and affords the product in moderate to excellent yields (80-90%). 14 
R3 
O 	O 	 Zn(Proline)i.  
` R3NHNH,  
lil 	R~, 	
wa[eq el. 
Ra 
R, = CH;, OC,H5, 	 R3 = Ph, H, Ph,CH,CO, PhCO, 2,4(NO2 hCH3 
R; = CI I], OC2H5 
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3.1.1 c. Microwave assisted Zn((L)proline/1 catnfyzed synthesis of 1,4-dilrydropyridines 
via tfantzsch reaction and 1,5-benzodiazepine derivatives 
Sivanurugan etal.'5 developed an efficient green synthesis of 1,4-DHP derivatives 
catalyzed by Zn[(L)proline]z complex in aqueous medium under microwave irradiation 
via Hantzsch reaction. This synthetic methodology provides easier separation of products 
in excellent yields. 
O R, O 	 0 R, 0 
O~~II 
R 	i 	Rx02mmol 
_________________ 	 R_ 
H;C 	O O 	MW 	 H,C 	N 	CH, 
R, - C41c, 2-fun!, 3-indolyl 
R, = OC,H,, CH3. OCH, 
34-(CI 13())C611,, 4-0I CH, OCblh 
X NOz, OH, Cl 
x - 
In 2010 they also described microwave assisted green protocol for the synthesis of 1,5- 
ben(zodiazepine derivatives in excellent yields." In each conversion, the catalyst was 
successfully recovered and recycled without significant loss in yield and selectivity. 
Ri 
RI~ 	 H Ri R, 
	
NH, 	 N 
O 	Zn((L)Prnlinc)i  
NII 	 (12 mmol. iw 	 N~ 
~ RI 
R 	 R i - CHj, CH,CH3, CH3(CH2)s 
Ri 
X=OH,CI 
X~- 
It_ =CI 1). CH,CI1, (CI 12)4, H 
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3.1.1 d. Znf(L)proliue/,mediated Henry reaction in aqueous media 
Reddy et. aL" reported an efficient synthesis of 2-nitro alcohols through Henry reaction 
under ambient conditions catalyzed by Zn[(L)proline]2 complex using environmentally 
benign solvent, water, as the reaction medium. The advantages of this protocol are high 
catalytic activity under very mild conditions, easy operation, and recyclability. 
O 	 OH 
	
I \ 	H 	tnI0.11'rollneJ2, 10  Oz 
Xif 	I 	+ CH,NO, 	 —~ Water, rt x 	/ 
X = p-NO,, o- NO,, NC, 0-Br! OMe 
3.1.1 c. Zn((L)prolinel2 as a water-soluble and recyclable Lewis acid catalyst for the 
syntitesis of 1,2-disubstituted benzimidazoles 
Rao et al reported an efficient procedure for the selective synthesis of 1,2-disubstituted 
benzimidazole derivatives from various electronically divergent aromatic aldehydes and o- 
phenvlendiamine using Zn[(L)proline]2 complex as an efficient Lewis acid catalyst. 
R 	Nil, 	Ho 	R 
\ 	\I Zn(L)Vrollnc],, 5  
NH1 	R, II2425C 
 
R,Ri =II 
R=CII,, R,= CH; 
R=CI,RCI 	 \R 
z 
Rz = CHy OCH;, NO, 
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3.1.1 f. Zn j(L)prolineJ2 catalyzed synthesis of Quinoxaline and pyranoJ2,3-d]pyrirnidine 
Heravi et.al'9 reported a simple, efficient, and ecof iendly method for the synthesis of 
functionalized quinoxalines from various 1.2-diketones and 1,2-diamines at room 
temperature in excellent yields within a short period of time. 
R 	 R ~ 
O Hi
N 
Zn(LPraline)2 
IOmol% \ N  
Acetic acid, r%. 
K R 
R, H,CH3 N% 
R = H, OCH„ F, CI 
These authors also reported the Zn[(L)proline]2 catalyzed synthesis of pyrano[2,3- 
d]pyrimidine derivatives from aldehydes, malononitrile, and barbituric acid in refluxing 
ethanol.`' 
O 	 0 Ar 
yII~ H 	CN 
HN 	A,CHO—~ eN Zn(L-Proline)z 17 mni% N 
ONO 	CN FuOH, Ref L, 	O~ i O NH, 
H 	 H 
Ar = p-Me, p-NO,, o-CI 
3.1.1p,. Zn((L)proline/z as a reusable catalyst for the synthesis of p-amino carbonyls via 
Mannich reaction 
Recently. Zn[(L)proline]2 catalyzed stereoselective synthesis of /l-amino carbonyl 
compounds in excellent yields via Mannich reaction has been reported by Kidwai et.al?I 
Reactions took 10-12 hat room temperature for completion with yields 85-93%. 
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CHO 	NH1 	0 	 0 kIN 	 R. 	H i 00. 
\ 
	
R2 	 SYn  
RI-H 	R?H, 
4-Cl 4-Cl, 
4-CUB 	3-CII, 
furvl Ph 
4-OCM3  
3.1.1 h. Zn/(L)prolineJ2 catalyzed synthesis of chromonyl chalcone 
Synthesis of chromonyl chalcones by reaction of 3-formylchromone with various 
substituted heteroaryl methyl ketones in water using Zn[(L)prolincj2 as an efficient Lewis 
acid catalyst was reported by Siddiqui et al .22 Reactions were completed at room 
temperature in 15-30 min and products were obtained in excellent yields. 
o o 	 O 	O 
R 
Zn(ymline)x R 	 H   
+ HNC—C—Q 
/ 	 II 	Wnleq eflax  
O 0 
R = H. CH, Cl 
\ }OII~ 	O OII 	
f
H 	OH 
O N O p N O O N 5 O O CHI p o 
3.1.1 i. Zn[(L)protineJ2 catalyzed Knoevenagel condensation under solvent-free/aqueous 
conditions 
They also reported the Knoevenagel condensation of 5-chloro-3-methyl-l-phenylpyrazole- 
4-earboxaldehyde with different cyclic active methylene compounds in water as well as 
under microwave irradiation in the presence of catalytic amount of Zn[(L)protinc]z? The 
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reaction proceeded smoothly and afforded the products in excellent yield (90-95%) within 
5-9 min. 
H 
Znhl )Prolhalz 
- 2h 	 —~ 
N 	CI 	 Water 
Ph 
Water ~Zn [(L)pro line]i 
H 
I ILY 
N 
V 
Ph 	o 0 Y 
= tl 	/ 	 I/ S 	 ~ N 
0 
	
o H O O Y 
Ch 
Y-H, CHI 
I 	 x=O.S 
N O 0 / O O CHo 
IIL 
3.2. PRESENT WORK 
In continuation of our efforts in developing selective, efficient, mild and ecofriendly 
synthetic methodologies for the preparation of biologically relevant benzopyran 
derivatives herein, this chapter we describe mild, practical and convenient synthetic 
protocol for the synthesis of benzopyran derivatives using Zn[(L)proline]2 complex as a 
water-tolerant Lewis acid catalyst in water. Use of water soluble catalyst has the practical 
advantage that the catalysts can be reused after simple extraction of the water-insoluble 
products, provided that the catalysts show high catalytic activity in water. 
This chapter is divided into two sections. 
Z—O 
I10 	O 
0 
1 N\N 	O Z 
Ph 
CH=C-CH3 
Ph 
tET 
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SECTION A: SYNTHESIS OF DICOUMAROLS 
In this section, we have described the synthesis of dicoumamis in the presence of 
Zn[(L)proline)2 as an efficient, environmentally benign, water-tolerant, Lewis acid catalyst 
in water. 
[he dicoumarol is a naturally occurring anticoagulant drug that functions as a vitamin K 
antagonist and obtained from metabolism of coumarin in the sweet clover (Melilotus alba 
and Melilotus offieinalis) by bacteria Penicillium nigricans and Penicillium jensi.24 
Dicoumarol and its synthetic derivative warfarin sodium (coumadin) have shown to 
decrease metastases in animal models25 In clinical trials, these compounds have also 
demonstrated to have some activity against prostate cancer, malignant melanoma, and 
metastatic renal cell carcinoma.21  Compounds with this ring system also possess various 
other pharmacological activities such as insecticidal. anthelmintic, hypnotic, antifungal, 
phytoalexin, HIV processes inhibition, antimicrobial and antioxidant.2' Further, 
lanthanum(lll) complexes of dicoumarol have been reported to show potent cytotoxic 
activity 2e During the last decades, due to the importance of dicoumarols, several methods 
have been adopted for its synthesis viz use of DB1J,29 (Et2AIC13), 0 refluxing ethanol or 
acetic acid,31 molecular iodine?' POCl3 in dry DMF,33 manganous chloride b4 and thermal 
solvent-free reaction conditions35 etc. However, in spite of their potential utility some of 
the reported methods suffer from certain drawbacks such as long reaction Lime, expensive 
reagents, harsh conditions, low product yields and use of toxic catalysts that are harmful to 
environment. 
therefore. it was thought worthwhile to develop a new and mild protocol that overcomes 
the drawbacks of classical catalysis for the synthesis of dicoumarol derivatives in terms of 
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operational simplicity. reusability of the catalyst and economic viability. The present 
protocol provides a better alternative to the existing methods due to its shorter reaction 
time period, simpler reaction procedure and the formation of cleaner products in excellent 
vieIcl:. 
3.3. RESULTS AND DISCUSSION 
4-11,, droxvcoumav-in (29) ring at position I is highly reactive due to the presence of an 
elcen-on donatin t OH `Lroup and an electron withdrawing carbonyl group. The presence of 
a carbon Carbon double bond and a lone pair of electrons from oxygen make the euumarin 
ring very convenient at position 3 to react with the carbonyl group of aldehydes (181a—j) 
to give dicQtnnarD1 derivatives (182a—j ). In the present study various dicoumarol 
derivatives were synthesized employing a variety of aromatics heieroaroWlatIe aldehydes 
181 a—j) and 4-hyclrox\coumarin (29) in the presence of Zn[(L)proline]2 using water as 
reaction merunc (Table 8. Scheme 64). 
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Table 8 Reaction of 4-hydroxycotunarin with aromatic`heteroaroinatic aldehydes 
catalyzed by Zn((L)proline]: complex in water 
	
Entry 	Aldehv de 	Product 	Time (nun) 	Yield (°/u) 
C110  
182a 	c, 	o ~, ' 	5 	92 
Oil 
I \ 
0110  
182b II  '5 	 96 
' OIf 
CIIO  Oil 	(>H
~ 	~ I 
182c 	aoll  ' o 0 0 0 / 	9 	92 
CHIO 4 ~ 
182d 	('I 
('Ho 	cJl~ 	~~Ci~HI 
1822 	/ Cl 	o (~ (~ o 
6 	94 
5 	96 
NO- 
OH / OH 
1821 	NO2 	~!~U'~O o u 	 j 	 93 
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CHO 
ills 
182g 	OCII 
Cl 10 	i)tI 	OH 
182h 	 O O 
Mc 
C 110 
\ S 
S 
1821 	Mc 	O(1 r) O 
N 
CI K)  
1 821 \ 	 O 0 OHO  
8 	 91 
7 	73 
6 92 
5 91 
To validate our hypothesis and achieve catalytic evaluation of Zn[(L)prolinc]2, initial 
studies were carried out using 4-hydroxycoumarin (29) and 4-hydroxybcnzaldcltydc 
1 181 b) a: a model reaction under various rCaction conditions. 
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R 
OH 	 ZO[OHCHO
~O O R 'Hazer reflus p p 
29 	181a-j 	 182a-j 
Scheme 64. Synthesis of dicoumarol derivatives using Zn[(L)proline]2 catalyst in water 
3.3.1. Effect of various catalysts 
In order to show the superiority of Zn[(L)proline]2 over other catalysts various Lewis acids 
for the model reaction were used (Table 9).Our investigation revealed that the catalytic 
activity was found to be of the order: Zn[(L)proline]2 >AICI3> P_,05/silica gel >NiC12> 6M 
HCI>CuCl2>L-Proline>FeCI1>ZnCh>PTS. Initial examination indicated that 
Zn[(L)proline]2 was superior to other catalysts in terms of yield and reaction time. When 
the reaction was examined with AICl3. P205/silica gel, 6 M lid. NiClz, CuCl2, the reaction 
was completed in relatively short time (15-35 min) and the product was also obtained in 
good to moderate yields, but they generated harmful waste, which were harmful to the 
environment. Using L-Proline. ZnCl2 and FeCl3 the reaction furnished desired product 
(1826) in low yields whereas in the presence of PTS (p-toluene sulfonic acid) no product 
formation was observed. From Table 9 it is, thus, clear that Zn[(L)proline]2 exhibited the 
highest catalytic activity over other catalyst for the synthesis of 1826. 
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Table 9 Effect of various catalysts on the synthesis of 182b in water. 
Entr\ 	 Catalyst 	 Time 	 Yield(%) 
I Znj(L)proline], 5 min 96 
AICI; 15 min 89 
P O 	silica gel 20 min 79 
4 NiCI- 15 m111 75 
S 6N1 1101 15 mill 68 
6 Cu('1- 35 mill 54 
L-Proline 25 min 40 
FeC l ; 35 1111 25 
9 ZnCI- 48 h 24 
10 PTS - - 
No reaction 
3.3.2. Loadin oft/ice eatali-st 
The et'tcct of catalyst loading on the synthesis of 182b was investigated by varying the 
catalyst amount lrom tJ to 15 niol % (Table 10). When the reaction was performed by 
using less catalyst loa. hlrg t0 to 2.5 viol ",/u) reactions were either incomplete or took longer 
time for completion. An increase in the quantity of Zn[(L)proline]; from 2.5 to 5 mol % 
not only decreased the reaction time but also increased the product yield from 52 to 96 % . 
Further increases in the amount of catalyst had no significant change in the product 
formation. Thus. optimum catalyst loading was found to be 5 nlol % for the formation oi-
111Coltt11arols. 
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"Table 10 Effect of catalyst loading; on the synthesis of (182b). 
Intro 	 Catalyst (mo1 %) Time Yield (%) 
1 	 (1  48h 52 
' 	 2.5 1it 72 
5 	mill 96 
4 	 10 5 mill 96 
IS 5 inln 96 
3.3.3. Effect of','aI uuS solvents 
To compare the efficiency as well as capacity of the reaction under aqueous conditions, the 
Model reaction was also examined in various other protic and aprotic solvents (Table 11). 
It was uhservc(l that usint relatively less polar aprotic solvent Cl 12C12 the product was 
obtained in very low yield after a long period of time (entry 4). Employing aprotic solvents 
of relatively high polarity, 0 ];CN (entry 5), only trace amount of product formation was 
observed. In polar probe solvents CH;OH and CH;COOH relatively high yield of the 
product was obtained but reaction took longer reaction time period for completion (entries 
2 and 3. 1 lowever, when the reaction was performed in water, the reaction was completed 
S inn and the product %\ as obtained in excellent yield (entry 1).Thus, our study revealed 
that water was the best solvent for the ZnL(L)prolinel2 catalyzed formation of dicoumarols 
in terms of reduced reaction time and the maximum yield of the products. 
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Fable 11 Solvent Effect on the synthesis of (182b) in the presence of Zn[(L)proline], (5 
nlul °o). 
Entry 	Solvent Time Yield (%) 
1 	 H-O 5 min 96 
yleOI I 35 min 85 
CH:C'00H 45 min 65 
4 	 C11 1C1- 24 hr 32 
5 	 CH:C'N reaction not completed trace 
3.3.4. Catalyst recj•clin, crhilitt' 
Recycling study of Zn[(L)prolinc]2 was checked by using model reaction. Reaction of 4- 
hvdroxycoumarin (2 mniol). 4-hydroxybenLaldehydc (1 mmol) and Zn[(L)proline]_ (5 mol 
„) itti water t 10 ml .i were thoroughly mixed and retluxed for an appropriate time. The 
progress of the reaction \\ as monitored by TLC (Table 12). After completion of the 
reaction the crude product was extracted with dichloromethane and the catalyst was 
recovered by separation of aqueous and organic phases. The catalyst was recovered by 
precipitatifi,, the aqueous hi er by simple addition of acetone. Then, the catalyst was 
tiltered, dried at 80 ''C' for 2 h and used for the next cycle, adopting the same procedure for 
all the recycling studies. The results ("Table 12) revealed that the catalyst exhibited good 
catal\ tic activity up to three cycles without appreciable loss of its catalytic activity and no 
iimartinal difference +ii the yield of the product. After three cycles there was slight decrease 
in the VICKI of the product and it may be due to loss of catalytic activity of the catalyst as a 
rc alt of decomposition. 
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Table 12 Rccvclin<, studies of catalyst for model reaction 
Catalyst recycle 	 Time (nmin) 	 Yield (%) 
1I 	 5 	 95 
III 5 95 
IV 6 92 
The scope of the reaction was further investigated with different aldehydes with viable 
catal st. and the results obtained were satisfactory. 
The structural assignment of all the compounds (182a—j) was done by elemental analysis 
and spectroscopic data (IR. NMR and mass). The IR spectrum (Fig. 18) of the newly 
sFtuthe:itcd dicoumarol L182j) exhibited strong absorption bands at 1610 cfn* 1689 cm"I 
and 31 ;" cm _ 1 for C=C. ccn marin carbonyl and OH groups respectively. The 'H NMR 
(Fig. 19) exhibited a sharp singlet at 6 6.42 for methine proton. Twelve aromatic protons 
( tour protons of a pyridine moiety and eight protons of a couniarin unit) were discernible 
as multiplet in the range ci 6.90 18.64. Further confirmation for the structure (182j) was 
prov ided by mass spcctroscopv (Fig. 20) Inch showed M at ni/ 413 as base peak. The 
spectral iiata of other compounds followed similar pattern and are given in experimental 
section. 
The proposed mechanism for the Zn[(L)proline~_ complex catalyzed synthesis of 
dicoumarol derivatives can be visualized as given in Scheme 65. 
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SECTION B: SYNTHESIS OF 2-HYDROXY-4-CHROi IANON E:S 
This section of the chapter tacuses on the application of the Zn[L(proline)J2-water catalytic 
;v,tems for the synthesis ut ? hydroxt'-4 ebromaaQne derivatives by the reaction of 3- 
t(tnl\Ic1ronlonc (64) with different primary aromatic and hcteroarotmatic amine (183a-j). 
It is worth mentioning that chromone moiety forms an important component of 
pharmacophores of a number of biologically active molecules of synthetic as well as 
Itatural origin.'" Chromone and their derivatives are found in nature as pigments in plant 
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leaves and flowers. They are important for the synthesis of various oxygen heterocycles 
including xanthones and transition metal chelates"They are widely present in nature and 
exhibit low Ioxicily along with n wide variety of useful properties." They are also 
reported to exhibit signi ticant biological activities including anti-inflammatory's 
and iallergic.40 antibacterial,4 L neuroprotective,12  anti IIN;' antioxidant,1"1 antifungal4' etc. 
They also display spasmolytic. cardiotonic, antiarrhyth micand anticancer properties.'s "t 
Among the various chrrnnonc derivatives, 3-forrnylehromone (4-oxo-411-1-benzopyran- 
3-caiboxaldchydc) have attracted considerable attention as highly reactive compounds, 
which can serve as the starting materials in syntheses of a whole series of heterocycles 
with useful properties due to three strong electron deficient centers viz u. 	unsaturated 
kern function, a carbonyl group in the form of formyl group at position 3 and a very 
reactive electrophilic centre at C-2 ever since its convenient synthesis was reported by 
Noltara et.al.'s 
On the other hand, chromanones are widely distributed in many natural products.49 
Synthesis of ehromanones is of great interest in the field of organic chemistry because they 
display 'a remarkable domain of biochemical and pharmacological actions 5° They exhibit a 
wide variety of well documented biological activity including antioxidant?' antibaemrial,52 
antimalarial,' anticancer,-' antifungal,°!  topoisomerase I inhibitor.'6 antidiabetic', 
antiarrhylhmic53, psychoanaleptic, antiarnocbic and antidepressant properties s1  etc. Some 
ehtummnorc derivatives have been evaluated for I,, viirn antiviral activities against human 
immunodeficiency vu-us (HIV) and Simian immunodeficiency virus? °' They have also 
been claimed to be active in photosvnthesisb  and have hereditary bleaching affect (similar 
to antibiotics) on the plastid system of Euglena grad//s. ss Other 4-chromanones 
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derivati\ es have also been tt and useful in the treatment of bronchial asthma. `0 As a result, 
or the synthesis o}- 4-chromanone derivatives, different methods have been developed."4-` '' 
Unfortunately. many of these methods have certain drawbacks such as prolonged reaction 
time. use of toxic and volatile organic solvents and varied yields. The replacement of these 
hai.ardous Solvents with the environmentally benign solvents is one of the key areas of 
iireen c11emistry."', Hence. a more general and efficient method for preparing 4- 
cbnitNanQnes in high yield needs to be developed. 
3.4. RESULTS AND DISCUSSION 
Due to the exceptional reactivity of formyl group in 3-formylchrolnone as well as versatile 
biological activities of chromone, a series of 2-hydroxy-4-chromanone derivatives were 
svnthcsized employing ;-formylchromone (64) and different aromatic /heteroaromatic 
atitUfes (1$3a-.1). Usually. chrGltllonCs undergo ring, opening reactions via nitcleoplillc 
attack at the C-? position.`' The reaction between equimofar quantities of (64) and 
aromatic amines (1 S3a-j) affords a mixture of (184a) and (184b) which are difficult to 
5el rZIte (Scheute 66 
_ , 	I 	\ 
6 	4 010 	 CH =N 
64 	 18-la 
R 
U Nil \ 
•ii ,V 
txab / 
Scheme 66 
12S 
The Schitt base (l84a), however, has been obtained when a mixture of (64) and aromatic 
w»inc, is retluxed 161, two to several hours in organic solvents (benzeneitoluene,r " u 
ethanol ' In the presence of p-toluene-sulphouic acid (PTS) in varied yield (low to good). 
]n order to achieve the synthesis of(I8-1a) under orccn environment, a mixture of'(64) and 
different aromatic hetcroaromatie amines (183a-j) was relluxed in water in the presence of 
7.n[(L)prolincj2 . All the reactions were found to be completed within 10-15 min and 
aatlorded unexpected chroinanonc derivatives (1 85 -j) in excellent yields (87-93%) instead 
of' Schiff base (184a) (Table 13, Scheme 67). To further evaluate the scope of this 
protocol and following our catalysis objective, a variety of amines possessing both 
electron-releasing and electron-Withdrawn;, groups were employed. According to the 
table. the nature of' the substituent on the benzene ring did not affect the reaction time and 
the yields were excellent. 
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Fable 13 Ln [(1.)pro1inc], catalyzed reaction of 3-formylchromone (1 inmol) with amines 
(1 mmol) in e ater. 
Entry 	 Reactant Product Time (min) Yield (%) 
183a , 	 `— 10 93 
2 	 18311 cll-xH-~N 10 92 
183c 
O 	(III 
J _ 12 $9 
C11—\i4 	Ctl; \ / / 
l 	 183d 	 1J 	 89 
(I 
183e   	10 	90 
Q 
1, 	183t' 	 15 	 SS 
o 	011 
183g 	 _ 	10 	90 
0 	Oil 
183h 2 
p 	Ulf 
183i 	I 	v 
H—NII` 
\ / 	1 	q" 
\ 	~ -CI 
U 
U 	OH \ 
1$3j 12 	 9~  
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IY3:i-j 	 11i5a-j 
S 
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Scheme 67 
\ll The newly synthesized compounds were characterized using elemental and 
spectroscopic data. Thus, the infrared (IR) spectrum (Fig. 21) of (185a) displayed an 
absorption band at 3 355 eni ' and 3280 cm' due to the presence of Oil and \II groups 
respectively. The absorption bands at 1650 and 1376 cm-I indicated the presence of C=0 
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and C-N groups respectively. The 1 II NNIR (Fig. 22) showed the singlet of H-2 proton at 
6 x.71. (TI'he diagnostic singlet li,r H-2 proton in chromone appears at 6 7.88. 2 A 
downfield doublet intc~.:rating for one proton at d 8.33 (J = 11.4 Hz) was assigned to H-9 
proton. The doublet of H-5 proton appeared at i 7.99 (J = 7.8 Hz). Another downfield 
doublet discernible at 6 12.09 (J =1 1.-4 Ilz) was assigned to NH proton. The relatively 
hitter downfield effect on \11 proton was due to intramolecular H-bonding in its Z- 
configuration. The remaining three protons of chromanone and four protons of pyridine 
moieties were present in the form of multiplets at d 6.84-7.66. Further confirmation for the 
structure was provided by mass spectrum (Fig. 23), which showed 1' at nt/z 268.15.Thc 
spectral data oi' other compounds followed similar pattern and are given in experimental 
section. 
The plausible mechanism for the synthesis of (185a-j) in the presence of Zn [(L)proline], 
has been depicted in Scheme 68. Zn is capable of binding with the carbonyl oxygen 
mctnasin_ the reactivity of parent carbonyl group in (64). Subsequently. formation of 
inmine (64a1 with proline takes place. This is followed by nucleophilic attack of amines 
(1S3a-j) to the imine t64a) to form hydrogen bonded adduct (64b). Finally, water as 
noeleopbiM: attacks on elecuiophilic C-2 centre with the expulsion of Zn[(L)proline]: to 
give the desired 2-hydroxv chromanones (1 85a-j ). 
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64 
Scheme 68 
Further, attempts were made to get ( 184a) via dehydration of ( 185a-j ) under different 
conditions such as heating in the presence of PTS, AIO. H2SO4. P,Oi etc. The 
dehdration of (185a-j) did not succeed probably due to the formation of stable hydrogen 
bonded keto-amine system (Scheme 67). 
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Then. we Studied the efficacy of the catalyst to establish the feasibility of our strate,y and 
to optimize the reaction conditions using different Lewis acid catalysts, different molar 
ratios of catalyst and ditterent temperatures. Initially, model reaction was performed at 
room temperature in the presence of Zn[(L)prolinej,/H2() and the product was obtained in 
\ cry lo \\ vield after a lone reaction of time (Table 14, entry 2). In the absence of 
Zn[( L )proline]2, under reflux condition the result was not promising, and a very low yield 
as obtained (Table 1-I. entry 3). 
3.4.1. Ef fret of catall•.st loading 
Theft we. studied the e tact of catalyst amount on the reaction rate and product yield by the 
reaction of (64) with ?-anlinopyridine (183x) as model reaction. After systematic 
screening. we observed that the best results were obtained when the reactions were carried 
out with 10 mol °;, of Zn[(L)proline1, in water at rellux temperature. With amount Tess 
than I 0 tllol 	of the catalyst the reaction either did not complete or took several hours to 
complete whereas. further. Increasing the amount of catalyst more than 10 rnol % did not 
increase the product v field or the reaction rate. 
3.4.2. Effect of different catalysts and temperature 
For purposes of comparison, we also scrutinized the reaction under the same conditions 
by ci pkoyine various other Lewis acids including CuSO4. CuCI;, Z.nCl2, A1CI,. Zn(OAc)2, 
L-praline, FeCI; (Tahle 14). Result showed that using L-proline alone product (185a) was 
obtained within short reaction time but in very low yields (entry 4). In the presence of 
ZntO.-\c1_. the reaction \\a, not successful, to give any desirable product tentry 5). When 
CuSO4. CuCI_ (entries (,. ") were used to promote the reaction, a mixture of products was 
obtained in low yield. Further. the catalysts with high Lewis acidity such as ZnCl2, AIC13 
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and FeC!; tailed to catalyze the reaction efticiently and resulted in poor yields of the 
corresponding product; (entries 8. 9. 10). At room temperature in the presencc of 
Ln{kl.)prolinC!, HO and in the absence of Zn[(L)prolinc121H20 at reflux temperature 
\\ c:: prolott ,d and yield of the product was very low (entries ? and 3). 
TL 	reults confirmed the high catalytic activity of Zn[(L)proline], in the current 
synthesis. 
Table 14 Reaction of 3-forntvlchromone (1 n,nlol) with 2-aminopyridine (1 mniol) in the 
presence of various catalysts in water. 
Entry 	Catalyst  	Temperature 	 Time 	Yickt (%) 
1 	Znr(L )prolinc] 	relax 	 10 min 	93 
7n((1_)pruline] 	r.t 	 6 h 	 46 
3 - reflux 1011 42 
4 L prolinc reilux 50 mill 42 
7.n(U:Ac) reflux S h 15 
retlux 7 Ii 40 
CuC'1, rcllux 5 h 40 
Zn( - I , reflux 6 It 34 
rellux 6 h 35 
11) FeC1; reflex 45 [hill 25 
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3.4.3. Keu abilitt- of the cola/i's! 
For practical applications of any catalyst. the lifetime of' the catalyst and its level of 
tCt1s,thlI1t\' are very Ht1[ortanit factors. Although recycling of hoinogclieous catalysts is 
difficult and generally not preferred. Since we arc using water as the reaction medium and 
one of the special properties of Zn[(L)proline], is its insolubility in organic solvents and 
solubility in water which is tairlv good for a homogenous catalyst. Therefore, we studied 
the possibility of recycling and reusing the catalyst for the model reaction of 3- 
tOtm% lchyorc ne (64) \v ith 2-aminnpyriBne (183a) in the presence of Zn[tL)pro1incj, and 
the react ioiis were carried Out lltldcr similar conditions in water. After completion of 
reaction in specified time, by cooling the reaction mixture to room temperature, the crude 
product was extracted with dichloromethane and the catalyst was recovered by separation 
of aqueous and organic phases. The catalyst was recovered by precipitating the aqueous 
layer by simple addition of acetone and drying at 80 °C for 2.5 h. To rule out the 
possibihitv of catalyst leaching the recovered catalyst was recycled to promote the model 
reaction att'ordin, the corresponding products (Table 15). The results revealed that 
catalyst exhibited excellent catalytic activity up to three cycles. 
Table 1-5 Reevclin stud\ of the Zn L)hroline]:(10 mol",4,) for the model reaction. 
Catalyst recycle 	Time (min) 	Yield (`%,) 
10 93 
IT 10 93 
III 10 9, 
IV 10 90 
V it) $7 
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3.1. l V\( I.l StON 
In :unrinar . we h,,\ c developed a practical, efficient, and scalable one-pot synthesis of 
different benzopvran derivatives (dicotunarols and 2-hydroxy-4-cluronlanoncs) using 
stable. iiicxpeiiSi\e. easily preparahlc and recyclable Zn[(L)proliiiej catalyst in green 
soli ent water. The catalyst Showed a unique class of catalysis in comparison with other 
catal\ st<. I he po ertitl catalytic activity of 7n[(L)prolineJz for these transformations can 
be sustained) by mild reaction conditions. use of water as solvent, cleaner reaction profiles, 
simplicit\ in operation. excellent yields of the products, faster reaction rates and 
reusahilit\ oi'the catalyst %\ itlt no loss in its activity. 
3.6. EXPERIMENTAL 
\1eItln ponhf, were taken in Riechert Thermover instrument and are uncorrected. The IR 
spectra were recorded on a Perkin Elmer spectrometer in KBr,1 II NMMR spectra on a 
Bruker DRX- 0O Spectrometer using tetra methyl silane (TIvlS) as an internal standard and 
D\ISO-,/, ('DCI , as solvent. Chemical shifts are reported in hpm doww ntield front THIS as 
internal standard and coupling constants J are given in Hz. Mass spectra were obtained on 
a D \RT-AIS recorded on a JEOL-Aces TOF JMS-T1OOLC mass spectrometer having a 
I):\R"l source. The micro analytical data were collected on an Elementar vario EL Ill 
elemental analyzer. 4-I f\ dhroxvcoumarin and aldehydes were of commercial grade and 
\\ re used without further purification. 3-Formylchromolnc 4 and Zn[(L)proliiie ' were 
synthesized by reported procedures. The purity of all compounds was checked by TLC on 
_lass plates coated with silica gel (E-Merck G254). 
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3.6.1. 5ntlzcsis of the Ziz/(L)prolinc/2 catalyst 
(L)Proliine t20 mmuh \vas dissolved in absolute ethanol (50 mL) containing potassium 
hv dh,xide 120 annol i and tua<enciically stirred for 15 Ihin in a round-bottomed flask at 
room temperature. III order to maintain the metal to ligand ratio of 1:2, 10 nlnlol of 
ZutN0,),.6H,0 was dissolved in a small quantity of double distilled water and added in 
drops to the (L)l'roline solution. The contents were vigorously stirred at room temperature 
1r h h by using a tua2setic stirrer. The ZnI(L)prolinej2 complex was obtained as a white 
solid. It as collected by iiltraitiun and dried at 70 °C. in vacuum for 6 h. 
3.6.2. (;erreral procedure for the synthesis of dicouinarols (182u j) 
.1 mixture of 4-hvdrox\-coumarin (29) (2 mmol), aldehyde (181a-j) (1 mmol), 
/n[(L )proline]: (5 mul 'd and water (10 mL) was taken in a round bottomed flask and 
rednzcd on it heating mantle at 1 10 °C for specified time. The progress of the reaction was 
monitored by thin-la\ eI chromatography (TLC). Upon completion of the reaction, the 
mixture was cooled to roost temperature. The crude product was extracted with 
dichlorontethanc. dried over anhydrous Na2SO4 and concentrated to furnish (182a—j). The 
catal\ st was recovered by simple separation of aqueous and organic pleases. The catalyst 
present in the aqueous layer was rccovcrcd by precipitating the aqueous layer by addition 
of acetone and used for the subsequent cycle. 
3.6.3. Genera! procedure for the st'hthes'!s of 2-lrti•llroxyy-4-drronznnonres (18 ec j 
;A mixture u1 3-1en-nn kduomcae (64) (I.00 mmul), niuines (183a—j) (1.00 mniol), Zn 
[(L)prolinej- ( 10 awl °,.) and water (10 mL) was rcfluxcd in it heating mantle at reflux 
temperature for an appropriate time..-\fzcr completion of reaction, as monitored by TLC, 
reaction mixture was Fooled to room temperature. The crude product was extracted with 
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tichdoioinethaiie. as lid with water, dried over anhydrous sodium sultate and 
concentrated to furnish (I 85a-j). The pure compounds were obtained by recrysfallizafiQH 
frunl mctlltol chorti,rnl mixture (8:2 V V). The catalyst was recovered by simple 
separation of aqueous and organic phases. The catalyst present in the aqueous layer was 
reco%creel by precipitating the aqueous laver by addition of acetone and used for the 
lll?~C'lllellt C%CIe. 
3.6.4. Spectral data of compounds 
3,3 "-(P/zen) l,netl{t•lc,u')hl.-(-1-M•dru.ya'-211-c•ht•oH:eu-2-Hire) (182u) 
Puritied h\ rccr\stallh;alion from (.hlorotorlll-methanol (1:4 V V) mixture. 
\V htte crystalline solid. 
N1.p 
I R I K 13) 1):,",\ Lill 
1I N\IR (I)\1SO-Jr. 3(I() \11-{z) 
ESI-\1S 
a=len1eHfa1 analysis tar ('•;H .•O,. 
228-230 C. 
3083 (011), 3027 (011), 1670 (C-0),1614 
(C0). 
6. 1$ (I 1 I, s. CH), 7.21-8.42(131-I. in. Ar-1-i ); 
412.2$ (N1.). 
Calculated C, 72.8$; H. 3.91. 
Found: C. 72.69; 11, 
3.3 	 (182b) 
Purlticd by re r\;tal 1/;itloll from Chloroform-il1etl1a1lUl (1:4 V V ) mixture 
White crystalline solid. 
Nip. 	 222-225 °C: 
IR 11:13x1 t,,,:.."cnl 	 3448 (OH). 3060 (OH). 1668 (('-0). 1611 
(C=O) 
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II N\1R (t)XISO-J,,. $O) Nil lzy 	: 6.19 t 11-1. s. Cl-H), 6.57--7.88(_131-I,m.Ar-H). 
FSI-\IS 	 : 428.02(M-). 
Li 	in~ntal analysis tier t •:H i ,,O- 	: Calculated C:,70.I5; H. 3.76: 
Found: C. 70.35: H, 3.964%,. 
3.3 "-(2-lydrox1X el{htniet/r lent)bis-(4-hrdtudv-2f -I-chructtell-2-Dire) (I82c) 
Purified by recrvstallizatl'.)ll from (Iiloro60rm-methanol (1:4 V/V) mixture. 
Yellowy crystalline solid. 
~l.p 254-257°C. 
IR(KBr) u,;,, cnC 	 : 3338 (OH), 3065 (OH), 1714 (C=O). 1673 
(C=O). 
'II NMR (DNlSO-,1,,, 300 \1Hz) 	: 6.29 (1H, s, CI1), 6.67-7.88(131-I,rn,Ar-H). 
ES1-MS 	 : 428.30 (M'). 
Elemental analysis for C,;H IbO- 	: Calculated C,70.15; H, 3.76%; 
Found: C, 69.94: H, 3.55%. 
3,3'-(4-ChIutopkcIc1-(nret1r)'Iefe)bis-(4-Inydruxy-2H-chrovLea-2-litre) (182d.1 
Purified by recrystallization from Chloroform -methanol (1:4 V/V) mixture 
White crystalline solid. 
Nip. 	 : 250-253 °C 
IR(KBr) u 	crn t 3030 (OH), 1670 (C=O), 1605 (CO), 768 (C-Cl). 
'H NNIR (DN1SO-d,,. 300 N1llz) 	: 6.19 (1 H, s, C11). 7.09-7.98(13H, n1, Ar-H). 
FSI-N1S 	 : 446.18 (MT). 
Elemental analysis for C,S H,;C1O~, 	: Calculated C, 67.25; H, 3.38%; 
Found: C. 67.04. H. 3.58%. 
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3.3 -( 2-Chlurophe►rt'Inirtb'lene)Gis-(1-/r1'rlroxti'-211-eIltQrtterr-2 orrc) (182e) 
Pun lied by rccrvvsttllll /MI011 lfoni hlorolorn-mmethano] (1:4 V/V) mixture. 
\V'hits .l\ stalline solid. 
\I.1). : 	198-200 	C. 
IRiKBr) v,,,,\ cm : 	3079 (OH), 1670 (C=O), 1615 (CO). 769 (C- 
CI). 
\IR (DNISO-c/,.3n(t \I1Iz) : 	6.08 (111. s. Cl I), 7.05-7.8$(13H, in. Ar-H) 
ES1-Alti -1-16.16 (M ). 
Elemental analysis : 	Calculated C, 67.25: H. 3.38%: 
for C-Al1C1O,. Found: C. 67.20; H, 3.5$. 
3.3 -(3-.\its-uDhem1l'1ruu't/r1'Ie,ue)6is-(J- !ryrlruz}•-211-c•!rrQnterr-2-uire) (182/) 
I'l1CtI1ed by I"cCf1'Slallt /:Ills)!! !YUln ehlUl'ulOfal-methanol (1:4 V.t) mixture. 
\\ hit,: solid. 
\1.t). 	 : 	123-125 'C 
lk (Ken) u..,, ells' 	 : 	3064 (011), 1660 (C=0), 1616, (CO), 1565 
(.NO). 
'II \\IR (DNISO-d,,. 300 \II-Iz) 	: 	6.37 (11-1. s• CII),6.59-7.89 (12H. m. Ar-H). 
F.SI-\IS 	 : 	457.14(N1 ). 
1.1 nl,ntal analysis 	 : 	Calculated C, 65.70; 11, 3.30: N. 3.06Yu 
torC .11 -AO. 	 Found: 0,65.49; H, 3.49: N, 3.26'/0. 
3.3 	 (182x) 
P e-itied by reervstallii.nloll from chlol-o orm-methanol (1:4 V V) mixture 
Light yellow crystalline solid. 
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Nip. 	 : 	254-259 "C. 
IR ({'Hr) uWJ\ cm 	 : 	3495 (011), 3074 (OH), 1668(0—O). 1612 
(C=O). 
H \\ill (DN1SO-c/.. 300 \IHz) 	: 	3.58 (3H, s. OC'H;)1 6.26 (1H. s, CH). 6.55 
7.92 (1 111, m. gar-II). 
FSi-\[S 	 458.15(.M'). 
1Ilcmc.iltal analysis 	 : 	Calculated C. 68.18: 11, 3.96';%%: 
I'Or C -,.H ,O, 	 Found: C. 67.97: H. 4.16%. 
3.3 " -(2- TIiopIze,n'lzr1etht•lc'rzc')bi.,-(4-!nd1ro.vti•-2H-c•hronrerr-2-isr1e) (1821x) 
!s : 	h\ sc rsaalliiat,. ', !1o!?? (hlurilUSm tl?~tlnoi (1:4 \ V! mixtuc: 
Gr«ru crystalline soli( 
\1.1. 	 : 	210-21 3(dec) °C. 
IR (KRr) u.:,. c;m- ' 	 : 	3074 (011), 1660 (C=O) , 1612 (CO): 
Ii \NIR(DNISO-J(,. 300 \lllz) 	: 	6.19 (1 H. s, CH), 6.$6-7.22 (31-I. m,CH), 
7.30--8.04 (SH, m, Ar-11): 
1.ISI-\IS 	 : 	418.09: (M'). 
Elemental analvyis 	 : 	Calculated C. 66.08: H. 3.31%; 
tr (,:H.4O„S 	 Found: C, 66.27:1-1, 3.52%. 
3,3 	 (182i) 
Pisritied h\ recrvstaliiz.U1rn from Chloroform-methanol (1:4 N' \-•) mixture 
Yellt 	crystal line ,ulid. 
Nip. 	 : 
 
1R tKBr v,_, cm” 	 : 	3078 (OH). 1664 (C=O), 1616 (CO). 
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'H NMR (DMSO-d,;, 300MIIz) 	: 	6.15 (IH, s, CH), 2.41 (3H, s,C113), 6.58-- 
6.62 (2H, m, CH), 7.26-8.05 (8H, m, Ar-H). 
ESI-NIS 	 : 	432.12.(Ivl-). 
Elemental analysis 	 : 	Calculated C, 66.72; H, 3.73%; 
for C'41-I:(,O,S 	 Found: C, 66,50; H, 3.53%. 
3,3 '-(.V-pti ridt bnetlt 1e,ic)bis-(l-It t'[!i'o.YV-2Ji-Chromei1-2-one) (182]) 
Purified by recrystallization from Chloroform-methanol (1:4 V'V) mixture 
White crystalline solid. 
M.p. 
IR (KBr) u;,,a.;'cm-I 
' H NN1R(DMSO-d. 300 M1-1z) 
ESI-\1S 
252--254 °C. 
3184 (OI1), 3137(OH), 1689 (C=O), 
1610 (C=O). 
6.42 (1 H, s, CH), 7.23-8.64 (121-I, m, Ar-H). 
413.13(M`). 
Elemental analysis 	 : 	Calculated C, 69.79; H, 3,36; N, 3.39%; 
for C'41-I i ;NO~, 	 Found C, 70.01; 1-I, 3.55; N, 3.19%. 
3-(P'rid}'!ruuiaon:etlrtvlene)-2-)zydroxy-cIiromunr-4-oize (185u) 
Purified by recrystallization from methanol-chloroform (8:2 V/V) mixture. 
Light yellow solid. 
M.p. 	 : 	121-124°C. 
IR (KBr) u,, /cm 	 : 3355(01-I), 3280 (NI I), 1650 (C=C), 1376 (C-N). 
'II NMR (300 MHz, C'DC1) 	: 6 (ppm) 3.53 (s, 1II, 01I), 5.71 (s, 1II, I1-2), 
6.84-7.66 (m, 7H, ArH), 7.99 (d, J = 7.8 Hz, 
1 H, C-5), 8.33 (d, J= 11.4 Hz, H-9), 12.09 (d, J 
= 11.4 Hz, I H, NH, D20 exchangeable). 
ESI-MS 	 : m/ 268.15 (M-). 
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Elemental analysis for 	 : 	Calculated. C. 67.22; H, 4.51; N, 10.45. 
C:;1l i 2N,O; 	 Found: C, 67.02; I-I, 4.28; N, 10.66. 
3-(Berrothiuzolylunriiionzethv1c'ne)-2-h}'droxychroinan-4-ones (1856). 
Purified by recrystallization from methanol-chloroform (8:2 V/V) mixture. 
Light yellow solid. 
NM.p. 	 : 	142-145°C. 
IR (KBr) u,,,;,,,/cni- ' 
'[-I \\iR (300 MHz, CDCI3) 
3209 (OH), 3078 (NH), 1648 (C=O), 1373(C-
N). 
S (ppm) 3.53 (s, 11I, 011), 5.72 (s, III, H-2), 
7.05 (d, J =11.4 Hz, 1 H, H-9), 7.10 — 7.99 
(m, 7H, ArH), 8.06 (d, J = 7.8 Hz, C-5), 
12.31 (d, J = 11.4 Hz, I1-i, NH, D2O 
exchangeable). 
ESI-MS 	 : 	m.%z 324.15 (M-). 
Elemental analysis for 	 : 	Calculated C, 63.02; H, 3.73; N 8.64. 
C:-H.O:S: 	 Found : C. 62.80: 14, 3.95; N, 8.41. 
3-(p-Toh•luniinometh}•le;ie)-2-lij,droxy-chronnati-J-one (185c). 
Purified by recrystallization from methanol-chloroform (8:2 V/V) mixture. 
Light yellow solid. 
hip. 	 : 	150-155 °C. 
IR (KBr) u /cm ' 	 : 	3320 (OH), 3200 (NH), 1653 (C=O), 
'H NNIR (300 MHz. CDCL) 
1365 (C-N). 
6 (ppm) 2.51(s, 3H, CH3), 3.18 (s, IH. OH), 
5.91 (s, 111, H-2), 6.80 — 7.73 (nl, 7H, ArH), 
7.89 (d, J = 7.8 Hz, C-5), 8.33 (d, J = 12.3 
Hz, 1H, H-9), 12.19 (d, J = 12.3 Hz, I H, NH, 
D2O exchangeable). 
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ESI-\IS 	 n,/± 281.14 (M+) 
Elemental analysis for 	 : 	Calculated C, 72.66; H, 5.380; N, 4.98. 
C,-H,5NO;: 	 Found: C, 72.89; H, 5.61; N. 4.72. 
3-(1p-.1letlzoxypheiij,iuuiiIzo;rtetliyle!ze,-2-liydroxy-chrontait-4-one (18Sd) 
Purified by recrystallization from methanol-chloroform (8:2 V/V) mixture. 
Yellow crystals. 
M.p. 	 : 	120 -123°C. 
IR (KBr) u,:,~,,: cm i 	 : 	3376 (OH), 3078 (NH), 1672 (C=O), 1378(C- 
N). 
11 \SIR (300 MHz, CDC1 ) 	 6 (ppm) 3.64 (s, 3H, OCH3), 6.51 (s, IH, 
OH), 6.57 (s, 1H, H- 2), 7.09 — 8.34 (m, 7H, 
ArH), 7.91 (d, J=10.5Hz, 1H, H-9), 8.41 (d, 
J=7.8 Hz, C-5), 1228 (d, J=10.50 Hz, 1H, 
NH, D2O exchangeable). 
ESI-MS 	 : 	m/_ 297.14 (M-). 
Elemental analysis for 	 : 	Calculated C, 68.74; H, 5.09; N, 4.71. 
Found: C, 68.50; H, 4.85; N. 4.90. 
3-(p-:\'itropheizylufriiitoiiietliylette)-2-1iydroxy-c/cromeari-4-oite (185e) 
Purified b~' recrystallization from methanol-chloroform (8:2 V/V) mixture. 
Light yellow crystals. 
M.p. 	 : 170-173 °C. 
IR (KBr) u/ cm 	 : 3184 (OH), 1656 (C=O), 1369 (C-N) cm' 
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H N NIR (300 MHz. CDCl3,) 	: 6 (ppm) 5.81 (s, I H, OH), 6.16 (s, 1 H, H-2), 6.64 
(d, J=12.0 Hz, 1 H, H-9), 6.92-8.27 (m, 7 H, 
ArH), 8.32 (d, J=8.1 Hz,C-5), 12.21 (d, J=1 1.7 
Hz, 1H, NH, D20 exchangeable). 
ESI-\IS 	 nil: 312.13 (M). 
Elemental analysis for 	 : 	Calculated C. 61.54; 1-1, 3.87; N, 8.97. 
C : ,;H i ,N_O ; 	 Found: C. 61.34; H, 4.10; N, 9.20. 
3-(n,-.\'itrophe„ylan,i„on,ethylene)-2-l,ydroxy-chron,a„-4-oize (I8Sf) 
Purified by recrystallizatioW from methanol-chloroform (8:2 V/V) mixture. 
Yellow solid. 
168-172 °C. 
IR (KBr) u,,1, /cm 	 3410 (OH), 3263 (NH), 1665 (C=O), 
1343(C-N). 
'H N lx (300 MI-lz. CDCI:) 	 6 (ppm) 2.80 (s, 11-1, OH), 6.17 (s, I H, 1-1-2), 
6.97 (d, J=13.5 I Iz, 111, 1-1-9), 7.00-8.36 
(m, 7 H, ArH), 8.89 (d, J=9.6 Hz, C-5). 
ESI-MS 	 : 	m/ 312.15 (M`). 
Elemental analysis for 	 : 	Calculated C, 85.70; H, 6.55; N, 8.27. 
Found: C, 85.24; H, 6.56; N, 8.15. 
3-(a- \'up/itl,ylun,r„o,nerllti•lencee-2-Irl-droty-chron,a„-d-one (185x) 
Purified by rccrystallization from methanol-chloroform (8:2 V/V) mixture. 
Vcllo solid. 
N1.p. 	 : 	150-153 °C. 
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IR (KBr) umax /cm - ' 
I H NMR (300 MI-iz CDC1;) 
ESI-\lS 
Elemental analysts for  
3245 (OH), 3099 (NH). 1678 (C=0), 1337 
(C-N). 
6 (ppm) 3.55 (s, 1H, OH), 6.52 (s, 1H, H-2), 
7.10-8.35 (m, 10 H, ArH), 7.93 (d, J =10.8 
Hz, 1 H, H-9), 8.41 (d, J = 8.1 Hz, C-5), 13.75 
(d, J = 11.1 H, Nil, D20 exchangeable). 
m/ 317.06 (M+). 
Calculated C. 75.77; H, 4.73; N, 4.41. 
cNO, 	 Found: C, 75.98; 1-1, 4.93; N, 4.62. 
3-(p-Hj'dvoxfiphebl},1uninane1hhylene)-2-Irydroxy-chromxn-4-one (185h) 
Purified by recrystallization from methanol-chloroform (8:2 V/V) mixture. 
Yellow solid. 
M.P. 
IR (KBr) u,,:'c m 
'H NMR (300 MHz, CDCl, 
ESI-MS 
Elemental analysis for 
C.~,H..-,NO, 
160-162 °C. 
3340 (OH), 3220 (OH), 3284 (NH), 
1645 (C=O), 1362 (C-N) 
6 (ppm) 5.57 (s, I H, OH) 6.66-7.76 (m, 
71-1, Arl1), 6.58 (s, 1 H, 1-I-2), 8.39 (d, J = 8.1 
Hz, C-5), 8.84 (d, J = 12.9 1iz, 1H, H-9), 
1 1.52(s, 11-i, OH), 
12.84 (d, J = 12.9. I H, NI-I, D20 
exchangeable). 
m, 283.11 (M'). 
Calculated C, 67.92; 11, 4.63; N, 4.94. 
Found: C, 68.11; H, 4.83; N, 4.68. 
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3-(p-Chlot•ophenlplunii»ouiethj,lene)-2-{tydr•oxyy-ehi•onlanr-4-ogre (1851). 
Purified by recrystallization from methanol-chloroform (8:2 VN) mixture. 
Light yellow solid. 
M.P. 
IR (KBr) iu 	- 1 
'Ii NyIR (300 MHz, CDCIO.) 
ESI-\IS 
Elemental analysis for 
C~<,H12NO;C1  
142-145 °C. 
3441(01-I), 3267(NH), 1669 (C=O), 
1 380 (C-N). 
6 (ppm) 4.99 (s, 1 H, OH), 5.27 (s, 1H, H-2), 
7.19 -8.12 (m, 7H, ArH), 8.06 (d, J = 13.8 
Hz, I H, H-9), 8.17 (d, J = 8.1 Hz, C-5), 10.33 
(d, J= 13.8, 1H, NH, D20 exchangeable). 
nz/z 301.12 (M-). 
Calculated C, 63.73; H, 3.98; N, 4.64. 
Found: C, 63.50; H, 4.19; N, 4.38. 
3-(Phenj ,1arnin urn eflij ,lease)-2-hydauxy-chro,nun-4-one (18Sj) 
Purified by recrystallization from methanol-chloroform (8:2 VN) mixture. 
Yellow solid. 
M. p. 
IR (KBr) a icm I11J.1 
1H NMR (300 MHz. CDCI~ 
ESI-vlS 
Elemental analysis for 
C:<,H iaNO3 
135-138 °C. 
3184 (OH), 1653 (C=O), 1317(C-N). 
6 (ppm) 2.92 (s, IH, OH), 5.65 (s, 1H. H-2), 
6.84 - 7.66 (in, 7H, ArH), 7.89 (d, J— 7.8 Hz, 
C-5), 8.34 (d, J = 10.8 Hz, 11-1, H-9), 11.59 
(d, J = 10.5 Hz, 11-1, NH, D,0 exchangeable). 
min 267.10 (Me). 
Calculated C, 71.97; H, 4.90: N, 5.04. 
Found C, 71.75; H, 5.13; N, 5.04. 
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Fig. 19. !H NNIR spectrum of 182j 
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Fig. 22. 'H NMR spectrum of 185a 
Fig. 23. Mass spectrum of 185a 
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CHAPTER 4 
SYNTHESIS, CHARACTERIZATION AND in vitro ANTIBACTERIAL AND 
AN'I IFENGAL EVALUATION OF NOVEL HALOPYRAZOLE DERIVATIVES 
(Journal of Saudi Chemical Society (2011) doi:I0.10161j jscs.2011.03.016) 
4.1. REVIEW AND LITERATURE 
Research and development of potent and effective antimicrobial agents represent one of 
the most important advances in therapeutics, in the control of serious infections as well as 
in the prevention and treatment of some infectious complications of other therapeutic 
modalities such as cancer chemotherapy and surgery.' In recent years, the number of life-
threatening infectious diseases caused by multi-drug resistant Gram-positive and Gram 
negative pathogen bacteria have reached an alarming level in many countries around the 
world.` ' Over the past decades, these enteric bacterial infections are responsible for 
morbidity and mortality in immuno-compromised individuals such as those suffering from 
tuberculosis, cancer or AIDS and in organ transplant cases mostly in developing countries 
and areas such as the Indian sub-continent, part of South America, tropical part of Africa, 
etc.'{' Every year millions of people are being killed by some or the other Gram-positive 
and Gram-negative strains of bacteria. These bacteria mostly lead to food poisoning, 
rheumatic, salmonellosis and diarrhea.' Thus, antibiotics provide the main basis for the 
therapy of microbial (bacterial and fungal) infections. However, overuse of antibiotics has 
become the major factor for the emergence and dissemination of multi-drug resistant 
strains of several groups of microorganisms.8 Furthermore, the pharmacological drugs 
available are either too expensive or have undesirable side effects or contraindications .9 A 
number of clinical reports in the United States and worldwide have independently 
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described the emergence of vancomycin resistance in methicillin-resistant Staphylococcus 
aureus (MRSA) isolates and other human pathogen Gram-negative isolates1° . Escherichia 
coli are responsible for the world's most common and serious infectious diseases like 
invasive dysentery and diarrhea. septicemia. inflammations of liver and gall bladder, 
appendix, meningitis, pneumonia etc.''-' 3 Generally, there are complains of abscess of the 
brain which is a very bad problem of E. coli infection.'4 In case of E. coli infection 
amoxicillin. norfloxacin and ciprofloxacin are generally used, but have harsh side effects.15 
Toxicity and resistance to the drugs also play important role in the treatment failure." The 
different parasitic bacteria such as Staphylococcus aureus, Streptococcus pyogenes, 
Salmonella tlphlnlll/7I[I)I, E. coli have important effects on the human's mucosal health. 
The infections with these microorganisms may have significant impact on huge demolition 
of host tissue and severe diseases. More than 90 % of the cases of vaginitis are of 
candidiasis, trichomoniasis, and bacterial vaginosis 17 . Thus, these microorganisms 
commonly infect healthy people in large communities, thus creating a serious health 
problem around the globe. Therefore, the discovery of novel and potent antimicrobial 
agents is the best way to develop effective therapies. For this reason, the present stratagem 
for the synthesis of new compounds is aimed in the direction of developing new pyrazole 
derivatives to inhibit the growth of Gram-positive, Gram-negative bacteria, and fungi. 
Antibacterial and antifungal activities of the azoles are the most widely studied and some 
of them are in clinical practice as antimicrobial agents.18 In particular, pyrazoles gained 
much attention as antimicrobial agents after the discovery of natural pyrazole C-glycoside 
pyrazofurin which showed broad spectrum antimicrobial activity.19 
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NH2 
C-glycoside pyrazofurin 
Pvrazoles have been studied for over a century as an important class of heterocyclic 
compounds and still continue to attract considerable attention , as they are the core 
structure of numerous biologically active compounds, including blockbuster drugs such as 
Celebrex an inhibitor of cyclooxygenase (COX-2) used as potent anti-inflammatory,20 
Viagra, an inhibitor of 5-phosphodiesterase, used for the treatment of erectile dysfunction, 
21 Acomplia. antagonist of the CB-1 cannabinoid receptor, used for the treatment of 
obesity.'" Mepiprazole for the treatment of anxiety neuroses.23 Besides this, pyrazole 
derivatives are reported to have the broad spectrum of biological activities, such as anti- 
inflammatorv24, herbicidal25, cytotoxic26, 	analgesic,27 cholesterol-lowering,28 
hypoglycemic."' anti hypertensive '0. 	antidepressant, 	anticonvulsant,3 ' 	antiviral,32 
antiangiogenic activity'' and A3 adenosine receptor antagonists34 etc. They are also found 
applications as pharmaceuticals. agrochemicals, photographic, sunscreen materials etc. 
Some of the pyrazole containing drugs having wide variety of activities are given below: 
H2 
O CH3 
0 \ 0 	NI 	I NON 
CF3  H3C'  CH3 
CH3 
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\ N 
CI 	/ 	cl 
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Celebrax 	 Viagra 	 Acomplia 
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HN 
i 
N~ 
CI 
Mepiprazole 
4.2. PREI:NF WORK 
A systematic invvc.tiation of this class of heterocyclic moiety revealed that pyrazole 
containine pharmacoactive agents play important role in medicinal chemistry. The 
prevalence of pyrazole cores in biologically active molecules has stimulated the need for 
eletant and efficient ways to make these heterocyclic lead. Therefore, in view of the 
abo~'e-mentioned findings and to identify new candidates that may be of value in 
designing new. potent. selective and less toxic antimicrobial agents, this chapter describes 
the synthesis and antimicrobial evaluation of halopyrazole derivatives. 
This chapter is divided into two sections. 
Section :X: Synthesis of novel halo pyrazole derivatives 
In this section synthesis of t\Vo novel halopvrazo(es (187 and 189) is described using 5- 
chlon,- 3-methvl- l -hhcnvlhv razole-4-carboxaldehydc (105) as starting material. 
4.3. REST LTS AND DISCUSSION 
5-chloro-3-methyl-l-phenvlpvrazole-4-carbozaldehyde was obtained by Vilsmeier Haack 
reaction of pyrazolone."' 1)ue to the exceptional reactivity of formyl group in 5-chloro-3- 
methyl- I -phenylpyrazole-4-carboxaldehyde (105), it was taken as synthon for the 
generation of novel halopyrazoles. Thus, in an initial attempt to synthesize (187), (105) 
was heated With 5-acetyl- I , 3-dimethylbarbituric (174d) acid in the presence of piperidine 
in ethanol followed by addition of bromine at room temperature (Scheme 69). 
160 
As expected. ( 187) was obtained in good yield. A plausible mechanism for the formation 
of t 1K7) has been depicted in Scheme 70. As clear from Scheme 70, Claisen Schmidt 
condensation takes place between heteroaldehyde (105) and 5-acetyl 1,3-diroeth}1 
barbituric acid (1744) in the presence of piperidine to give heterochalcone (186a) which 
reacts With bromine to ftn-m dibromodihydro derivative (186b). Subsequently the 
intermediate (186b E undergoes dehydrobromination to give final product (187). In order to 
synthesize a library of bromopqrazoles, similar reaction was carried out employing 
hetcroaldehyde (105) and (188) under retlux conditions followed by addition of bromine at 
room temperature i Scheme 69), However, the reaction stopped at the Stage of (189) and 
did not gi\ e bromop%razole ( 190) alter addition of' bromine. The failure of reaction of 
(189) with bromine to give expected dibromo dehydro derivatives is may be due to the 
steric hindrance from bulky aromatic and heteroaromatic ring (Scheme 69). 
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Scheme 69 Sv,ithetic route of compounds (187) and (189) 
The structures of the compounds isolated were characterized by elemental and spectral 
analysis (IR. I H NNIR. "'C N\IR and Mass spectrometry). The IR spectrum (Fig. 24) of 
(187) showed the carbonyl absorption band of harbituric acidity moiety at 1730 cii . The 
absorption bands for carbonyl group and carbon—carbon double bond of the a, 13- 
unaturat (1 system appeared at 1689 and 1623 cm-I . respectively. The 'H NMR spectrum 
Fig. 251 showed 1-1, proton as sharp upheld singlet at 6 7.81. The aromatic protons of the 
N-phenyl-p}-razole-moiety were present in the form of multiplet at 6 7.46 7.62. Six 
protr)ns of N ('II I groups Were discernible as two sharp singlets at O 3.32 and 3.45 
\\ herea> protons of' CI I : group of pyrazole unit were present in the form of another sharp 
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singlet at o 2.61. Further confirmation of the structure was done by mass spectrum (Fig. 
26), which showed I' at 450.6 as base peak. The 'C NMR spectrum (Fig. 27) was also in 
accordance with the proposed structure given in the experimental section. 
The IR spectrum (Fig. 28) of 	showed two strong absorption band at 1597 and 1535 
cm- f r C=C' and C—N bonds respectively. The 1 H NMR (Fib. 29) exhibited a sharp 
sin_I.t at (> 2.54 for three methyl protons of pyrazole moiety. Five aromatic protons of 
p\ n1coce unit appeared a; ulultiplet in the region 6 7.35-7.57. The protons H„ and Ht, were 
present as trans coupled doublets at (i 7.20 (.1 = 16.5 Hz) and 7.66 (J = 16.5 Hz). Further 
confirmation of the structure was provided by mass spectrometry (Fig. 30) which showed 
N1' at 384.12 as base peak. The "C NMR spectrum (Fig. 31) was also in accordance with 
the proposed structure.The other peaks were observed at their normal position and are 
in the experimental BCetloli. 
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4.4. ExPER1M1:\TAl. 
\leltin_i points were taken to Reichert Thermover instrument and are uncorrected. The IR 
spectra were recorded on Perkin Elmer RXI spectrometer in KBr. 'H NMR spectra were 
recorded on E3rukcr DR\- 0O and Brukcr Avance 11-400 spectrometer using tetramcthyl 
silane GYMS) as an internal standard. '-C NMR spectra were recorded on a Bruker 
DR\-100 Spectrometer (100 MHz.) with DMSO. Mass spectra were recorded on JEOL-
\ee a TOF JMS-T I UOLC DART-AIS spectrometer. MV licroanalytical data were collected 
using Carlo Erba anal\ zer model 1108. The purity of all compounds was checked by TLC 
on glass plates (20 <5 cm) coated with silica gel (E-Merck G254, 0.5 mm thickness). The 
plates «ere run in chloroform—methanol (4:1 V V) mixture and were visualized by iodine 
vapors. The 	Cllloro J metI1vS-L pIlenylpyrazole-4-carbuxaldehyeie 'r and 5-acetyl-l3- 
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dinlethvIbarbituric acid 	were synthesized from 3-methyl-l-phenylpyrazole-5-one and 
l .? dimeth\ lbarhiturie acid. respectively by reported procedures. 
4.4.1. Getleral Proceriure for the synthesis of compound 187 
To a \%ell stirred solution of 5-acetyl-1.3-dimcthv'lharbituric acid (1744) (4.52 Innlol) in 
ethanol ( 1- mL) containing pyridine (0.5 mL), 5-chloro-3-methyl-1-phenylpyrazole-4- 
;,Irhrx,tldch\'dc (105) (4.52 tnnlol) was added in the portion. The reaction mixture was 
then ,tarred at room t,:mperaturc tier I It. Bromine (4.52 mnlol) was then added dropwise to 
the vizorously stirred solution over a period of 20 min. After complete addition of Br, the 
reaction mixture was further stirred for another 3 h. The monobronloderivative (187) was 
precipitated. filtered off. and washed with 15 mL of ether to remove the excess of bromine. 
Further purification was made by recrystalllzatiotl from the chloroform -methanol (4:1 
\' \ i mixture. 
4.4.2. General Procedure for the .st'nlhc's1S of 'compound 189 
.\ nfixttnre of J T'Illuru ? mcih\'I I phenvlp)'razule 4 carbuxcldehy4e (105) (4.52 nlmol), 
?. } dinitrutoluene (188j (4.52 mnfoll and pyridine (0.3 mL) in ethanol (12 mL) was 
relluxed in a hcatln~ii mantle for about 2.5 h. On completion of reaction (as checked by 
TLC ). the reaction mixture was poured into 25 mL ice cold water, acidified with cone-
11(1. The solid. thus. Obtained was filtered washed with water. methanol. dried and 
purified by rzoystallization from chloroform—methanol (3:2 V/V) mixture. 
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4.5. Spectral Data 
(Z/-?-I~rnntu-3-(5-chlnru-3-meth}•!-1 /)l:e,i}'lpl-i"a;,u!-d yl)-1-(1,3-dintetht•!-?,4,6 
V'inlidiwutrionre•-?-tv/)prop-2-em-1-uwit (187) 
Pucilicatiov was made by reergstallization from the chloroform—methanol (4:1 V/V) 
mixture. 
['ale yellow crystals. 
\1.1,. 	 : 	180-182°C. 
IIZ (KBr) u,.,,,,;cm , 	 : 	1730 (C=O), 1689 (C~O). 1623 (C=C). 
'H NNIR (400 MHz. C[).1> 	: 	3 2.61 (s, 3H, C'H,,), 3.32 (s, 3H, N -CH;), 
3.45 (;, 31-1, N -CI1;), 7.16-7.62 (m. 511. AT 
1-1), 7.81 (s, I H, 11,). 
C NNIR ( 100 Ml Iz. D.\ISO) 	: 	O 14.27, 27.73, 29?8, 38.94. 105.52, 124.53. 
124.99. 128.40, 128.67, 128.79, 137.13. 
148.57, 157.13, 165.12, 174.42. 
r.SI MS 	 : 	lit/_ 490.6 (M`). 
Elemental analysis 
For C'; .,H ; ,,\,O.,I3r('l 	 Calculated C. 47.57, H. 3.35: N. 11.67. 
Found: C. 47.42: H, 3.49: N, 11.56 
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5-('h1oro-4-/2-(2,4-dinritroophen 'l)-tiniti•1/-3-»tc'tl>1,1-1-phenyl-1!I pyrazole (189) 
Purifieatiom was made by recrystallization from the chloroform—methanol (3:2 VV) 
1Vi\tllrc. 
c11U11 crystals. 
\1p. 	 122-125 °C. 
IR i hHrj u v cm 	 1597 (C=C), 1535 (C=N). 1345 (C—N). 
11 \\IR (300 \Il lz. CDCI-,) 	: 	 6 2.54 (s, 31-1, C1-13), 7.20 (d, 1 H, J= 16.5 Hz, 
H„), 7.35-7.57 (m, 5H, Ar—H), 7.66 (d, 1H, 
J= 16.5 Hz, Hb), 8.00 (4, 1H, J= 8.7 Hz, He ), 
8.45 (d. 111, J= 8.7 Hz, Hd), 8.85 (s, 1 H, He). 
( N\IR (100 M111z. D`ISO) 	: 	14.65, 115.1 1, 117.54, 120.84, 120.99, 
124.98, 125.28, 128.72, 129.28, 129.39, 
139.37, 147.12, 149.05, 151.85. 
1 Sl \IS 	 : 	nt'- 354.12 (M ) 
F: L 111cntal analysis 
For C 1 ,,HEN404Cl 	 Calculated C, 56.19; 1-1, 3.40; N, 14.56. 
Found: C. 56.06: 1-1, 3.53: N, 14.51 
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Fig.24. IR spectrum of 187 
Fig.25.'H NMR spectrum of 187 
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Fig.26. Mass spectrum of 187 
Fig.27. '3C NMR spectrum of 187 
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Fig.30. Mass spectrum of 189 
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Fig. 31. 13C NMR spectrum of 189 
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Section B: Antimicrobial evaluation of pyrazole derivatives 
The synthesized compounds described in the section A have been screened for their in 
vitro antibacterial and antifunual activities. 
4.6. In vitro antibacterial studies of compounds 187 and 189 
4.6.1. Microorganism used 
The newly synthesized compounds were screened for their antibacterial activity against 
Streptococcus pyogenes (clinical isolate), Melhicillin resistant Staphylococcus aureus 
(MRSA+ve), P.scudomonas aeruginosa ( ATCC-27853), Kiebsiela pneumaniae (clinical 
isolate) and Escherichia co/ (ATCC- 25922) bacterial strains by disk diffusion method." 
A standard inoculwns (1-2 X 10' c.f ii ml 03 Mc Farland standards) was introduced onto 
the surface of sterile agar plates and a sterile glass spreader was used for even distribution 
of the inuculums. The disks measuring 6 min in diameter were prepared from W'hatman 
no. ! filter paper and sterilized by dry heat at 140 °C for I Ii. The sterile disks previously 
soaked in a known concentration of the test compounds were placed in nutrient agar 
medium. Solvent and growth controls were kept. Ciprofoxacin (30 µg) was used as 
pnsirice control while the disk poured in DMSO was used as negative control. The plates 
were inverted and incubated for 24 h at 37 °C. The susceptibility was assessed on the basis 
of diameter of zone of inhibition against Gram positive and Gram-negative strains of 
bacteria. Inhibition zones were measured and compared with the controls. The bacterial 
zones of inhibition values are given in Table 16. 
172 
Cable 16 Antibacterial activity of compounds 187. 189 and positive control ciprofloxacin. 
Diameter of zone of inhibition (111111). 
Compounds (iram-positi\'e bacteria Gram-negative bacteria 
S. pl'Ql'P1lex .IIRSA'.  P. QLfl1gi!osa K. pneuinoniae E. coh 
187 19.40.4 19.4=0.4 26.3±0.4 14.6±0.2 18.7=0.4 
189 19.2-0.2 1 R.2±0.'_ 25.2±0.2 14.1=0.4 17.5=0.2 
Bta!idarL1 22.5:0.4 2 ] .;_i-0.4 31.0-0.2 19.0--O.2 27.00. I 
l)\1SO - - - 
l u iav onirol (stanvi.finEi fi;N11xo:ioxac1n and negative control (DMSO) measured by the Halo Zone Test (Unit, mm). 
.\Lih cilhn resistant Sap) iv o tits oureus (NIRSA } Ve). 
Nlln11llll111 inhibitor\ concentrations (MICs) were determined by broth dilution 
technique. The nutrient broth, which contained logarithmic serially two fold diluted 
amount ut test compound and controls was inoculated with approximately 5 X 10' 
c.f.u. mL of actively d1% iding bacteria cells. The cultures were incubated for 24 h at 37 °C 
and the growth was monitored visually and spectrophotornetrically. The lowest 
concentration (highest dilution) required to arrest the growth of bacteria was regarded as 
11M1inium inhibitory concentration (MIC). To obtain the minimum bactericidal 
concentration (MBC), 0.1 mL volume was taken from each tube and spread on agar plates. 
The number of c. fit, was counted after 18— 24 h of incubation at 35 °C. MBC was defined 
as the lowest drug concentration at which 99.9"o of the imoculums were killed. The 
minimum inhibitory concentration and minimum bactericidal concentration are given in 
[able 17. 
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Table 17 \IIC and \113C results of compounds 187, 189 and positive control 
ciprofloxacin. 
Compounds 	Cram-positive bacteria 	 Gram-negative bacteria 
S. plogL'tles 	_IIR31-1 	P. ueiugiirosu 	K. pneurHotule 	E. coil 
NIIC NIBC MIC MBC 	NIIC MBC 	MIC MBC MIC MBC 
187 	12.5 	50 	25 	50 	25 	100 	25 	100 	50 	100 
189 	12.E 	100 	25 	50 5)) 	100 	 50 	100 	25 	100 
Stndard 25 12.5 6.25 12.E 	12.5 25 	6.25 25 	6.25 25 
NI IC (ug mL). minimum inhibitory concentration, i.e., the lowest concentration of the 
compound to inhibit the growth of bacteria completely NIBC (1t g inL), minimum 
bactericidal concentration. i.e.. the lowest concentration of the compound for killing the 
bacteria colnpletely. 
4.7. In vitro antifunl;al studies of compounds 187and 189 
47. I. Micruur tutism used 
For assaying antifun,al activity Caflclicla cilhicns, Aspergillus fumigants, Trichophvtotn 
n:('n1u,Jr)l)1v1c., and Pe,ticillium tnurtne)Jci were recultured in DNISO by agar diffusion 
method. 
Sabourauds ai.tar media as prepared by dissolving peptone (I g). D-glucuse (4 g) and 
agar l2 g) in distilled water l 100 nQ and adjusting pH to 5.7. Normal saline was used to 
nuke a suspension of spore of fungal strain for lawnin_g. A loopful of particular fungal 
strain was transferred to 3 mL saline to get a suspension of corresponding species. 20 mL 
of agar media was poured into each Petri dish. Excess of suspension was decanted and the 
plates were dried by placing in an incubator at 37 °C for 1 h. Using an agar punch. wells 
were male and each well was labeled. A control was also prepared in triplicate and 
maintained at 37  -(.' for 3-4 days. The fungal activity of each compound was compared 
with uriscofulvin as standard drug. Inhibition Zones were measured and compared with the 
controls. The fungal zones of Inhibition values are given in "fable 18. 
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Table 18 Antifungal activity of compounds (187, 189). Positive control (Griseofulvin) and 
negative control (DMSO) measured by the halo Zone Test (Unit, mm). Diameter of zone 
of inhibitioa (nun)- 
Compounds 	 CA 	AF 	 TM 	PM 
187 	 21.4±0.2 	19.9=0.3 	16.2±0.2 	13.5+0.4 
1R9 	 212±0.4 	19.4±0.2 	153±0.4 	12.2±02 
Standard 	30.5±0.2 	26.5=0.2 	23.5±0.3 	21.5,0.5 
D19SO 	 - 	 - 	 - 	 - 
CA; Candida albicans, AF; Aspergilhis fgmigatus, TM; Trichophyton 
rnentagrophyles, PM, PeWiei1fiim, marnefjef. 
The nutrient broth, which contained logarithmic serially Iwo fold diluted amount of test 
compound and controls was inoculated with approximately 1.6 X 10'— 6 X 10° c.fu./mL. 
The cultures were Incubated for 48 It at 35 °C and the growth was monitored. The lowest 
concentration (highzst dilution) required to arrest the growth of fungi was regarded as 
minimum inhibitory concentration (MIC). To obtain the minimum fungicidal 
concentration (MFC), 0.1 mL volume was taken from each tube and spread on agar plates. 
The number of c.Cu. was counted after 48 h of incubation at 35 °C. MFC was defined as 
the lowest drug concentration at which 99.9% of the inoeulums were killed. The minimum 
Inhibitory concentration and minimum fungicidal concentration are given in Table 19. 
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Table 19. \IIC and NIFC of compounds 187, 189. Positive control griseofulvin. 
Cimp. 	('.\ AF TM PM 
\11C \1FC MIC NIFC MIC 	NIFC MIC 	MFC 
187 25 	50 25 100 12.E 	50 50 100 
181) 50 	100 50 100 25 	100 50 100 
Standard 6.25 	25 12.5 25 6.25 	25 12.E 25 
CA: Candldw a/hicuns, :\F:I-1.,per,illu.; firin1gatlrs, TM; Tric/1uplrvton nieHtagrophrtc.. 
P\1. Peicill11lu uru;ilellri. `IIC (Fl`_ mL), minimum inhibitory concentration, i.e., the 
lowest concentration of the compound to inhibit the growth of fungi completely: MFC 
(Lt,, n1L), minimum fungicidal concentration. i.e., the lowest concentration of the 
compound for killing the fungi completely. 
The PBE 1pereentaa1 bacteriostatic efficiency. %) was obtained as, PBE = 100-"MIC 
and fungicidal tlmgistatic activity (MFC M1IC) as obtained are presented in Table 20. The 
ratio NIFC NIIC was calculated in order to determine if the compound had a fungistatic 
(\IFC NIIC >> 4) or tun ideal (MFC \IIC _ 4) activity and the results have been 
summarized in Table 20. 
Table 20 PBF and funweidal fungistatic activity (,'v1FC. MIC) of compounds 187 and 189. 
Compounds 	PI3F=111u NIIC' 	 MMFC'MIC 
Bacteria tested 	 FunI-*i tested 
SP \l1fS:l PA KP EC 	 CA 	AF 	T\4 	PM 
18' 	 5 	4 	4 	4 	1 	 2 	4 	4 	2 
189 	 8 	4 	2 	2 	4 	 2 	2 	4 	2 
('ipr>tlo\acin 	16 	I0 	S 	16 	16 	 - 	- 	- 	- 
CiruL'otiilvin 	- 	- 	- 	- 	- 	 4 	2 	4 	2 
SP: S. pl -ogeues, r IRS.A: Methicillin resistant Staphylococcus aureus• PA; P. ueruginosa 
KP: K. pneumuniae. E(': E. coli, CA: C albicuns, AF: .-1. Jilmigalus, TM: T. 
i )itot;'ruhhl'tcs, P`I: P mw1a1/tei. 
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The investigation of antibacterial screening data (Cables 16 and 17) revealed that all the 
tested compounds (187) and (189) showed moderate to good bacterial inhibition. All the 
compound showed good inhibition against S. pyogenes, Methicillin resistant 
Stapinlococcu.s aureus (MRSA +ve), P. uentginoso, K. pneumonia and E. eoli species. 
MIC of compounds was in the range of 12.5-50 µg/rnL. The MBC of compounds was 
found to be two or four folds higher than the corresponding MIC results. 
The anlifungal screening data (Tables 18 and 19) showed moderate to good activity. The 
compounds (l87 and 189) showed good fungicidal activity against C. alIicans, A. 
fumigates, T mentagrophyres and P. marnefjei fungal strains. MIC of compounds was in 
the range of 12.5-50 p ml. The MBC of the compounds was found lo he two or four 
folds higher than the corresponding MIC results. Most of the compounds showed good 
fungicidal activity against various fungal strains (Table 20). 
4.8. CONCLUSION 
In summary, a convenient method for the synthesis of novel halopyrazole derivatives has 
been developed. The procedure offers advantages such as mild reaction conditions as well 
as simple experimental and product isolation procedures, thus, making the current protocol 
as useful and inleres[ng methodology for the synthesis of novel halopyrazoles in good 
yields from cheap and readily available starting materials. The antibacterial, antifungal 
screening data revealed that the halopyrazoles may be used as template for future 
development through modification and derivatization to design more potent and selective 
antimicrobial agents. 
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CHAPTER 5 
SYNTHESIS AND ANTI-INFLAMMATORY EVALUATION OF 
INDOLE DERIVATIVES 
Section A: Microwave-Assisted Solvent-Free Synthesis of Indolylchalcones and 
pyrazolines 
(Green Chemistry Letters and Reviews 4,2011,63-68) 
5.1. REVIEW AND LITERATURE 
In recent years, green chemistry has been focus of considerable attention and is becoming 
an increasingly popular technology.' The aim of green chemistry is to reduce chemical-
related impacts on human health and virtually eliminate contamination of the environment 
through dedicated sustainable prevention program. Therefore, several newer strategies 
such as solvent-free (dry media), solid-supported with and without microwave (MW) 
irradiation.'-" mechanochemical mixing (grinding),' 9 use of room temperature ionic 
liquids,10''' supercritical carbon dioxide, t'- and water 1' as reaction media and many more 
techniques include approaches for the creation of "benign-by-design" are now accepted 
worldwide by different researchers for the synthesis of a variety of organic compounds. 
The processes which are designed by green routes help in the promotion of resource and 
energy utilization efficiently. It involves low level of waste, and is inherently safe making 
the processes economically and environmentally beneficial. 
In recent years, Microwave-assisted organic reaction enhancement (MORE) is well-
established technique for rapid and efficient synthesis of variety of heterocycles 
particularly from the viewpoint of green chemistry. It provides a safe, clean and 
convenient way to heat reactions to elevated temperatures, accelerates many syntheses 
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providing selective activation and allows fast optimization of chemical reactions compared 
to conventional heating.'4 Generally, most of the organic synthesis are carried out by 
conductive heating with an external heat source such as Bunsen burner, hot plate mantle, 
water bath, oil bath etc. This technique is comparatively slow and inefficient for 
transii rring energy into the system. It depends on the thermal conductivity of the various 
materials that must be penetrated and results in the temperature of the vessel being higher 
than that of the reaction mixture leading to formation of side product or decomposition of 
product. substrate and reagent. In microwave heating, microwave irradiation passes 
through the walls of the reaction vessel and produces efficient internal heating by direct 
coupling of microwave energy with molecules (solvent, reagents, catalysts) that are 
present in the reaction mixture by avoiding the local overheating at the reaction walls, 
which can lead to high product yield with less side product. Molecules with a permanent 
dipole that are subjected to the high frequency oscillating electromagnetic field associated 
with microwaves will try to align themselves with this field. As the field oscillates, these 
molecules are continuously aligning and realigning with this field. The rapid motion and 
resulting intermolecular friction cause intense internal heat that can increase up to 10 °C 
per second. Due to this rapid increase in temperature the heating profile is different from 
conventional thermal heating and this is the main contributing factor to accelerate the rate 
of reactions under microwaves irradiation. Another phenomenon encountered when 
performing microwave heating is the specific microwave effect. This can be expected 
when the polarity is increased during the reaction from the ground state to the transition 
state. When stabilization by dipole-dipole electrostatic interactions of the transition state is 
more effective than that of the ground state, this results in an enhancement of reactivity by 
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lowering the activation energy. It also provides an opportunity to work with open vessels, 
thus. avoiding the risk of high pressure and hazards of inflammable solvents.!` Microwave 
technologies have also found especially extensive application in medicinal chemistry in 
the field of drug discovery processes. 16 
Chalcone or 1,3-diary!-2-propene-1-ones, are essential group of natural as well as 
synthetic products with widespread distribution in fruits, vegetables, spices, tea and soy 
based foodstuff and has been subject of great interest for possessing interesting 
pharmacological activities.!' Chemically, chalcones consist of open-chain flavanoids in 
which two aromatic or heteroaromatic rings are joined by three carbons, a,(3-unsaturated 
carbonyl system. The presence of a reactive a. (3- unsaturated keto function in chalcones is 
found to be responsible for their biological activities such as antimicrobial,'8 anti- 
l (J 	 -)1 inflammatory. anticancer,2`0  cytotoxic chemo preventive,22  " antilieshmanial,23  
antifociceptive,2-1 atiprolifirative.25 antimalarial,2 6 antiviral27 anti—HI V,28 antioxidant 29 etc. 
Due to this diversity of bioattivity, chalcone could be considered a `privileged structure', 
as described by Evans and coworkers.30 Chalcones also belong to the class of the 
anihochlor pigments which usually give yellow to orange colours to the tissues in which 
they are located. Although chalcones are not responsible for pigmentation in the most 
yellow-coloured flowers, but they are still attractive to insects and in such a way they 
contribute to the flowers' pollination31. Some of the synthesized chalcones with important 
biological activities are highlighted below. 
185 
5.1.1. AntilieslJmanial chalcones 
Mei-Lin Go and his co-workers synthesized different substituted chalcones and studied 
their antilieshmanial activvit\.'- 
Me 
MeO 	/ 
—R 
MeO 
R = 4-CH3, 4-CI, 3-CI, 2.4- F, 4-NO,, 4-OCH3, 
3-Quinolinyl, 4-Quinolinyl 
O 
MeO 
R= 2, 4-difluoro. 2.4-dimethoxy, 3-quinolinyl, 4-
quinolinyl 
5.1.2. Antimicrobial activity 
A. Geronikaki et al33 synthesized novel thiazole based chalcone and evaluated their 
antimicrobial activities. 
CH, \ ~ R 
H:C.\ 
ii 
	
s 
O 
R = H. 4-NO., 4-OMe, 3-CI, 3-OMe 
Baviskar et al334 have synthesized novel chalcones and studied their antimicrobial activities. 
- 
I 
s 
R = (:,11~, 3-NO.0:,.II,. 4-N(CI1,)2 C,,I1 . 4-(X'H;C:H,. 3.4,5-(()C'H,)2, G.H,, 4-O}G,Hi, 3-E3rC,,H,, 3-PC'c,H, 
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Batovska and his co-workers3i have prepared chalcones and studied their antifungal 
activities. 
0 	H 
/ 	OH 
Cl  
H 
5.1.3. Antioxidant chalcones 
Kayees Ahmad et al3l, synthesized novel chalcones and evaluated for antioxidant activity. 
O 
X-o-Ct.3.\L,.. 
l 1 	A 
(, 	
r 
 
0 	 NO, 
NOZ - 	CHI  
Ar- 	Br 
H3C 	C'H, 
5.1.4. Antiinflam►natorj ,  chalcones 
Kumar and et al'' have synthesized heterocyclic indole derivatives and reported anti-
inflammatory activity [72]. 
R = p-OS. m-OCH;, SS. KtCNz1_, p-OCSi,, rr- 0001  
Okunrobo and co-workers'8 have prepared novel chalcone and studied their anti-
inflammatory and gastroprotective activities. 
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0 
x , 	\ 
Y 
4-NO, 	 2,4.6-0CH 3 
4-NO, 3-Br 
X-- 4-OCH3 	ti 3-Br 
4-0C113 2.4.6.00}13 
2.4-011 	 H 
4-NO, 4-CI 
Ramaa et.a139 have prepared fluorinated chalcones and studied their anti-inflammatory 
activities. 
F 	 R 
I \ 
F O 
R 4-OCH,. 3-NO.. 1 Me, 2-CI, 3-Br, 2-NO,. 4-CI, 4-F 
5.1.5. Anticancer chalcones 
Khan et. a140 synthesized novel boronic and bis chalcones and evaluated their anticancer 
activity. 
0 
I0  
13 	() 
OII 
5.1.6. Antimalarial chalcone 
0 0 
Me 
Liu et al41 studied invitro antimalarial activity of some novel cahlcone. 
R, 
R i =H.R;= Cl. H 
R 1 =R,-R1=OCll 
RI =H.R=OCH,,R,=H 
Chalcones are good accessible starting materials for the synhesis of various biologically 
important heterocyclic compounds such as benzothiazepine.42 pyrazolines.' 1,4- 
diketones,'' flavones,4' pvrazoles.46 dihydropyrimidines,46 isoxazolines46 etc. Additionally, 
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these are also important intermediates in many addition reactions of nucleophiles due to 
inductive polarization of carbonyl group present at the p-position. Thus, the synthesis of 
chalcones has generated vast interest to organic as well as for medicinal chemists. 
"Therefore, several strategies for the synthesis of these systems have been reported in the 
literature;'. The most common method involves the Claisen-Schmidt condensation of 
equimolar quantities of substituted acetophenone with substituted benzaldehyde in the 
presence of an aqueous alcoholic alkali.48 A number of acid-catalyzed methods are also 
reported in the literature which includes the use of A1C13 39 dry HC1,50 Zn(bpy)(OAc)2,5 ' 
TiCL'2 Cp2ZrFI2/NiC125 ' and RuCl3.54 Recently various modified methods for the synthesis 
of chalcones has been also reported in the literature , such as using SOCl2,15 lithium 
nitrate.,' amino grafted zeolites,5 zinc oxide,'8 , water,59 Na2CO3,hO PEG- 400,61 silica-
sulfuric acid,62 ionic liquid°' and microwave irradiation.6' Unfortunately, many of these 
methods have drawbacks such as use of organic solvents either during condensation 
reactions or during isolation of the products by way of extraction, use of expensive 
stoichiornetric amount of reactants, use of hazardous and environmentally polluting 
solvents, low yields, extended time, tedious procedure etc. Although, several modifications 
have also been made to counter these problems, yet, the development of selective and 
better strategies for the synthesis of a, n-unsaturated carbonyl compounds is still in high 
demand. 
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5.2. Some recent examples for the synthesis of Chalcones under green environment 
(a) Solvent-free synthesis of chalcone under Ultrasound irradiation catalyzed by 
alkaline doped carbons 
Ultrasound irradiation has been increasingly used in organic synthesis in last three 
decades. Comparing with traditional methods, this method is more conveniently and easily 
controlled Recently, Aranda et.al°5 presented a green protocol for the Claisen-Schmidt 
condensation between benzaldehyde and acetophenone catalyzed by alkaline-doped 
carbons (solid phase) under ultrasonic activation in the absence of any solvent to yield the 
chalcone in excellent yields. 
(b) 1,AG03 mediated synthesis of chalcone under microwave irradiation 
A simple and convenient method for the synthesis of chalcones using 12-A1203 under 
microwave irradiation has been reported.°° Reaction completed in short time period 
(80sec) with excellent yields (79-95%) of the products. 
II 	0 
	
i_nyo~. Mw 	I \ 
60 iec 	R / 	C\R 	 - 
O 
R=H4-0H4L0.NO, 4-OM 3.0.0n3 OMe. 
2NO 	CH2n 
K = H 2-OH, 4-0H. 4-OMe. 2 J-OMe, 
(c) Bronsted acidic Ionic liquid mediated synthesis of chalcones ss 
According to Liu et.a1 7 the -SOJH- functionalized acidic ionic liquids was found to be an 
efficient dual catalyst and solvent for Claisen-Schmidt condensation of benzaldehyde and 
acetophenone by providing an easy synthesis of chalcones under mild reaction conditions. 
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	0 	11 v 	 0 
Acidic catal\ st  
(93.8°o) 
(d) Bismuth (III) chloride mediated synthesis of chalcones under solvent free condition 
Sandhu et. a168 reported an environmentally benign protocol for the synthesis of chalcones 
by the Claisen Schmidt condensation of aldehydes with ketones using eco-friendly. non-
toxic hismuth(lll)chloride catalyst under solvent-free condition. In this protocol, the 
reaction time is very short, yields are high and there are no other pollutants formed. 
p 	 0 
O 
a  
Solvent-free 
R 	Ri  
R1 = H, CH3, Cl 	 O 	(85-90%) 	R i 
R I 	I 	G5 OcMe EtO O  
(e) Srnthesis of chalcones using C-200 as solid support under grinding conditions 
Kumar et a169 reported an easy. safe and effective method for the synthesis of pyrazolyl 
chalcones by grinding pyrazole aldehydes and acetophenones in the presence of activated 
barium hydroxide (C-200) in high yield within short span of time. 
Ar 	CI-t0 	 0 
OII Ba(OH), 	 Ph 
u 	R \ Grinding 
Ph 	 Ar (90-96%) 
X 
Ar=Ph, 	X 4-CH;, 4-OCH, 4-F, 4-Br, 4-Cl, 4-NO-,, 4-C,H5 
R= 	 Y = 4-Br, 4-OCH,, 4-C,HS ,CH3, 2-Furyl, 2-Thienyl 
1' 
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Among the various derivatives of chalcones, the pyrazoline nucleus is a ubiquitous feature 
of various compounds possessing many pharmacological and physiological activities and 
are present in a number of pharmacologically active molecules such as phenazone/ 
amidopyrene/ methampyrone (analgesic and antipyretic), azolid/ tandearil (anti-
inflammatory), indoxacarb (insecticide) and anturane (uricosurie).1° The pyrazoline 
function is quite stable and has inspired chemists to utilize this stable fragment in biouclive 
moieties to synthesize new compounds such as cyclopropane'I and pyrazole.'Z The 
discovery of this class of drugs provides an outstanding case history of modem drug 
development and points out the unpredictability of biological activity from structural 
modification of a prototype drug molecule. Literature survey reveals that numerous 
pyrazoline derivatives have found their clinical applications as non-steroidal anti-
inflammatory drugs (NSAIDs) such as felcubuzone, famprofazone, and ramifenazone.73  
Certain compounds containing the pyrazoline moiety have been demonstrated to have an 
important therapeutic potential, such as anti-inflammatory, 74 antibacterial,k antipycetic,J6, 
anticonvulsant,77 antidepressant,' antihypertensive,'9 antioxidant,eo antitumor, 
anticancer and antidiabetic83 agents etc. Some recently explored pyrazoline derivatives 
with important biological activity are listed below. 
5.2.1. Antimicrobial activity 
liharmal et a184 synthesized some pyrazoline derivatives as biologically active agents. All 
the compounds showed antimicrobial activity against S. typhosa and A. niger. 
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Basa~varaj et al synthesized some 111-pyrazolines bearing benzofuran as biologically 
active agents. They exhibited high antimicrobial activity against S. aureus and moderate 
activity against E. coil. 
CFl_; 
CI 	 1'h 
n 	NON` 'R 
R CI. Ph 	
l~lhf 
5.2.2. Antinociceptive pyyrazolines 
Kaptancikli et al8` synthesized 1-[(Benzoxazole/13enzimidazole-2-yl) thioacetyl] 
pyrazoline derivatives and evaluated for antinociceptive activity. 
NON 
N / 
\ I 
5.2.3. Antidepressant pyrazolines 
Palaslca et alb' synthesized ten new 3, 5-diphenyl-2- pyrazoline derivatives and evaluated 
their antidepressant activities by the 'Porsolt Behavioural Despair Test' on Swiss-Webster 
mice. 
R1 R, 	OCH1 
1 	ocH, 
N N11 
R, = 11, CI, Br. CH;. OC113 
R+ = II. CI 
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5.2.4. Atttimrcobacterial pvrazolines 
Ozdemir et al synthesized new 1-[(N, N-disubstituted thiocarbamoylthio) acetyl]-3-(2- 
thienyl)-5-aryl-2-pyrazoline derivatives 1361 and evaluated for in vitro antimycobacterial 
activity against Al. tuberculosis H37Rv. 
~y 
o ~s 
0 
Mamolo et a!89 synthesized 5-aryl-l-isonicotinoyl-3- (pyridin-2-yl)-4, 5-dihydro-1f1- 
pyrazole derivatives and tested for their in vitro antimycobacterial activity. The 
compounds showed an interesting activity against a strain of M. tuberculosis and a human 
strain of Al. tuberculosis 1-14. 
5.2.5. Analgesic and Anti inflammatory pyrazoline 
Khode S et.al.'° synthesized a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-l-
phenyl-2-pyrazolines and evaluated significant anti-inflammatory activity in acute 
inflammation such as carrageenan induced paw edema in rat model. 
~4 
NN 
X 
O o 
X = C6H5, 4-OMe-C6H4, -CH=CH-C6H4, 4-Cl-C6H4. 4-OH 
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Panneer Selvam et al`" synthesized a series of 1- (4-substitutedphenyl)-3-phenyl-lH-
pyrazole-4- carbaldehyde and tested for their anti-inflammatory and analgesic activities. 
` tip  
C'HO 
R — H, far. CI, F. NFC0CI13 
5.2.6. Antinnalarial pr•razolines 
B.N. Acharya et at - Synthesized a series of 1,3,5-trisubstituted pyrazolines and evaluated 
for in vitro antimalarial efficacy against chloroquine sensitive (MRC-02) as well as 
chloroquine resistant (RKL9) strains of Plasmoditun.Mciparum. 
Rio 
OCHE 
\ / OCZHy 
O 
Pyrazoline, derivatives as typical ICT (Intramolecular Charge Transfer) compounds are 
known as fluorescent brightening agent, which exhibit excellent fluorescent property93. It 
can absorb light of 300-400 nm and emit blue fluorescence. Pyrazoline contains two 
nitrogen atoms, one of which forms an electron-donating p-it conjugated system. 
Therefore, it is able to function as hole-transporting materials used in Organic 
electroluminescent devices (OELD).94 A variety of methods have been reported for the 
preparation of this privileged class of compounds but one of the most convenient method 
for the synthesis of 2-pyrazolines was described by Fischer and Knoevenagel in the late 
nineteenth century by the reaction of a, (3-unsaturated ketones ( acrolein) with phenyl 
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hydrazine in acetic acid under refluxing condition.95 However depending on the reactivity 
of molecules and need of the chemist they have synthesized the pyrazolines under different 
solvent media & acidic or basic conditions. Later. Auwers et al.96 corraborated that the 
product of this reaction was I -phenyl 2-pyrazoline. During the last century, after these 
pioneering studies, numerous 2-pyrazolines were synthesized by the reaction of u, (3- 
enones with hydrazines. This simple and convenient procedure has remained one of the 
most popular method for the preparation of 2-pyrazolines. 
5.3. Sonic recent examples for the synthesis of pyrazolines under green environment 
(a) Stvnthesis of 1,3,5- triaryl-2 p►yrazolines under ultrasound irradiation 
Ji-Tai 1.i et.al9 reported an efficient and practical procedure for the synthesis of 1,3,5- 
triarvl-2-pyrazolines by the reaction of chalcones and phenylhydrazine hydrochloride in 
sodium acetate-acetic acid aqueous solution under ultrasound irradiation in in 83-96% 
yield in 1.5-2 h. 
x 
0 	 NHNH2CI 	 N— 
+ I 	 H2O, UV 
Y~ 	CH3COOH. CH3COONa / 
X 
(83-96%) 	Y 
X= C6H5, 4-CI, 3-NO2 , 
Y= 4-OCH3, 4-CH3, 4-CI, 3-CI, 2-CI, 2-Br, 4-NO2 
(b) Synthesis of 3,5-arj'lated 2-pyrazolines under microwave irradiation 
Azaritar et.al `'s demonstrates a rapid, efficient and environmentally friendly method for 
the synthesis of 3,5-arylated 2-pyrazolines under microwave heating, at 80 'C in excellent 
yields and the results obtained confirmed the superiority of the microwave irradiation 
method over the classical heating. 
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O 	R, 
	
R~ 
N—N 
R'=H CI 	 (82-99%) 
R2 = Me. CI, OMe. NN, 
R3- H, Ph. CONH, 
(c) Basic alumina mediated synthesis of pyrazolines under microwave irraduiation 
A new and efficient synthesis of pyrazoline derivatives was described by Desai et.al99 
using basic alumina under microwave irraduiation. With this environmentally benign 
approach, the reaction time brought down from hours to minutes along with a yield 
enhancement. 
It 	s CI 	CI 
/ c—cH=uH 	t II 	Basic AmminaAK,CO3 
II_N NHNH, MW 	R 
NON 
H2NS (62-82%). 
R II, 2-NO,, 3-NO„ 2-CI. 4-CI. 4-N(MC),, 4-OCT,. 3-0c6115, 4.0CH3, 3-OH, 3,4,5(OCH3)3 
(d) Synthesis of pyrazolines using Poly(ethylene glycol) (PEG-400) as green solvent 
Dawane et.al100 prepared a series of 2-pyrazolines by the base catalyzed treatment of 
appropriate chalcones with 4-(4'-chlorophenyl)-2-hydrazino-thiazole using poly (ethylene 
glycol) (PEG-400) as a green reaction medium. 
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/ N 	PEG 
li 
S 	N}HNli_ 
RZ 
Ra 
ç c l 
R' 
/ 	N 
1 
H 
CI 
X=  
s 
R ;= H. OH 
R. 	11, I, 13r 
R a =11. CI. Me. NH.,OMe 
R.=H,CI.Me,1,Br 
5.4. PRESENT WORK 
The indole nucleus is an important structure in various natural or synthetic alkaloids and in 
medicinal chemistry.101 Indole derivatives have been reported to possess several biological 
activities including anticancer.'° antioxidant, l°' antirheumatoidal l°4 anti-HIV,1° anti-
inflammatory. 106 antimicrobial. 107 antiviral1°8 and also play a vital role in the immune 
system. )9 Indole derivatives also display diverse variety of pharmacological activities that 
are useful in the treatment of fibromyalgia, chronic fatigue and irritable bowel 
s~ ndrome.I I"-112 The substituted indoles have been referred to as privileged structures since 
they are capable of binding to many receptors with high affinity.' l' 
Prompted by the above-mentioned biological properties of indoles, chalcones, pyrazolines 
as well as the utility of microwave irradiation in organic synthesis, it was worthwhile to 
prepare novel series of indolyl chalcones and their substituted pyrazoline derivatives via 
microwave irradiation method. The present study also compares the efficacy of reaction 
techniques under the conventional and the microwave irradiation methods. 
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5.S RESU1; f 5 AN I) DISCUSSION 
During the present ;tide. the synthesis of indolyl chalcone (192a-c) was carried out by 
Claisen-Schmidt condensation employing indole-3-carhoxaldchyde (137) and hetcroaryl 
active methyl compound, (191 a-c) undcr conventional heating method in the presence of 
piperidine as a basic catalyst and methanol as solvent. The reaction took longer time 
period (~9-12 h for completion of reaction with moderate yield (65-70 "i%) of the products. 
Keel nn in mind the key principles of 'green chemistry' and to obtain chalcones in a short 
;pan of time with unproved yield, the reaction was carried out using microwave irradiation 
technique under solvent-tree condition (Scheme 71). As visualized, the reaction proceeded 
smoothl\ under solvent-free condition and the chalcones (192a-c) were obtained with 
substantial increase in yield (82-92 %0') within few minutes (6-13 min) (Table 21). The 
assigned molecular structures of all indolvi chalcones (192a-c) were based on 
spectroscopic analysis (1R. '11 \\IR and \1S) and elemental analysis data. The IR 
spectrum (Fig. 32) of (192a) showed characteristic absorption band at 3251 cm-t and 3 384 
Cn: Llac to the pres nicc \11 and Oil groups of indole and coumarin moiety respectively. 
The :out11,u, in carbon %I ahsorption band was present at 1689 cin". The 1 H NMIZ spectrum 
(Fig. 33) showed traes olclinic protons Ha and 11b of u,O-unsaturated carbonyl system as 
ortho coupled doublets at a 8.43 (J = 16 Hz) and 8.58 (J =16 liz). The Value of spin-spin 
coupling constant J,,:. itl the ranee 15-16 1Iz is indicative of the E-contiguration of chalcone 
for the oletinic bond of the CO-Cl1—CI-1 group. Four aromatic protons of coumarin and 
live protons ol indolc moieties including I-1;\ proton were discernible in the form of 
tiultipta at v 7.29-8.21. Further support for the formation of(192a) was provided by mass 
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spectrum (Fig. 34) which showed molecular ion peak at nu/_ 331 (M * ). The spectral data of 
other compounds followed similar pattern and are explained in experimental section. 
Table 21 Synthesis of indolyl chalcones (1 92a-c) under conventional heating and 
Microwave irradiation method. 
Entry 	Product 
1 	192a 
192b 
192c 
Conventional heating Microwave irradiation 
Time (Ii) 	Yield (%) Time (min) Yield (%) 
10 — 65 	11 	87 
12 	70 	13 	92 
9 	69 	6 	82 
Ilb 	0 
C~~, 	
\icthanol.'Piericiinr
I 	 \ 
{ 
13- 191a-e 	 11 	192a-c 
CH 
/ 	 V
ItFT 
	 / 
	
oil 	O 	c)II 
191a 192b 192c 
Scheme 71. Svnthesis o/fifrdo/t I chalcones (192a-c) 
Et•forts were made for the synthesis of novel pyrazolines (193a-t) by the reaction of 
incIO1Vl chalcones with hydrazines both under conventional heating method and microwave 
irreadiatiop. Under eons entional method pyrazolines synthesized by rcfluxinb of indolyl 
chalcones (192a-c) with hydrazine hydrate (177a) and phenyl hydrazine (177b) in 
niapanol in the presence of catalytic amount of piperidine (Scheme 72). The reaction took 
loitecr time (7-15 h) for completion with lower yield (57-68 °/%) of the products. When the 
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same reaction was carried out under microwave-irradiation reaction in solvent- and 
catalyst-free environment, the reaction proceeded efficiently and the reaction time brought 
down from hours to minutes (5-1 i min) with excellent yield of products (76-89%) (Table 
22 ). 
I ormation of pyraiolines ( 193a-f) was confirmed on the basis of IR :11 NMR, and mass 
spectral analysis. The IR spectrum (Fig. 35) of(193a) showed two broad absorption bands 
at ,189 cm"' and 3270 cm'' due to the presence of NH groups of pyrazoline and indole 
muicties. The absorption band for the coumarin carbonyl group was discernible at 1680 
cm . The 'H NN,IR spectrum (Fig. 36) showed a broad singlet (D2O exchangeable) at O 
10.3', due to the presence of NII proton of indole moiety. The aromatic region of the 
spectrum exhibited nine protons in the range () 7.09-8.11 due to four protons of coumarin 
and live protons of indole moieties including I [A proton. The presence of pyrazoline unit 
W,H c~tabilishcd by the presence of two doublet of doublets at O 4.01 (He), 4.16 (Hf) and a 
triplet at r) 5.41 (1-Id). Further evidence for the formation of pyrazoline (193a) was 
provided h recording the mass spectrum (Fig. 37) which showed molecular ion peak at 
in: 345.15 ( \-1+). 
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Table 22 Synthesis of indolyl pyrazolines 193a-f under conventional heating and 
%1igiro%%ave irradiation method. 
Entry Product Conventional heating Microwave irradiation 
Time (h) Yield ('%,) Time (min) 	Yield ('%) 
I 193a 7 66 5 	SQ 
193b 10 61 8 	78 
193c 13 68 10 	95 
4 193d 15 57 13 	76 
193gi 11 61 12 	85 
6 193f 9 68 7 	 89 
R 
\lrlbamQl piperidinc 
	
1 Hf 	He 
193a-f 
193x: R-H 	W1 	 I / 
193b: R-C„H;  
1"a. R II 	 OH 
'f 1;  
193c: IZ-I1 
193d: R - c II' .111 'I 
193e. RII 
1931'. 	R=Cv11; 	I1F 1 
1{ 
oil 
Scheme 72. St';iillcsis u/ prra ohm' derii•atri'e.5 front inclolvl chalconcs (I 93a-I) 
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5.(6. CO\CLlS1O\ 
Itt search of potentially active molecules containing indole moiety we have developed an 
efficient. facile. and practiLally convenient :_,rcen methodology for the synthesis of indolyl 
chaleoncs and corresponding pyrazolines employing WiCro\raVe irradiation protocol. The 
notable leanures such as simplicity in operation, excellent yields of the products. faster 
reaction rate:, and cleaner reaction profiles make the cur rent protocol feasible and 
.Mfrs, tiv C. 
5.7. EXPERI1IE\"1'.AI. 
Melting points of all Synthesized compounds were taken in Riechert Thermover instrument 
and are uncorrected. The IR spectra were recorded on Perkin Elmer RXI spectrometer in 
Kl3r. 'H \\IR spectra \\crc recorded on a Rruker DRX-300 and Broker Avance II 400 
spectrometer using ts1rau11tE \ cilane (THIS) as an internal standard and DMSO-d(, CDCI,, 
as solvent. FAB may; acorn were obtained on Jeol-SX-102 spectrometer and DART-MS 
was recorded on a JEOL-Acct 'I OF JNIS-Tl00LC mass spectrometer having a DART 
source. Elemental anal\ ses C. I-1 and N) were conducted using the Elemental vario EL III 
elemental analyzer and their results were found to be in agreement with the calculated 
values. 5-Acetvl-l-3-dintethyl barbituric acid and 3-acetyl-4-hydroxycoumarin were 
synthesized by reported procedures 114. I1'. Other chemicals were of commercial grade and 
used Without further purification. The homogeneity of the compounds was checked by thin 
laver chrontatographyiTLO on glass plates coated with silica gel G254(E. Merck) using, 
cli harotd1"Ill nie fhanol ( 311 I mixture as mobile phase and visualized by iodine vapors. All 
cx )eriinents under nlicro\v av e irradiation were carried out using an unmodified domestic 
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microwave oven (National. Model NN-SSS7WF, 1.3 KW. 2450. mltimode equipment. 
full power). 
5.7.1. Sivithesis of inelol►'/ chulcones (192u-e•) ulu/er• conventional heron method 
lo a solution of 3-oCet\ l-4-hVdroxy couinarin (Iminol)/ 5-acetyl-1. 3-Clnlcthyl barbituric 
acid (1 mmol) u dcl]ydroacetic acid (191a-c) (1 mmol) in methanol (10 mL) containing 0.2 
fill 	f hipericliWe v a; added lnc]ole- 3-carboxaldchydc (137) (1 mmol). The reaction 
mixture va; heated under reflox on a water bath tar 9-12 h. Ater completion of the 
reaction (Winnitored by T1.( 1. the reaction mixture was cooled at room temperature. The 
solid, thus, obtained was filtered, washed with eater, alcohol and dried to afford the 
i 1)2a-c). 
5.7.2. Si'ntlie.\i.c of i,ulol 1 c•/ia/cones (192a-c) uncles- microwave irrucliatiun imetlod 
\ mixture of ii tole ; carho~tildchyde (137) (l mmol), 3-acety1-4-h\droxycoutslarin (1 
1]]llb)1) 5-aeet\ 1-1.3-dimeth\ lbarbituric acid (l mmol ) dchvdroacctie acid (191 a-c) (1 
nlmol) and hiheridine (0.2 ml,) was placed in an open pyrex beaker and subjected to 
nucrowave irradiation wing domestic microwave oven and Irradiated for appropriate time 
till the reaction was completed. The progress of the reaction was monitored by TLC. On 
completion of the reaction, reaction mixture was slurred in cold water (50 ml,) and the 
yellow solid obtained was filtered, dried and recvrstallised from CHCI;-N/1eOH (2:3) 
mixture to give (I 92a-c) in excellent yields. 
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5.7.3. Spectral data of compounds 
2E-I- (1-!/t'droxt'-1-hc►r;,nhtrwr-2-one-3-ti!)-3-(I H- iiidol-3yI)-2 ppropeiw-l-orne (192a) 
Ptnr ilied by recrystallization from chloroform-methanol (2:3 vv) mixture. 
Orange crystals 
M.p. 
IR (KBr) u113 .Y;cm'' 
'H NMR (400 MHz, CDCI3) 
ESI-MS 
Elemental analysis for  
>300°C. 
1689 (C=O), 3251(NH), 3384 (01-1). 
6 (ppm) 7.29-8.21 (m, 9H, Ar-H+HA), 8.43 (d, l H, 
J=16 Hz, Ha), 8.58 (d, 1 H, J=16 Hz, Hb), 8.68 (s, 
1H, NH), 19.27(s, 1H, OH). 
m/: 331.13 (M ) 
C20H,,NO4 	 : 	Calculated C, 72.57; H, 3.98; N 4.23 
Found C, 72.84; H, 4.02; N, 4.21 %. 
2E-1-(1,3-Dinuctlti'1-2,4,6-pr riinidiizetrioize-5'-v!,)-3-(JH-indo!-3 yl)-21propcnt-1-one 
(1 9 2b) 
Purified by recrystallization from chloroform-methanol (2:3 v, v) mixture. 
Yellow crystals 
M.P. 
IR (KBr) vmax/Cm 
'H NMR (400 MHz, DMMISO- d„) 
>300 °C. 
1654 (C=O), 3276 (OH). 
J (ppm) 3.35 (s, 611, 2 N-C11.), 7.25- 7.50 (m, 
5H, Ar-H+HA), 7.82 (d, 1H, J=16.1 Hz, Ha), 
8.31 (d.11-1, J=15.9 Hz, Hb), 11.05(s, 1H, 
NH). 
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ESI-NlS 	 nt/_ 325.15 (;VI-). 
Elemental analysis for 
	
Calculated C, 62.80; H, 4.65; N, 12.92; 
C,-Hi;N;O4 	 Found C, 62.97; H, 4.81; N, 12.90 %. 
(2G)-1-(4-Hrdrort-6-nret/rt1-2-oxo-2-H pti•t•utt-3-v1)-3-(IH-indolvl-3-y1)-2 propene-1- 
one (192c) 
Purified by recrystallization from chloroform-methanol (2:3 v. v) mixture. 
Light Orange crystals 
NI.p 
I 1. (KB r) u ,,: .,`cnl I 
1 I I \NIR (100 i✓v111z, D\'ISO- d,) 
FSI-NIS 
Elcilcnfal analysis for 
C 
295-298 °C. 
1699 (C=O), 3048 (NH), 3170 (OH). 
ii (ppm) 2.28 (s, 311, CI 1), 5.96 (s, I11, 1-I'), 
7.25-7.58 (m, 5H, Ar-H+H:~), 7.78 (d. 1H, 
.1=15.5 Hz. Ha), 8.13 (d, 1H..1-=15.4 Hz, Hb), 
11.6 (s. 11-1, NH) 18.74(111, s• Oil) 
m/ 295.1? (M ). 
Calculated C, 69.21; H, 4.43; N, 4.74 
Found C. 69.29: 11, 4.46: N. 4.70. 
S7.4 Preparation of i,relolt•l j'•u;•o/iHes (193a f) u„der conventional heating; method 
;\ mixture of itidoly lehaleones (192a-c) (2.5 mmol), hydrazine hydrate (177x) (2.5 
mmoll phenyl hydrazine (177b1 (2.5 mmol) and 0.1 mL of piperidine was retluxed in 
methanol on water bath for appropriate time. After completion of reaction (checked by 
TI.C' ). reaction mixture %%as cooled at room temperature until yellow color crystals (193a- 
f) '.'. cre obtained. It %va-s tiItered, washed with N1eOI I. dried and recrvstalIised from CHICI-,- 
\leOIl (2:; \ \.') mixture. 
5.7.5. Preparation of indolvi p1,razolines (1 93a-J) under microwave irradiation method 
\ i.1ixuI:c of indol\ l ;halrOncs (192a-c) (2.5 mmol) and substituted hydrazine (2.5 mmol) 
(177a-h i were taken in an open Pyrex vessel and irradiated in a microwave oven for the 
ahhr hriute time until the Completion of reaction (monitored by TLC). After completion, 
the reaction mixture \v au cooled at room temperature and was poured into cold water (50 
mL i. The solid as obtained was filtered, dried and recrystallised from CHC1.-McOH. 
5..6. Spectral dal. 
$-( 1 Ht dro.v 1-hey► opt ran-?-ogre-3 ,1'1) - 5-(I fI indol-3-v!) pvruzolrc (1 93a) 
Puri tied b\ reery talliaation from chlorotorus-methanol (2:3 VN) mixture. 
\:Itw. 0 I coaipound 
\I.l~. 
I l (1<13r) u,, cm 
~11 \\1R (400 M1ir. Cl)C1:1 
I 	l-N IS 
1;1ela1esttal tilllalvsIs tar 
Pale yellow crystals 
250-253 °C, 
1680 (C=O), 3189 (NH), 3270 (OH). 
(i (ppm) 4.01 ((1 H. dd, J=1$.$ Hz, 7.8 Hz, 
He). 4.16 (111. dd. .J=1 S.9 l lz, 9.72 1 Iz, Ht), 
5.41 (1 11, t,1= 17.9 Hz, 1-{d), 7.09-8.11 (m, 
91-1, Ar-H-H.A ), 10.35 (s, 111. Ni I). 
ni;= 345.15 (MV). 
Calculated C. 69.62; 11, 4.38: N. 12.17, 
C, 11i :N c): 	 Found C, 69.59: H. 4.36; N, 12.13 %. 
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1- !'he►►'I-3-(4-lt►vl►ox►-1-ben uh►'ran-2-une-3-t1)-5-(111 indol-3-t•!) jt•ra--oliue (193b) 
Purified by rcewst,IIilaticm from chloroform-methanol (2:3 VV) mixture. 
\~ll&\\ "n,tals 
Ni 
1R (N..Br) k),,.i,%em 
11\\IRt4(.IoiMllr.([)CI;I 
F.\H - NIS 
F1cmGm:II anal sis tur 
287-290 ''C 
1695 (C=O), 3058 (NH). 3344 (OH). 
() (ppm) 3.80 ((11-1, dd. J=18.9 1 Iz. 8.1 IIz, 
1-le), 4.32 (11-1, dd, J= 18.9 I Iz, 12.0 Hz, Hf). 
5.53 (1H, t, J= 12.0 Hz, Hd), 6.83-8.06 (m, 
14H, Ar-H-~H.. ), 8.24 (s, IH. NI-I), 14.2 (IH, 
s. 011). 
m, 421 (\1 f ). 
Calculated C. 74.17; 11, 4.54: N, 9.98: 
Found C, 74.29: 1-I, 4.66; N, 9.94 %. 
3-(I • $-1)ittrc'tlr I.1-', 4, h I.'t rirgi(lirrc tf icing-5 .► l)-3-(1 H inrlol-3 _y/)p1•ruzolirrc (193c) 
Puri lied h\ reel\ sta11iNation flow cliOrOt0rtn-methanol (2:3 V L') mixture. 
Yellow crystals 
\1.1, 	 : 	253-255 `C. 
I R i K13r) u:,..,. cm 
`H N.,IR 1400 NIHi. CCUCI,I 
1716 (C=0), 3224 (NII). 3344 (NIl). 
)(ppm) 3.35 (6H, s. 2N-C'H-,), 3-95 (1 H. dd, 
J18.- I Iz. 8.1 IIz. IIc)• 1.16 (111, del. J-18.7 
1 Iz. 8.8 1 Iz. Hf). 5.22 (11-1. t..J= 17.1 1 Iz. Hd). 
6.99-7.63 (m, 51-1, :1r H-rH v ), 10.41 (s, IH, 
Ni 1). 
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l Sl \1S 	 m:. 339.18 (M`). 
FI mental analy is for 	 : 	Calculated 0.60.23; I1, 5.05; N, 20.65: 
Found C, 60.33: H. 5.39: N. 20.63 %. 
1-Phe,rlrl-3-(1,3-dinretht•1-2.-1,6-pvrii ziditretrio►re-5-y!)-3-(1I!-iiidol-3 }'1) ppyrazoline 
(1 93I) 
Purified b% recrystallization from chloroform-methanol (2:3 V V) mixture. 
Yellow crystals 
\1. p. 
1R (KBr) t, v. cm 
11 N\IR (-10O villz. ('DCI,) 
FSI-NIS 
Flcmcntal analysis fur  
257-290 °C. 
1694 (C=O), 3384 (NH). 
6 (ppm) 3.35 (6H, s, 2N-CH;), 3.97 (1H, dd. 
J=18.311z, 8.1 Hz, Ile), 4.21 (111, dd, J=18.3 
Hz, 8.7 Hz, HI j, 5.17 (III, t, J= 11.7 I Iz, Hd), 
7.14-7.66 (m. I I H, Ar-H-H ;\ ), 8.17 (s, I H, 
Nil). 
,n;'. 415.15 (VI ) 
Calculated C. 66.56; H, 5.10: N, 1.68; 
('-:1I 2 N.0: 	 Found C. 66.65; H, 5.1 1, ; N. 1.65%. 
209 
3-Il-lltrlro.e►' G-yncr/1tI-?-oso-?-H-Arian-3 .GI)-3-(III-i,Tdult/-3 y1)-ptru;.ulrrc (193e) 
Puntied by rccrvtitalliration from chloroform-methanol (2:3 \' V) mixture. 
Nip. 	 234-237  °C. 
IR iKBr) v: em' 	 : 	1690 (C=O), 3085 (NH), 3199 NH), 3426 
(OH). 
1I NNIR 1400 Nil lz. CDCI:) 	: 	O (ppm) 2.28 (311. s, CH;), 3.66 ((111, dd. 
J=19.0 Hz. 6.0 1-iz. 1-He), 4.01 (1 H, dd, J=19.0 
Hz, 9.8 Hz, Hi), 4.87(1 H, dd, J= 9.7 Hz, 6.0 
Hz. lId), 7.42-8.20 (m, 5H, Ar-H+H), 12.1 
(III, s, NH). 
ESL-AIS 	 : 	nuz 310.17 (M ). 
Elemental anaalvi; for 	 : 	Calculated C, 66.07: H, 4.89: N, 1.35: 
(',-11 •:A:O 	 Found C. 66.10: 11, 4.96. N. 1.30%. 
I -Pitt tt,1- 3-r 1 l:, drrlx,-G-n~etlit l-Z-uxo-?-H-Ayr un-3-} 1)-3-(IH-iitdo1y1-3- 1)-jgvu o1ine 
(19 3/) 
Purified by reerystallizatlon from chloroform-methanol (2:3 \' V) mixture. 
Red crystals 
\1.1). 	 238-240 C. 
IR i KBr) u,,. c ni 	 1695 l('=O), 307$ (NH), 3351 (OH). 
'El \NIR 140() Mllz. ('l)CI:) 	 )(ppm)2.28(31-1, s, CH-,), 3.68 (Ill, dd, J= 
18.8 Hz, 8.0 1-lz, lie), 4.21(1 11. dd, J— 18.8 Hz, 
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12.0 lIz. lift 5.47(1H. dd,J= 12.0 liz. 8.0 
Hz, lid), 6.05(] H. s, I I), 6.80-7.61 (1 OH, iii, 
Ar-H--H.), 8.05 (1H. s. NH), 13.52 (IH, s. 
OH). 
ESI-NIS 	 : 	ni: 386.22 (M) 
Elemental analysis for 	 : 	Calculated C, 71.75: H. 4.97; N, 1.09: 
.11 N O 	 Found C, 71.72; 11, 4.99, N, 1.06. %.  
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Section B: Anti-inflammatory activities 
5.9. REVIEW & LITERATURE 
Inflammation is a defensive response of body, which induces physiological adaptations to 
minimize tissue damage and to remove the pathogenic infections. Such mechanisms 
involve a complex series of cellular and modular events including dilation of arterioles, 
venulcs and capillaries with increased vascular permeability and exudation of fluids 
containing plasma proteins as well as migration of leukocytes into the inflammatory area. 
A chronic inflammation is however an important contributory factor in morbidity and 
mortality. At macroscopic level such inflammatory disorders include rheumatoid arthritis, 
osteoarthritis, inflammatory bowl diseases, retinitis, multiple sclerosis, psoriasis and 
atherosclerosis.' 
In recent years, there is considerable therapeutic interest in novel anti-inflammatory 
drugs with mode of action different from that of the classical non-steroidal anti- 
inflammatory drugs (NSAIDs), mainly for use in patients with arthritis of varying degree 
of severity. The most prevalent side effects of NSAIDs is the occurrence of gastrointestinal 
damage such as gastritis, gastric ulcer, and renal toxicity.2-5  
Therefore, the discovery of new and safer anti-inflammatory drugs represents challenging 
goal for such a research area.' A number of heterocyclic bioactive compounds are used in 
various traditional systems of medicine to relieve inflammation.' The indolc nucleus is 
present in an astonishing variety of natural products endowed with potent and multiform 
biological activities. Indole nucleus is the active principle in a number of natural drugs, 
such as reserpine, strychnine, ergotamine and other alkaloids. Indole and their derivatives 
have been reported to possess wide spectrum of activities of pharmacological importances 
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These pharmacological activities have been the major interest behind the syntheses of the 
indole and their derivatives. Indole ring also constitutes an important template for drug 
design such as the classical NSAIDs indomethacin, tanidap and indoxole.9 
0 
NH, 
OI 	N 
0 OH 	
O 
 
I.domethaoin 	 ludoxnk 	 Icnidap 
In addition, the importance of lead molecules for the discovery of new synthetic drugs, 
several chemical structures are used as a starting point for chemical modifications in order 
to improve potency, selectivity or pharmacokinetic parameters. Furthermore, a systematic 
variation of substituents around the indole ring at 3-position has led to the exploration of a 
large number of potent biologically active compounds.1° A literature survey reveals that 
the compounds with the backbone of chalcone and pyrazolines attached to an indole 
nucleus may show an improved anti-inflammatory activity in carrageenan induced 
inflammation model.' 
Edema formation, leukocyte infiltration and granuloma formation represents such 
components of inflammation.i2 Edema formation in the paw is the result of a synergism 
between various inflammatory mediators that increase vascular permeability or the 
mediators that increase blood flow. 13 
The carrageenan-induced edema in the rat hind paw most widely used for the screening of 
new arrti-inflammatory agents.' Carrageenan is the phlogistic agent of choice for testing 
anti-inflammatory drugs as it is not known to be antigenic and is devoid of apparent 
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systemic eftccts. It has been used to evaluate the effect of anti-inflammatory agents like 
NSAIDs, which primarily inhibits the cyclooxygenase involved in prostaglandin synthesis. 
Thu;. keeping this in view, the present study has been undertaken to investigate the anti-
intl,iinnlatorV activit\ Of' the synthetic heterocyclic compounds (indolyl chalconcs and 
11yrazoline~) by carraeenan induced pa%v edema method. The evaluation of anti-
intlamnlatory activity vas carried out in the Department of Pharmacology, JNMC, Aligarh 
Muslim University, •\lie,ch. 
5.9.1. Screening of anti-intlammator~' activity of indolyl chalcone and pyrazoline 
compounds in rats 
Thy anti-intlaulnlator\ acti\ity of all the synthesised compounds was evaluated using 
ciira c;nan induced pen\ edema assay model of inflammation on \Vi:.tar rats, by adopting 
the method of \inter ei al.'' using aspirin as standard drug. Structure for the compounds 
evaluated for anti-iutlamtnatory activity listed in Scheme 73 and 74. 
5.9.1 a. Animals 
\\'iStar rats (1 50-2(X) _I of either sex were used for anti-inflammatory studies. They were 
housed at the temperature 24 1 ? °C with 12 h light:'dark cycles in polypropylene cages in 
groups of six animals each. The animals were fasted overnight before the experiment and 
given Water ad libitum. The study controncd to the guiding principles of Institutional 
Animal Ethics Committee (I.AIiC). J. N. Medical College, Aligarh, India. 
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5.9.1b. Experimental Design and drug treatment 
fhe animals are weighed and divided into three groups of six animals each. 
Group I- Received 2.5 °/o DMSO in the dose of 2 mLikg. p.o. I h prior to carrageenan and 
served as control. 
Group 1I- Received aspirin in dose of 100 mg/kg. p.o. I h before injection of 
carrageenan. 
Group III to XI — Received test compounds (192a-c and 193a-f) in the dose of 200 
mg/kg. po. I h before injection of'carrageenan. 
5.9.1 c. Carrageenan - induced paw oedema in rats 
The animals were handled gently to avoid too much of stress on them which could result in 
an increased adrenal output. A mark was made at the lateral maleous of the left hind paw 
so that the dipping was done to the same level \\hile measuring the paw volume. After I h 
of administration of a standard and the test compounds. the animals were injected 
subcutaneously with 0.1 mL of freshly prepared suspension of carrageenan (I % 
/V) into the subplantar region of right hind pa\\ of each rats. Immediately 
thereafter, the paw was immersed in water exactly to the mark. The measurement of the 
hind paw volume was carried out using digital Plethysmometer for animals in all the 
groups before treatment and after 1. 2. and 3 h of carrageenan injection. The initial volume 
of a pa\\ 	as measured \\ithin thirty seconds of the injection of carrageenan. The anti- 
inflammator\ activit\ \gas expressed as percent inhibition of the inflammation in the drug 
treated group in comparison with the control group. 
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The percent inhibition of edema was calculated by using the following formula: 
Inhibition — UU(\-l')"Xj'`100} 
X— mean increase in la volume of rats in the control group, 
V - mean increase in pw volume of rats in the treated group 
5.9.2. lndol I chaleoues screened for anti-intlasnmatory activities 
The ,eneml synthetic trate;v employed to prepare indolyl chalcone and indolyl 
h\- razolmm 	analogues were based on Claisen-Schmidt condensation, which has been 
previously explained in section A. 
i~ 	(lil 	 1921) 
~ J 
1. 	
IU.I 
Scheme 73 
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5.9.3. Indolyl pyraiolines screened for in vivo anti-inflammatory activity 
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Scheme 74 
5.9.3 a. Statistical unu/t'%i.% 
\Il the values x%ere expressed as Mean = SEM. Statistical significance was 
calculated by one way :\NOVA iollowcd by post lioc Dunnett's multiple comparison test. 
Rats in each group were six (n=6) and P < 0.05 was considered to be statistically 
sitnniticant. The software SPSS-20 was used to carry out all the statistical tests. 
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5.10. RESULTS 
Carry eeenan indoeced paw edema is one of the most commonly employed method 
fur the screening of acute inflammation. The anti-inflammatory activity was evaluated by 
recrdiiie Illean hind pa' volumes at 0, 1. 2 and 3 hours following carrageenan injection in 
control and test groups. 
'l he results of the anti-inflammatory effect of the indolvl chalcone (1 92a-c)and 
hyrazolincs (193a-t) are presented in Table 24, 25 & 26, 27. As shown in Tables, the 
entire invcstieated compounds (192a-c and 193a-f) exhibited moderate to good anti-
inflammatory activity with the percentage inhibition of edema formation ranged from 41.9 
to 93.5 "o at the end of 3 h. whereas, at the same time, the standard drug aspirin (100 
mg kg) showed 85.4"„ inhibition of inflammation in comparison with control. 
As indicated in Table 24 & 25, the indolvl chalcones 192a, 1921) and 192c decreased the 
paw edema at the end of 1. 2 and 3 h but test compound 192a showed the significant 
decrease in paw edema at I h (P < 0.05) whereas at the end of three hours all the 
compounds exhibited ,1,,nit1cant anti-inflammatory activity (P < 0.01) with the percentage 
inhibition of edema formation ranged from 41.9 to 69.3 % as compared to control group. 
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Fable 24 Et ect of indolvl chalcones compounds on carrageenan Induced paw oedema 
Mean paw volume ± SEM (nil) 
(;roup~ 	 0 11 	 1 11 	 2 Ii 	 3 h 
Control 	0.74±0.005 1.04±0.01 1.15±0.01 1.36±0.005 
l Clill 1:,) 
:aspirin 	0.7t - 0.005 0.94 :- 0.01 * 0.97 -I- 0.01 ** 0.87 -=- 0.005** 
(100 lug kg) 
1 C 	192a 	0.-5 - 0.02 0.93 - 0.02* 0.97 ± 0.02** 0.94 w 0.04** 
(20)) 111,._' 	ke. 
i( 	1921) 	0.79-0.01 0.97-0.02 0.97-0.03* 1.15~- 0.02** 
(20)111 g kg) 
T( 	192c 	0.51 = 0.04 0.97 - 0.03 1.01 ± 0.04** 1.01 = 0.03** 
(20O Ill_, kg) 
TC = Test compound 
* 1' <0.05 	 * * P <0.01 
Each avcraie value represents the mean -- SEM (n=6). 
1 he dhteleIHcz 111 results were considered significant when *pm,l.)J, and ** P<0.01 	its 
compared with the control group. 
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Table 25 Percentage Inhibition of paw edema by indolyl chalcones compounds in 
carrageenan induced paw 
Groups 	 Time intervals 
lh 	 2h 	 3h 
Control (DN1SO) 
(2mlkg) 
Aspirin 
(1 t)t) Inge kg 
TC 192a 
(200 mg kg)  
TC 192b 
(200 m° kg► 
TC 192c 
(200 tnc ke) 
TC — Test compound 
46.6 70.7 85.4 
40.0 46.3 69.3 
36.64 56.0 41.9 
46.6 51.2 67.7 
C%ctiLation of these indoM chalcone into their corresponding pyrazolines also decrease 
the paw edema at the end of I. 2, and 3 h but significant decrease in paw edema was seen 
in compound 193a. 193b. 193f (P < 0.01) and 193d (P < 0.05) at the end of I h. whereas 
at the end of three hours all the compounds exhibited significant decrease in paw edema 
t P 0.01) with the percentage inhibition of edema formation ranged from 60.9 to 93.E %  
a: compared to controlgroup. The percentage inhibition of edema of' indolylpyrazolines 
(193a-f) was found to be greater as compared to their parent compounds (192a-c) Table 
26 & 27. 
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fable 26 hffect of indolvl pyrazolines compounds on carrageenan induced paw oedema 
Mean paw volume 1 SEM (till) 
Groups 0 h 1 h 2 h 3 h 
Control (D11SO) 0.74 =0.005 1.04 ± 0.01 1.15 =.008 1.36 = 0.005 
(2 ml k) 
Aspirin 0.78 =0.005 0.94 = 0.01 * 0.97 ± 0.01 ** 0.87 t 0.005** 
(100 mg kg) 
TC 193a 0.77 - 0.04 0.88 - 0.02** 0.98 	0.03* 0.94 = 0.02** 
(200 in 	k) 
TC 193b 0.06 - 0.02 0.73 = 0.04** 0.75 = 0.02** 0.70 ± 0.02** 
(200 m._ k,-,) 
TC 193c 	0.85 t 0.03 
(200 m;; keg) 
T(.' 193d 	0.0=0.02 
(200 fig kg) 
T('193e 	0.8310.03 
200 m .keg) 
	
0.90 ± 0.02 	0.95 ± 0.03* 	0.91 ± 0.02** 
0.90 = 0.02* 	0.95 = 0.01 ** 	0.91 = 0.02** 
1.01 ± 0.04 	0.96 ± 0.03** 	0.94 ±0.03** 
TC 193f 	U.78 = 0.04 	0.94 0.03** 	0.91 ± 0.04** 	0.87 = 0.04** 
(200 mg kg) 
Tc = lest Compounds 
XP<0.05 	 **1'<0.01 
Each average value represents the mean = SEM (w 6). 
The (11i tercncc in results was considered significant when *P<0.05. and **P<0.01 as 
compared with the control group 
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Table 27 Perccntaige Inb hition of paw edema by indolyl pyrazolines compounds in 
carra zcCnall i iduced paw 
Time Interval 
Groups 	 I h 	 2 h 	 3h 
Control (DNISO) - - - 
(2m1k,) 
~piri» 46.6 70.7 95.4 
10) m<, k,l 
'TC 193a 63.3 48.7 72.5 
(200 m 	k 	) 
TC 193b 76.6 78.0 93.5 
(2I)0 ni 	L'_' 
TC 193c 33.3 39.0 60.9 
(200 m 	k 	) 
TC 193d 43.3 53.6 64.5 
(20O lll'Zrk 
TC 193c 40.0 43.9 70.9 
(200 m 	k i 
TC 193f 46.6 68.2 85.4 
(200m"ki) 
TC = Tc~t compounds 
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5.11. DISCUSSION 
The carraceenan induced paw edema model was used to screen the anti-inflammatory 
activity of the test compounds in acute phase of inflammation. Edema induced by 
c.trra`aeenau is believed to be biphasic: the tirst phase (l Ii) involves the release of 
serotonin and histamine and the second phase (over 3 h) is mediated by prostazlandins, 
cvcluoxy cnase products. Continuity between the two phases is provided by kinins.'` 
An insi,2ht to the anti-inflammatory actix itv with respect to the chemical structure of 
synthesized compound. revealed that compounds having chalcone and pyrazoline moiety 
at 	position of indole nucleus exhibited significant (P < 0.01) anti-inflammatory activity 
when compared with control group. 
Among the indolvl chalconc. compounds (192a) and (192c) with hydroxyl group on the 4 
position of Coummarin and py ran moiety showed good anti-inflammatory activity (P < 0.01) 
at :It,: cud of third hour; alter can'aicenan injection with 69.3 and 67.7 % reduction in the 
1,:i 	IcI:Ia respcetich. t. iilpoond (192b1 also shows significant ail1i-lnf1ammatory 
acn\ itv (P - 0.01) nth 41.9 0 edema inhibition indicating that the presence of groups 
forming hydrogen bonds in compounds (192a) and (192c) may be helpful in snore efficient 
binding with the receptors. 11 hereas the presence of bulky substitution dimethv l group in 
compound 192b reduced the activity Which may be due to the improper attachment with 
the receptor. 
Among the indolyl pyrazolines 1931), 193d and 193f (addition of phenyl hydrazine to 
compound 192a, 1921) and 192c respectively), compound (193b) was found to he highly 
active and exhibited signiticant anti-inflammatory activity (P <0.01) at first, second and 
third hours with 7(~.(, 78.() and 93.5 h reduction of paw volume respectively compared to 
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control group and inflam111atory activity was better than standard drug aspirin which 
decreased paw volume by`5 .4 % at the end o1' ihirLl hour. Compound (193t) and (193d) 
exhibited significant anti-inflammatory activity (P < 0.05) at the end of 1 It with 46.6 o 
and 43.3 % inhibition of paw edema which increases (P <0.01) at the end of second (68.2 
and 53.6 a ul and third hi (\ 5.4 °.'b and 64.5 °,'n) respectt\ CI V. 
On the other hand compounds 193a, 193c and 193e in the pyrazoline series where phenyl 
group was replaced by hydrogen (addition of hydrazine hydrate to 192a, 192b and 192c 
respccti\ elv) also exhibited significant anti-inflammatory activity (P < 0.01) at the end of 
three hrs but to a lesser extent than 193b, 193d and 193E (addition of phenyl hydrazine to 
192a, 1921) and 192c re pecti\ cly) indicating that addition of phenyl hydrazine markedly 
improved the anti-inflammatory activity. Compound (193x) of the coumarin moiety 
shows the significant decrease in paw edema at the end of I (P < 0.05) and third hrs (P < 
0.001) which reduced paw edema by the value of 63.3 and 72.5 °i% respectively, whereas 
compound (193e) and (1 93c) exhibited significant anti-inflammatory activity (P < 0.01) at 
the end of three his with -'0.9 and 60.9 % of edema inhibition. 
From the rctiults it is evident that all the chalcones and pyrazoli nes having indole 
substituent showed significant anti-1nflatrvnlatory activity from first hour onwards and 
reached the maximum at the third hour- and is comparable to that of the standard drug 
(aspirin►. This type of anti-inflammatory activity for this chalcone is understandable since 
tudol, derivatives are known to possess significant atitl-entlainmatog activity and a 
number of drugs belonging to this class are also being used as it NSAIDs. 
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5.12. CONCLUSION 
It I< concluded that all the chalcones and pyrazolines (192a-c and 193a-t) having indole 
moiety showed siunificant anti-inflammatory activity from first hour onwards and reached 
the niasimum at the third hour and is comparable to that of the standard drug (aspirin). 
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ABSTRACT 
NaHSO4-SiO2 is used as an efficient, mild and reusable catalyst for the synthesis of novel heterocyclic 
pyrazole (Sa-h) and pyranyl pyridine (7a-h) derivatives via heterocyclic (3-enaminones (3a-d) under 
thermal solvent-free conditions. The remarkable features of this green, new methodology are high con-
versions, cleaner reaction profile, simple experimental and work-up procedures. Structures of the newly 
synthesized compounds have been elucidated on the basis of elemental analysis and spectral data (IR. H 
NMR. 3C NMR and mass spectrometry). The catalyst is characterized for the first time by using scanning 
electron microscopy-energy dispersive X-ray (SEM-EDX) and powder XRD. The catalyst can be reused 
several times without significant loss of its catalytic activity. 
O 2012 Elsevier B.V. All rights reserved. 
1. Introduction 
Development of new solid-phase (solvent-free) reactions and 
transferring solution phase reactions to solid-phase are subjects of 
recent interest in the context of generating libraries of molecules for 
the discovery of biologically active leads and also for the optimiza-
tion of drug candidates [ 1). Hence, the challenges facing chemist 
this century is to develop new transformations that are not only 
efficient, selective and high yielding but also environmentally 
benign. A solvent-free organic reaction is an important synthetic 
strategy from the viewpoint of green and sustainable chemistry. 
Researchers have demonstrated that the solvent-free organic syn-
theses are generally faster, selective, higher yielding with cleaner 
products, environmentally benign and involve simple operational 
procedure as compared to the classical reaction (2]. 
Heterogeneous catalysts have gained much importance in 
recent years due to economic and environmental considerations. 
These catalysts are advantageous over homogeneous catalysts as 
they can be easily recovered from the reaction mixture by simple 
filtration and can be reused after activation, thereby making the 
process economically viable. A tremendous interest has sparked 
in various chemical transformations promoted by catalysts under 
heterogeneous conditions [3,4(. Silica supported sodium bisulfate 
• Corresponding author. Tel.: -91 9412653054. 
E-mail address: siddiqui ebalUyahoo.co.in (ZN. Siddiqun). 
1381-1169/S - see front matter 2012 Elsevier B.V. All rights reserved. 
htt p:// dx.doi.org/10.1016j.molcata.2012.07.024 
(NaHSO4 -Si02) has been found to be an efficient, inexpensive, non 
toxic, recyclable and ecofriendly heterogeneous catalyst in various 
useful chemical transformations such as protection and deprotec-
tion [5), Knovenagel condensation [6], and Biginelli reaction [7). It 
is also used in the synthesis of dihydropyridines [8]. xanthenes (9J, 
homoallylic amines )l0[. pyrazolines ] 11 J, amides [12). quinazoli-
nones 1131, and imidazoles 114). 
Pyrazole ring is an important structural motif present in numer-
ous pharmacological and agrochemically important compounds. 
including inhibitors of HIV-1 reverse transcriptase (15) and cele-
coxib derivatives as anti inflammatory agent (16). Pyrazoles can 
be synthesized by 1,3-dipolar cycloadditions of diazo compounds 
117). reaction of chalcones and hydrazines [ 18 ], a four-component 
coupling of terminal alkynes, hydrazine, carbon monoxide and 
aryl iodides [ 19( and the direct condensation of 1,3-diketones and 
hydrazines in fluoroalcohol [20]. A variety of other catalysts such 
as H2SO4 (21). polystyrene supported sulfonic acid [22], zirconium 
sulfophenyl phosphonate [23], Sc (OTf)3 1241, Y-zeolite (25), Mg 
(CI04 ) (26] have been also employed to affect this transformation. 
On the other hand, pyridine is one of the most prevalent het-
erocycle being the core fragment of different natural product! 
and pharmaceutical active agents (271. In addition to classics 
pyridine syntheses such as the Krohnke reaction, many nev, 
approaches have been also reported in the literature including 
condensation of amines and carbonyl compounds, cycloadditior 
reactions, multicomponent reaction (28-31) etc. Despite the wide 
range of conceptually different syntheses of pyrazole and pyridine 
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Zn(Proline)2: a novel catalyst for the synthesis of dicoumarols 
Zeba N. Siddiqui* and Farheen Farooq 
Received 29th March 2011, Accepted 23rd April 2011 
DO!: 10.1039/c l cv00l l Oh 
A novel, greener approach was adopted for the synthesis of dicoumarols (3a-j) using Zn(Proline). 
as a mild, non-toxic. Lewis acid catalyst in water employing 4-hydroxycoumarin (1) and 
aromatic heteroaromatic aldehydes (2a-j). The catalytic activity results suggest that the 
methodology adopted offers several advantages such as mild reaction conditions, low loading 
of catalyst, quantitative yields, short reaction time and operational simplicity. 
PAPER 
Introduction 
Dicoumarol I la) (Scheme 1) is it naturally occurring anticoagulant 
drug that functions as a vitamin K antagonist. Chemically. it 
is designated as 3.3'-methvlenehis[4-hydroxycoumarin] and 
obtained from metabolism of coumarin in the sweet clover 
(Melilutus alhu and Afeli(ottcc ofcinulis) by bacteria Pcnic•illiurn 
nigric•ans and Penicillium jensi.'•2 Dicoumarol and its synthetic 
derivative warfarin sodium (coumadin) have shown to decrease 
metastases in animal models.; Moreover, warfarin sodium 
therapeutically as an anticoagulant has emerged as one of the 
most substantial classes of drugs for the treatment of a variety 
of cancers and has shown to improve tumor response rates.''' 
In clinical trials, such compounds have also demonstrated to 
have some activity against prostate cancer. malignant melanoma. 
and metastatic renal cell carcinoma.7 "A recent study has revealed 
that the inhibition of NAD (P) H: quinone oxidoreductase 
(NQO,) with dicoumarol induces cell killing and oxidative stress 
in pancreatic cancer cells.'0 Further, lanthanum(ut) complexes 
of dicoumarol have been reported to show potent cytotoxic 
activity.' 1 Compounds with this ring system also possess 
various other pharmacological activities such as insecticidal, 
anthelmintic. hypnotic, antifungal, phytoalexin. HIV proteases 
inhibition, antimicrobial and antioxidant.'2-'9 During the last 
decades, several methods have been adopted for the synthesis 
of this important class of compounds and include use of DBU 
(1,8-diartbicyclo[5.4.0]undec-7-ene),20 (Et 2AICl,).2 ' refluxing 
ethanol or acetic acid. =` molecular iodine,'' POCI1 in dry DM F.24 
OH OH 
la 
Scheme I Structure of dicoumarol. 
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manganous chloride,25 and thermal solvent free reaction con-
ditions26 etc. However, in spite of their potential utility some 
of the reported methods suffer from certain drawbacks such as 
long reaction time, expensive reagents, harsh conditions, low 
product yields and use of toxic catalysts that are harmful to 
environment. Therefore, to avoid these limitations there is still 
a need for the development of a new protocol for the synthesis of 
dicoumarol derivatives in terms of operational simplicity, reusa-
bility of the catalyst and economic viability. 
The current environmental concerns encourage development 
of greener reaction conditions, where possible, and the tight 
legislation on the maintenance of green conditions in synthetic 
processes that insist on preventing the generation of waste products, 
avoiding the use of hazardous organic solvents, and minimizing 
the energy requirements. 27 The use of aqueous reaction media 
has received considerable attention in the context of green 
chemistry. During recent years. water has attracted great interest 
as an inexpensive and environmentally benign solvent due to 
its specific properties.' When organic compounds are suspended 
in water, their relative insolubility causes them to associate, 
diminishing the water-hydrocarbon interfacial area.293° In 
other words, the hydrophobic effect of water generates internal 
pressure and promotes the association of the reactants in the 
solvent cavity during the activation process and accelerates the 
1112 reaction: 
Lewis-acid catalyzed organic reactions in water have attracted 
much attention in organic synthesis because they allow environ-
mentally friendly processes under mild reaction conditions." 
Proline is the most prominent amino acid for the coordination 
of Zn, its secondary amino group and carhoxylate function 
being ideally suited for Zn2 in low coordination number, which 
makes Zn complex a moderately soft Lewis acid. Zn(Proline)2 
is an efficient, stable, inexpensive. recyclable, water compatible. 
Lewis acid catalyst which is not dissociated under reaction 
conditions." This complex is soluble in water hut insoluble in 
organic solvents, which allows simple and quantitative recovery 
of the catalyst." Zn(Proline), appears to be a particularly 
efficient catalyst for both enamine and enolate type catalyses.;c' 
Among the various zinc-amino acid complexes. the Zn(Proline)2 
810 1 Catal. Sci. Technol., 201 1, 1, 810-816 	 ~. ,,:,~ ,. • ; ;,~ c :1• 	- .. u > I 
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A practical one pot synthesis of novel 2-hydroxy-4-chromanone 
derivatives from 3-formylchromone 
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Abstract. A one pot synthesis of 4-chmntanone derivatives (Sa—j) is described using Zn((L)(proline)]2 as 
catal'st in aqueous media. The compounds have been characterized on the basis of elemental and spectral 
data SIR, 'H NM R  and mass). The adsantages of this pnnocul include high yields, mild reaction conditions, 
ens ironmentally benign and simple operational procedure. The use of water as solvent and Znf (l.)prolinel, as 
recyclable, non-toxic catal\ si make such sN nthesis a truly green pnxcess. 
Keywords. 3-Forntvlchrontone: "Zn((I.tprolinej,, -t-chrosnanone: water: ;green synthesis. 
1. Introduction 
Chromone moiety forms an important component of 
pharrnacophores of it number of biologically active 
molecules of synthetic as well as natural origin.' 
Chromone and their derivatives are found in nature 
as pigments in plant leaves and bowers. They are 
important for the synthesis of various oxygen heterocy-
cles including xanthones and transition metal chelates. 
They are widely present in nature and exhibit low toxi-
city along with a wide variety of useful properties. ' They 
are reported to exhibit significant biological activities 
including anti inflarnnmatory. 	antiallergic.' antibacte- 
rial,'' ncuroprotective, anti HIV,' antioxidant.'' anti-
fungal. "' etc. They also display spasmolytic, car-
diotonic, antiarrhythmic" and anticancer properties.'' 
3-Forms Ichromone (4-oxo-4H- I -benzopyran-3-car-
boxaldehyde) has been frequently y used for the svn-
thesis of various heterocyclic derivatives ever since its 
convenient synthesis was reported by Nohara et al.' 
Derivatives of 3-formvl chromone are useful synthetic 
building blocks in both organic and medicinal chem-
istry.' ` 3-Formvlchromone has been chosen for the 
present study due to the reason that it carries three elec-
tron deficient centres viz. a.f -unsaturated keto func-
tion. a carbonyl group in the form of formyl group at 
position 3 and a sery reactive electrophilic centre at 
C-2. In the present paper. the products (chromanones) 
of reaction of 3-formvlchromone with primary aro- 
`For correspondence 
matic/heteroaromatic amines under green reaction con-
ditions have been invcstigated. It is pertinent to men-
tion that chromanones represent an important group 
of compounds which display it remarkable domain of 
biochemical and pharmacological actions. They have 
been examined for antioxidant.' antibacterial, "' anti-
malarial.' anticancer. ' antifungal,'' topoisomerase 
inhibitor, "' psychoanaleptic. antianloebic and antide-
pressant properties.'' Some chromanone derivatives 
have been evaluated for in vitro antiviral activities 
against human immunodeficiency virus (HIV) and 
Simian immunodeficiency virus (SIV).'~ ~' They have 
also been claimed to be active in photosynthesis'' and 
have hereditary bleaching effect (similar to antibiotics) 
on the plastid system of Euglena s,'racilis..` Other 4-
chromanone derivatives have also been found useful in 
the treatment of bronchial asthma. 
As it result, for the synthesis of 4-chromanone deriva- 
tives different methods have been developed. 	These 
methods have certain drawbacks such as prolonged 
reaction time. use of toxic and volatile organic solvents 
and varied yields. The replacement of these hazardous 
solvents with the environmentally benign solvents is one 
of the key areas of green chemistry. Among various 
green solvents, water is the most popular as it is inex-
pensive. thermally stable, recoverable, biologically com-
patible, and non-toxic. In recent years. water-mediated 
organic synthesis has become one of the most impor-
tant aspects in organic chemistry in order to meet the 
environmental demands. -"' '['his strategy becomes one 
of the most powerful green chemical technologies if such 
reactions could be carried out using homogeneous or 
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KEYWORDS 	 Abstract Two novel halopyrazole derivatives (3, 5) were synthesized from 5-chloro-3-methyl-l- 
5-Chloro-3-methyl-l-phenyl- 	phenvlpyrazole-4-carboxaldehvde (t) using appropriate synthetic routes. Newly synthesized com- 
pyrazole-4-carboxaldehyde: pounds were characterized using elemental analysis, spectral data (IR, 'H NMR. '`C NMR and 
Pyrazoics; 	 mass spectrometry) and were evaluated for their in vitro antimicrobial activity. The minimum inhib- 
Antibacterial activity: 	 itory concentration (MIC), minimum bactericidal concentration (MBC) and minimum fungicidal 
Antifungal activity concentration (MF(') were determined for the test compounds as well as nix reference standards. 
The investigation of antimicrobial screening revealed that compounds (3, 5) showed good antibac-
terial and antifungal activities, respectively. 
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1. Introduction 
In recent years. the number of life-threatening infectious dis-
eases caused by multi-drug resistant Gram-positive and 
Gram-negative pathogen bacteria has reached an alarming le-
vel in many countries around the world (Berher et al., 2003; 
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Mitscher et al., 1999). Morbidity and mortality because of en-
teric bacterial infection are the major health problems in some 
areas like the Indian subcontinent, portions of South America 
and tropical fraction of Africa (Qadri et al., 2005: I)evasia 
et al., 2(X16). Every year millions of people are being killed 
by some or the other Gram-positive and Gram-negative strains 
of bacteria. These bacteria mostly lead to food poisoning, 
rheumatic, salmonellosis and diarrhea (Khan et al.. 2008). 
Thus, antibiotics provide the main basis for the therapy of 
microbial (bacterial and fungal) infections. However, overuse 
of antibiotics has become the major factor for the emergence 
and dissemination of multi-drug resistant strains of several 
groups of microorganisms (Harbottle ct al.. 2006). Further-
more. the pharmacological drugs available are either too 
expensive or have undesirable side effects or contraindications 
(Berger. 19S5). Thus, in light of the evidence of rapid global 
spread of resistant clinical isolates, the need to find new anti-
microbial agents is of paramount importance. 
r 
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A highly efficient, simple, and ecofriendly microwave-induced synthesis of indolyl chalcones and 
pyrazolines 
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One-pot synthesis of indolyl chalcones (3a—c) employing indole-3-carboxaldehyde (I) and heteroaryl active 
methyl compounds (2a-'e) under microwave irradiation is described. The indolyl chalcones (3a-c) are transformed 
into medicinally important pyrazolines (5a—f) using different hydrazines. Application of microwave irradiation 
leads to many remarkable advantages, such as solvent- and catalyst-free reaction conditions, simple work up 
procedure. shorter reaction time, in addition to ecofriendly 'green chemistry' economical and environmental 
impacts. 
Keywords: green chemistry: microwave irradiation; indole-3-carboxaldchyde; chalcones; pyrazolines 
Introduction 
In recent years, green chemistry has been focus of 
considerable attention and is becoming an increasingly 
popular technology (1). The aim of green chemistry 
is to reduce chemical-related impacts on human 
health and virtually eliminate contamination of the 
environment through dedicated sustainable preven-
tion program. For organic reactions there is an urgent 
need for reducing toxic, volatile solvents in use. Many 
green synthetic methods have been studied by different 
researchers for the synthesis of it variety of organic 
molecules (2). Microwave irradiation is a newly 
established, convenient synthetic method and con-
tinues to affect synthetic chemistry significantly by 
enabling rapid, reproducible, and scaleable chemistry 
development (3,4). This technique has been applied 
to a variety of reactions resulting in reduction of 
reaction time, higher yield, greater selectivity, cleaner 
reaction products, and easier manipulations (5). It also 
provides an opportunity to work with open vessels. 
thus avoiding the risk of high pressure and hazards of 
inflammable solvents (6). 
Indole nucleus annulated to carbocyclic and 
heterocyclic ring(s) is one of the most ubiquitous 
scaffolds found in an astonishing variety of pharma-
ceuticals (7), functional materials (8-10), agrochern-
icals (11), and alkaloids (12) endowed with potent and 
multiform biological activities. They are also reported 
to possess anti-inflammatory (13), antimicrobial (14), 
antifungal (15), antioxidant (16), etc. activities. Indole  
derivatives display diverse variety of pharmacological 
activities that are useful in the treatment of 
fibromyalgia, chronic fatigue, and irritable bowel 
syndrome (17-19). Besides being biologically active. 
they are also used extensively as synthons in organic 
synthesis that possess potentially reactive 
site for a variety of chemical reactions. Indole-3-
carboxaldchyde is a naturally occurring component of 
Brassica vegetables (cabbage, broccoli). It induces a 
G- I cell cycle arrest of human breast cancer (20). The 
diversity of the iodole nucleus has motivated research 
aimed at the development of new economical efficient 
and selective synthetic strategies. As a part of our 
ongoing research work in the identification of new 
chemical entities (21) with variety of pharmacological 
activities, we herein report microwave-assisted access 
to a series of indolyl chalcones and their conversion to 
other heterocycles like pyrazolines from indole-3-
carboxaldchyde and demonstrate its superiority over 
classical heating methods. It is worth mentioning 
that chalcones are the precursor of flavonoids, 
isoflavonoids, and have displayed an impressive array 
of biological activities (22-25). Particularly, indolyl 
chalcones have been reported as anti-inflammatory 
(26), antiproteolytic (27), anthelmintic (28), anti-
cancer (29), and antiproliferative (30). They are also 
reported as antitumor, immunodepressant, carcino-
genic, and therapeutic agents for autoimmune diseases 
(31), whereas pyrazolines are pharmacologically ac-
tive compounds and have been reported to possess 
antiandrogenic (32), antibacterial (33), antifungal 
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